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Abbreviations used in this thesis without definition
include:
PBS: Phosphate buffered Saline, pH7.4.
BFU-E: Blast forming unit erythroid.
GM-CFC: Granulocyte macrophage colony forming cell.
SDS-PAGE: Sodium dodecyl Sulfate polyacrylamide gel 
electrophoresis.
Kb: Kilo-base.
dNTPs: deoxyribonuc1eotides (dATP, dTTP, dCTP, 
dGTP).
DMEM: Dulbecco's minimal essential medium.
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Abstract
The aim of this thesis was to isolate the cDNA 
for the murine IL-3 and to express it in eukaryotic 
and prokaryotic systems.
The WEHI-3B cell line was used as the main source 
of IL-3 mRNA. A sensitive assay for IL-3 mRNA was 
developed using microinjection of X e n o p u s 1 a e vis 
oocytes. The IL-3 secreted from the oocytes was 
assayed using the IL-3 dependent cell line 32Dcl-23.
IL-3 mRNA was partially purified by 10-20 fold on 
sucrose density gradients. The enriched IL-3 mRNA was 
then used for the construction of the cDNA library 
which was screened using the hybridization-translation 
method. A short cDNA clone, pILMl, was isolated. An 
oligonucleotide corresponding to the pILMl cDNA insert 
was synthesized and used as a probe to screen a second 
cDNA library which was enriched for longer cDNA 
clones. A longer clone, pILM3, carrying the entire 
coding sequence for murine IL-3 was isolated. The 
cDNA insert of pILM3 codes for a polypeptide of 166 
amino acids including a signal peptide of possibly 27 
amino acids. The predicted protein sequence of mature 
processed IL-3 indicates a MW of 15,102 with four 
potential N-g1ycosy1 ation sites. The N-terminal 
sequence of the mature IL-3 (Ihle et al., 1983a) is in
(v)
complete agreement with the reading frame but starts 
at residue 33 suggesting an additional proteolytic 
cleavage has occurred apart from the cleavage of the 
signal peptide.
The pILM3 cDNA insert carrying the coding 
sequence for IL-3 was subcloned into an SV40 
expression vector (pSV2-neo). The recombinant 
expression plasmid, pILM4, was microinjected into the 
nucleus of the X e n o p u s oocytes and also used for the 
transformation of monkey COS cells. In both cases, 
b i o l o g i c a l l y  a c t i v e  IL-3 was p roduced. The 
recombinant IL-3 produced from the pILM4 transformed 
monkey COS cells was used to study the biological 
activities of recombinant IL-3. The recombinant IL-3 
supported growth of the IL-3 dependent cell lines 
32Dcl-23 and FDC-P1, induced 20aSDH in splenic 
lymphocytes from nu-nu mice and showed multilineage 
hemopoietic growth factor activity.
The IL-3 cDNA was also expressed in E. c o 1 i as a 
mature protein starting with residue 28 (Serine) or as 
a fused polypeptide with an extra 9 amino acids and 
starting with the residue 27 (Alanine). In both 
cases, the expressed IL-3 was biologically active. 
This indicated that glycosylation is not essential for 
biological activity and that the expression in 
bacteria is feasible. The IL-3 expressed as a mature
( V i )
p r o t e i n  w a s  l e s s  s t a b l e  t h a n  t h e  
p o l y p e p t i d e .
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This chapter briefly reviews relevant literature 
prior to the commencement of the work described in 
this thesis. More recent work pertaining to this area 
of research will be reviewed in the Discussion 
(Chapter 5) together with the results of the thesis.
A. A general review of interleukin-3.
1.1 Introduction.
The immune response to antigen depends on a 
network of interactions between the various leukocytes 
of the blood and lymphatic systems. Regulation of 
these interactions has been shown to be mediated, at 
least in part, by chemical ’messengers’ secreted by 
the cells involved. The generic name of ’lymphokines’ 
was initially proposed by Dumonde et al. (1969) for 
these chemical messengers, because the first to be 
described were produced by antigen-stimu1ated T- 
lymphocytes. Similar factors produced by cells of the 
macrophage/monocyte series have likewise become known 
as 'monokines'.
Lymphokines and monokines have traditionally been 
defined on the basis of their biological activity in a 
particular assay, rather than on the basis of
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d e f i n i t i v e  b i o c h e m i c a l  a n d  b i o l o g i c a l  p r o p e r t i e s .  The  
p r a c t i c e  o f  n a m i n g  s u c h  f a c t o r s ,  l i k e  l y m p h o c y t e ­
a c t i v a t i n g - f a c t o r  ( LAF )  ( G e r y  a n d  H a n d s c h u m a s c h e r , 
1 9 7 4 )  a n d  T - c e l l  g r o w t h  f a c t o r  (TCGF)  ( Ko o p ma n  e t  a l . ,  
1 9 7 8 ) ,  w i t h  a c r o n y m s  a f t e r  a c t i v i t i e s  p e c u l i a r  t o  
v a r i o u s  b i o a s s a y  s y s t e m s  h a s  g e n e r a t e d  a n  u n s y s t e m a t i c  
n o m e n c l a t u r e .  To t r y  a n d  r e m e d y  t h i s ,  a n e w t e r m  
' i n t e r l e u k i n '  wa s  p r o p o s e d  i n  t h e  S e c o n d  I n t e r n a t i o n a l  
L y m p h o k i n e  Wo r k s h o p  ( E r m a t i n g e n ,  S w i t z e r l a n d ,  May 2 7 -  
3 1 , 1 9 79  ) t o  n a m e  t h o s e  f a c t o r s  t h a t  a c t  a s  
c o m m u n i c a t i o n  s i g n a l s  b e t w e e n  d i f f e r e n t  p o p u l a t i o n s  o f  
l e u k o c y t e s  ( A a r d e n  e t  a l . ,  1 9 7 9 ) .
I n t e r 1 e u k i n - 1 ( I L - 1 )  a n d  i n t e r 1 e u k i n - 2  ( I L - 2 )  
w e r e  d i s t i n g u i s h e d  by t h e i r  b i o c h e m i c a l  p r o p e r t i e s  a n d  
b i o l o g i c a l  a c t i v i t i e s .  I L - 1  w a s  d e f i n e d  a s  a 
m a c r o p h a g e  d e r i v e d  f a c t o r  w i t h  a m o l e c u l a r  w e i g h t  o f  
1 2 , 0 0 0 - 1 8 , 0 0 0  w h i c h  p l a y s  a n  e s s e n t i a l  r o l e  by  
f a c i l i t a t i n g  t h e  p r o d u c t i o n  o f  o t h e r  l y m p h o k i n e s  by 
h e l p e r  T c e l l s  ( L a r s s o n  e t  a l . ,  1 9 8 0 ;  S m i t h  e t  a l . ,  
1 9 8 0 a ,  b ) .  I L - 2  w a s  d e f i n e d  a s  a f a c t o r  w i t h  a 
m o l e c u l a r  w e i g h t  o f  3 0 , 0 0 0 - 3 5 , 0 0 0  w h i c h  a p p e a r s  t o  
m e d i a t e  t h e  d i f f e r e n t i a t i o n  a n d  a m p l i f i c a t i o n  o f  
c y t o t o x i c  T c e l l s  ( M o r g a n  e t  a l . ,  1 9 7 6 ;  G i l l i s  a n d  
S m i t h ,  1 9 7 7 ;  W a t s o n  e t  a l . ,  1 9 7 9 ;  N a b h o l z  e t  a l . ,  
1 9 8 0 ) .
A n o t h e r  g r o u p  o f  f a c t o r s  w h i c h  i s  r e l e v a n t  t o  
t h i s  r e s e a r c h  i s  t h e  f a m i l y  o f  h a e m o p o i e t i c  r e g u l a t o r s
- 3 -
c a l l e d  c o l o n y  s t i m u l a t i n g  f a c t o r s  ( C S F ’ s ) .  T h i s  
n o m e n c l a t u r e  d e r i v e s  f r o m  t h e  a b i l i t y  o f  t h e s e  f a c t o r s  
t o  s t i m u l a t e  t h e  d e v e l o p m e n t  o f  c o l o n i e s  o f  
d i f f e r e n t i a t e d  c e l l s  f r o m  c o m m i t t e d  p r o g e n i t o r  c e l l s  
i_ n_ I Ü I £  . F o u r  d i f f e r e n t  C S F ’ s h a v e  b e e n  
d i s t i n g u i s h e d  by M e t c a l f  ( 1 9 8 1 )  v i z .  M-CSF,  GM-CSF,  G-  
CSF a n d  m u l t i - C S F .  T h e  CSF o f  m o s t  r e l e v a n c e  t o  t h e  
p r e s e n t  w o r k  i s  m u l t i - C S F  ( i n t e r l e u k i n - 3 ) .
1 . 2  I n t e r l e u k i n - 3 .
I h l e  e t  a l .  ( 1 9 8 1 )  d e s c r i b e d  w h a t  t h e y  b e l i e v e d  
t o  be a u n i q u e  l y m p h o k i n e  n a me d  i n t e r l e u k i n - 3  ( I L - 3 ) ,  
w h i c h  wa s  i s o l a t e d  a n d  p u r i f i e d  f r o m  C o n A - s t i m u l a t e d  T 
l y m p h o c y t e s  a n d  w h i c h  c o u l d  i n d u c e  t h e  e x p r e s s i o n  o f  
2 0 - a - h y d r o x y s t e r o i d  d e h y d r o g e n a s e  ( 20aSDH)  i n  s p l e n i c  
l y m p h o c y t e s  f r o m  a t h y m i c  m i c e  ijn v i t r o . A c o n v e n i e n t  
s o u r c e  o f  I L - 3  w a s  f o u n d  t o  b e  t h e  WE H I - 3 B  c e l l  l i n e  
( W a r n e r  e t  a l . ,  1 9 6 9 ) ,  a m y e l o m o n o c y t i c  l e u k e m i a  l i n e  
w h i c h  p r o d u c e s  r e l a t i v e l y  h i g h  l e v e l s  o f  I L - 3  
c o n s t  i  t  u t  i  v e 1 y ( H a p e l  e t  a l . ,  1 9 8 1 ;  L e e  e t  a l . ,  1 9 8 2 ) .  
I L - 3  c a n  a l s o  be  o b t a i n e d  f r o m  l e c t i n -  o r  a n t i g e n -  
s t i m u l a t e d  T l y m p h o c y t e s  a n d  a n u m b e r  o f  T c e l l  
l y m p h o m a  a n d  h y b r i d o m a  l i n e s  ( I h l e  e t  a l . ,  1 9 8 1 ;  
I s c o v e  e t  a l . ,  1 9 8 2 ,  Yu n g  e t  a l . ,  1 9 8 1 ;  C l a r k - L e w i s  
a n d  S c h r a d e r ,  1 9 8 1 ) .
WE H I - 3 B  c o n d i t i o n e d  m e d i u m  a l s o  p o s s e s s e s  a 
v a r i e t y  o f  o t h e r  C S F - t y p e  a c t i v i t i e s ,  v i z .  b u r s t
- 4-
promoting activity (BPA) (Iscove et al., 1982); P-cell 
stimulating factor (PSF) (Clark-Lewis and Schrader, 
1981); mast cell growth factor (MCGF) (Yung et al., 
1981); hemopoietic cell growth factor (HCGF) (Bazill 
et al., 1983); histamine producing cell stimulating 
factor (HCSF) (Dy et al., 1981); and multicolony- 
stimulating factor (Multi-CSF) (Metcalf, 1981). At 
the commencement of the work described in this thesis 
there was already general agreement that many, if not 
all, of these activities could be attributable to a 
single factor and that IL-3 was a CSF. In terms of 
biochemical characterization of this factor, the most 
extensive characterization was of IL-3 from WEHI-3B 
cells by Ihle et al. (1982a, 1983a). Since we used 
the WEHI-3B cell line as the source of mRNA for 
cloning exper i m e n ts  and because IL-3 is a more 
systematic name it will be used in preference to the 
alternatives throughout this thesis.
1.3 Biochemical properties of interleukin-3.
IL-3 was r e c e n t l y  p u r i f i e d  to a p p a r e n t  
homogeneity (Ihle et al., 1982a; Ihle et al., 1983a). 
The purification procedure described results in a 
1,800,000-fold purification, with yields of 5-10% of 
the initial activity and gives 2-10yg of IL-3 from 150 
litres of WEHI-3B conditioned medium. The molecular 
weight of IL-3 was reported to be approximately 28,000
- 5-
when analyzed using SDS-PAGE. The specific activity 
of the purified IL-3 was from 0.05ng/unit (Ihle et 
al., 1982a) to 0.2ng/unit (Ihle et al., 1983a). The 
NH2~terminal sequence reported for the homogeneous IL- 
3 was: Asp-Thr-His-Arg-Leu-Thr-Arg-Thr-Leu (Ihle et 
al., 1983a). Comparison with known protein sequences 
indicated that the Nl^-terminal sequence of IL-3 was 
unique.
1.4 Biological activities of IL-3.
IL-3 was initially defined as the factor in 
conditioned media from C o n A - stimu 1 ated splenic 
lymphocytes that induces 20aSDH in culture of nu/nu 
splenic lymphocytes (Ihle et al., 1981). Although it 
was originally proposed that 20aSDH was a specific T 
cell marker, it is now clear that this enzyme is also 
found in myeloid and stromal cell lines (Schaffar- 
Deshayes et al., 1983; Garland and Dexter, 1982; see 
Discussion). Thus the induction of 20aSDH is not a 
satisfactory definition of IL-3. Recently the 
biological activities of IL-3 were studied using 
highly purified IL-3 from WEHI-3B conditioned medium 
(Ihle et al., 1983a). It was demonst ra te d  that 
purified IL-3 showed a typical dose-response curve in 
all the assays for WEHI-3B growth factor, mast cell 
growth factor (MCGF), P-cell stimulating factor (PSF), 
histamine-producing cell-stimulating factor (HCSF) and 
co1ony-stimu1 ating factor activities (CSF) (Ihle et
- 6-
al., 1983). These results taken together with the 
data obtained with cDNA clones encloding IL-3 (see 
below) indicate that IL-3, burst promoting activity 
(Iscove et al., 1982), histamine- producing cell- 
s t i mu l a t in g  factor (Dy et al., 1981), P-cell 
stimulating factor (Clark-Lewis and Schrader, 1981), 
multi-CSF (Metcalf, 1981), hemopoietic cell growth 
factor (Bazill et al., 1983) are alternative names for 
the same polypeptide.
The spectrum of biological activities observed 
for IL-3 indicate that it supports the growth of cells 
in all hemopoietic lineages i_n vitro including early 
precursors which are still pluripotent. It is thus 
the most broadly acting member of the family of 
hemopoietic growth factors identified to date and 
could potentially regulate hemopoiesis jLn vivo.
1.5 IL-3 dependent cell lines.
Greenberger and his coworkers first reported that 
continuous cell lines could be established from 
Moloney retrovirus-infected long term bone marrow 
cultures using WEHI-3B conditioned media (Greenberger 
et al., 1979). Because of the dependency on the WEHI- 
3 conditioned medium, the cells were termed ’factor- 
dependent'. Subsequently, both Greenberger (1980) and 
Dexter et al. (1980) found that viral infection was 
not necessary to obtain f ac to r-dependent cells.
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Several of these factor-dependent cell lines were 
examined for the ability of IL-3 to support their 
growth. Partially purified IL-3 did support the 
growth of C3Hffv, 32Dcl-23 and FDC-P1 lines (Ihle et 
al., 1982b; Hapel et al., 1982) and these cell lines 
responded in a dose dependent way to IL-3.
1.6 Hemopoietic growth regulators related to IL-3.
A number of glycoprotein growth factors active on 
cultured mouse hemopoietic cells have been described 
which are biochemically distinct from IL-3. Most of 
these act individually on cells in only one or two of 
the various hemopoietic lineages (Nicola and Vadas, 
1984). For example erythropoietin (Miyake et al., 
1977), M - C S F , CSF-l(Tertian et al., 1981) and GM-CSF 
(Burgess et al., 1981). GM-CSF is the most closely 
related to IL-3 in terms of its biological activity. 
Both GM-CSF and IL-3 are produced by antigen- or 
m i togen-stimu1ated T lymphocytes and also by T-cell 
hybridomas and T-cell lymphomas (Burgess et al., 
1981). However, no GM-CSF is produced by the WEHI-3B 
cell line. Although GM-CSF can also support the 
growth of the macrophage-granu1ocyte precursors, it 
differs from IL-3 in not supporting mast cell growth 
(Clark-Lewis and Schrader, 1981) or the formation of 
eosinophil (Clark-Lewis and Schrader, 1981), or 
megakaryocyte colonies (Iscove et al., 1982). GM-CSF
- 8-
is r e a d i l y  s e p a r a t e d  f ro m  IL-3 by c o l u m n  
chromatography because it is more strongly retarded 
than IL-3 on DEAE at pH7.2 in low salt (Ihle et al. , 
1983a; Burgess et al., 1977).
B. Recombinant DNA approaches to lymphokine biology.
As can be seen from the discussion of the 
biochemical properties of IL-3, purification of 
lymphokines by conventional biochemical methods is 
quite difficult due to the minute amounts of material 
available and their very high biological activities 
(50% activity at approx 10 Even after extensive
purification there is still the problem that part of 
the b i o l o g i c a l  a c t i v i t i e s  o b s e r v e d  might be 
attributable to other contaminating factors.
A complementary approach is to isolate cDNA 
clones encoding the lymphokine. This enables 
definition of the lymphokine from its predicted 
protein sequence and the biological properties of 
’recombinant' lymphokine which can be determined after 
expression of the cDNA clones in eukaryotic or 
prokaryotic systems. P roduction of recombinant 
lymphokines on a large scale enables wide ranging 
biological studies to be carried out including 
clinical trials in the case of human lymphokines. The 
availability of cDNA clones opens up the approach of 
site directed mutagenesis for structure/function
- 9-
studies and enables research on lymphokine gene 
expression and rearrangements to be done.
At the commencement of the work described in this 
thesis, recombinant DNA techniques had been applied to 
two of the lymphokines produced by antigen-activated T 
lymphocytes, viz. y-interferon and interleukin-2.
1.1 Isolation of cDNA clones encoding y-interferon.
Human immune interferon (IFN-y) cDNA clones have 
been isolated by two groups (Gray et al., 1982; Devos 
et al., 1982). In both cases, enriched human IFN-y 
mRNA was used to construct the cDNA library. Total 
mRNA was fractionated by electrophoresis on denaturing 
agarose gels (Gray et al., 1982) or by sucrose 
gradient centrifugation (Devos et al., 1982). The 
IFN-y mRNA activity was determined by injecting 
aliquots of each fraction into Xenopus laevis oocytes 
(Gray et al., 1982; Devos et al., 1982). The IFN-y 
mRNA was enriched about 20 fold (Gray et al., 1982) or 
10-30 fold (Devos et al., 1982). Two different 
methods, differential hybridization and hybridization- 
translation were used by Gray et al. (1982) and Devos 
et al. (1982) respectively to isolate the human IFN-y 
cDNA clones. The frequency of the IFN-y mRNA in total 
mRNA was estimated to be about 1:2,400 (Gray et al., 
1982). The DNA sequence of the cDNA clone codes for a 
polypeptide of 166 amino acids, the first 20 of which
- 10-
coraprise a signal peptide (Gray et al., 1982; Devos et 
al., 1982). The encoded amino acid sequence has two 
potential g1ycosy1 ation sites and is quite basic in 
character.
Identification of the sequence as IFN-y was 
confirmed by expression of the cDNA clone in bacterial 
(Gray et al., 1982) and mammalian cells (Gray et al., 
1982; Devos et al., 1982). The expression of IFN-y in 
bacterial cells was performed by joining the cDNA 
sequence starting from amino acid 21 in phase with the 
t r p promoter (Gray et al., 1982). For the expression 
of IFN-y in mammalian cells, the whole cDNA sequence 
was cloned after the SV40 late promoter in the same 
orientation (Gray et al., 1982; Devos et al., 1982). 
In both systems the expression product was shown to 
have antiviral activity which was imm un o 1ogica 11y 
indistinguishable from that of the IFN-y produced by 
stimulated human lymphocytes.
1.2 Isolation of cDNA clones encoding interleukin-2.
cDNA clones coding for human interleukin-2 (IL-2) 
were isolated from a cDNA library using similar 
methods to those used to isolate the human IFN-y cDNA 
clones (Taniguchi et al., 1983; Devos et al., 1983). 
The human IL-2 mRNA from Jurkat III cell line 
(Taniguchi et al., 1983) or from normal splenocytes 
(Devos et al., 1983) was enriched about 10 fold
- 1 1 -
( T a n i g u c h i  et al. , 1 983) by s u c r o s e  g r a d i e n t
c e n t r i f u g a t i o n .  IL-2 m R N A  a c t i v i t y  was assayed by 
t r a n s l a t i o n  in the X e n o p u s 1 ae vis oocytes. A cDNA 
l ibrary was c o n s t r u c t e d  f r o m  the e n r i c h e d  IL-2 mRNA  
and the plasmid containing the cDNA copy of human IL-2 
was i d e n t i f i e d  by the h y b r i d i z a t i o n - t r a n s 1 a t i o n 
method. The frequency of the human IL-2 mRNA in total 
m R N A  was e s t i m a t e d  to be 1:20,000 (Taniguchi et al., 
1983). The DNA s e q u e n c e  of the cDNA codes for a 
p o l y p e p t i d e  of 153 a m i n o  acids. The first 20 a m i n o  
acids p r o b a b l y  c o m p r i s e  the signal peptide. The 
d educed a m i n o  acid s e q u e n c e  conta i n s  no p o t e n t i a l  
g 1 y c o s y 1 a t i o n  s ites. A l t h o u g h  the a m i n o  a c i d  
s e q u e n c e s  d e d u c e d  from the DNA s e q u e n c e s  of the cDNA 
clones o b t a i n e d  by T a n i g u c h i  et al. (1983) and by 
Devos et al. (1983) are the same, there is one base 
different between their DNA sequences.
The cDNA was cloned after the SV40 early promoter 
in the sam e  o r i e n t a t i o n  and was e x p r e s s e d  in m o n k e y  
COS cells. The e x p r e s s i o n  product had b i o l o g i c a l  
activities characteristic of human IL-2 (Taniguchi et 
al., 1983). B i o l o g i c a l l y  act i v e  h u m a n  IL-2 was also 
directly expressed in EL_ coli under the control of trp 
& PL promoter (Devos et al., 1983)
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1.3 Gene o r g a n i s a t i o n  for y - i n t e r f e r o n  and 
interleukin-2.
The two lymphokines, human i nter1eukin-2 and 
human immune interferon, appear to have similar 
regulation. Both lymphokines are produced by mitogen- 
or antigen-activated spleen cells (Morgan et al., 
1976; Gillis et al., 1978; Yip et al., 1981). Their 
expression appears to be regulated at the level of 
trans c r i p ti o n  since spleen cells do not have 
detectable levels of mRNA prior to antigen activation 
(Wallace et al., 1981a; Efrat et al., 1982). It is 
therefore interesting to compare the gene organization 
of these two lymphokines.
Both the human IL-2 and IFN-y genes exist as a 
single copy per haploid human genome (Fujita et al., 
1983; Gray et al., 1982). The human IL-2 chromosomal 
gene organization is similar to that of human IFN-y. 
Both contain three introns interrupting the coding 
sequence (Degrave et al., 1983; Fujita et al., 1983; 
Gray and Goeddel, 1982; Taya et al., 1 982). There is 
no significant homology between the cDNA sequence of 
human IL-2 and human IFN-y (Degrave et al., 1983) and 
the human IL-2 and human IFN-y genes only show weak 
homology in the 5’ flanking region (Fujita et al., 
1983).
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C . Aims of the thesis
At the commencement of this work there was 
sufficient information to suggest that IL-3 was an 
important hemopoietic growth factor. Its biological 
activities were not fully defined, however, and its 
relationship to other factors required clarification. 
No work had been reported on the molecular biology of 
IL-3. The aim of this project was to complete the 
critical first steps in the application of recombinant 
DNA techniques to the study of IL-3 by isolating a 
cDNA clone for murine IL-3 and expressing it in 
eukaryotic and prokaryotic systems.
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C h a p t e r  2
T r a n s l a t i o n  o f  mRNA e n c o d i n g  m u r i n e  i n t e r l e u k i n - 3  i n  
X e n o p u s  l a e v i s  o o c y t e s .
I . I n t r o d u c t i o n .
X e n o p u s  l a e v i s  o o c y t e s  p r o v i d e  a v e r y  s e n s i t i v e  
a n d  c o n v e n i e n t  t r a n s l a t i o n  s y s t e m  f o r  t h e  
i d e n t i f i c a t i o n  o f  mRNA a n d  f o r  t h e  s t u d y  o f  
t r a n s l a t i o n a l  c o n t r o l  i n  l i v i n g  c e l l s .  T h e  
t r a n s l a t i o n  o f  i n j e c t e d  mRNA i n  t h e  X e n o p u s  l a e v i s  
o o c y t e s  w a s  f i r s t  d e m o n s t r a t e d  by  G u r d o n  e t  a l .  
( 1 9 7 1 ) .  The  X e n o p u s  l a e v i s  o o c y t e s  a r e  e n o r m o u s  c e l l s  
w i t h  a d i a m e t e r  o f  1 mm o r  m o r e  a n d  a r e  r e s i l i e n t  
e n o u g h  t o  w i t h s t a n d  t h e  i n j e c t i o n  o f  up  t o  1 0 0  
n a n o l i t e r s  o f  l i q u i d ,  a v o l u m e  w h i c h  r e p r e s e n t s  10 - 20% 
o f  t h e  v o l u m e  o f  t h e  o o c y t e  ( L a n e  a n d  K n o w l a n d ,  1 9 7 5 ) .
T h e  c h a r a c t e r i s t i c s  o f  t h e  X e n o p u s  o o c y t e  
t r a n s l a t i o n  s y s t e m  a r e  d i s c u s s e d  b e l o w : -
( i )  V a r i e t y  o f  mRNA’s t r a n s l a t e d .
I t  h a s  b e e n  d e m o n s t r a t e d  t h a t  t h e  o o c y t e  
t r a n s l a t i o n  m a c h i n e r y  c a n  t r a n s l a t e  a w i d e  v a r i e t y  o f  
e u k a r y o t i c  mRNAs i n c l u d i n g  mRNAs f r o m  v e r t e b r a t e s ,  
i n v e r t e b r a t e s ,  p l a n t s ,  f u n g i  a n d  v i r u s e s  ( T a b l e  2 . 1 ) .
The  t r a n s l a t i o n  o f  n o r m a l  p r o k a r y o t i c  mRNA s u c h
Table 2.1 Examples o f  mRNAs t ra n s la te d  by Xenopus oocytes.
Nature and source o f  RNA New p ro te in s  synthesized References
Xenopus
V i t e l l o g e n i n  and albumin Xenopus v i t e l l o q e n i n  and Berr idge and
mRNA from Xenopus la e v is  
1 i ver
Other ve r te b ra tes
albumin Lane (1976)
Human
13S mRNA from conA 
induced human leukaemic T 
c e l l s  (Ju rka t -111 )
Human i n t e r l e u k i n - 2 Taniguchi  e t  
a l .  (1983)
Poly(A)-RNA from 
p o l y ( r l ) .  po ly ( rC )  induced 
c u l tu re d  human fo re s k in  
f i b r o b l a s t s
Human in te r f e r o n Reynolds e t  a l . ,  
(1975)
Gibbon
14-16S RNA from gibbon 
lymphosarcoma c e l l  l i n e ,  
MLA 144
Gibbon i n t e r l e u k i n - 2 Lin e t  a l . ,  
(1982)
C a l f
14S RNA from c a l f  lens 
e p i t h e l i a l  c e l l s
aA2 c r y s ta l  1 in Berns e t  a l . ,  
(1972)
Rabbit
9S RNA from r a b b i t a -  and 3 - r a b b i t  g lob in Lane e t  a l . ,
r e t i c u lo c y te s chains (1971)
Mouse
11-12S mRNA from c u l tu red  
murine T lymphoma l i n e ,  
EL4
mouse i n t e r l e u k i n - 2 Bleack ley e t  
a l . ,  (1981)
Duck
9S RNA from duck a \  a^, and 3-duck g lob in Lane e t  a l . ,
r e t i c u lo c y t e s chains (1973)
Carp
poly(A)-RNA from carp 
i s l e t
carp p r o in s u l i n Rapoport (1981)
Table 2.1 (cont inued)
In ve r t eb ra t e :
Honey bee
Crude RNA from queen bees Promel1i t i n - 1 i k e  substance Kindas-Mugge e t
venom glands a l . , (1974)
Plant s
Crude RNA from s e l f - Undefined p l a n t  pro te in Van der  Donk
p o l l i n a t e d  s t y l e s  of 
Petunia  hybrida
(1975)
Poly(A)-RNA from pa r s l ey Flavanone synthase (FS) Schroder e t a l .
ce l l  suspension c u l t u r e s and phenylalanine (1977)
( Pet rosel inum hor tense 
Hoffm).
ammonia-lysae (PAL)
Poly(A)-RNA from pea and V i c i l i n  and legumin Bassuner e t a l .
French bean cotyledons r e l a t e d  pro t e ins (1983)
Mould
Poly(A)-RNA from Secre tory  p ro t e ins Dicou e t  a l . f
Dictyostel iurn discoideum 
axenic s t r a i n  AX2 c e l l
(1979)
c u l t u r e
Vi ruses
60-70S RNA and 30-40S RNA Viral  s t r u c t u r a l  p ro t e ins Ghysdael e t a l .
from avian myeloblas tos i s  
v i rus
p27, pi 9, pi 5 and p12 (1977)
38S poly(A)-RNA from viron p ro t e ins  p24, p15, Ghysdael e t a l .
bovine leukemia v i rus plO (1979)
Bacter i a
5 ' -end capped [3 - Lac t amase 3- L a c t a m a s e Wiedmann e t a l .
mRNA from E. col i (1984)
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as those from f2, MS2 or Q3 phage in X en o p u s oocytes 
has not been detected (Gurdon et al., 1971; Marbaix 
and Huez, 1979). H o w e v e r ,  it was r e c e n t l y  
demonstrated that 5’-end capped 3-lactamase mRNA of E. 
c o1i could be successfully translated in oocytes 
(Wiedmann et al., 1984).
(ii) The stability of the introduced mRNA in the 
Xenopus oocytes.
It has been demonstated that the rabbit and mouse 
a and 3 globin mRNA is very stable in Xenopus oocytes 
and is efficiently translated for four to fifteen days 
(Gurdon et al., 1973). It is also known that human 
globin mRNA (Maniatis et al., 1976), human placental 
lactogen mRNA (Mous et al., 1979), and Xenopus liver 
vitellogenin and albumin mRNAs (Berridge and Lane, 
1976) are translated for long periods of time after 
their injection into Xenopus oocytes.
Although the 3'-0H poly(A) segment is not 
required for the translation of mRNAs (Bard et al. 
1974, Williamson et al., 1 974, and Soreq et al., 
1974), the 3'-0H poly(A) segment of the eukaryotic 
mRNA plays a very important role in the stability of 
the mRNA in the cytoplasm during translation (Gurdon 
et al., 1973; Marbaix et al., 1979). The deadenylated 
globin mRNA was degraded rapidly after injection into 
the Xenopus oocyte (Marbaix et al., 1977). When the
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poly (A) was readded at the 3 ’-0H end of poly (A)-f ree 
globin mRNA using an ATP:RNA adenyItransferase from E. 
c o 1 i (Sippel, 19 73), this "reconstituted" mRNA was 
indeed shown to be as stable as native poly(A)- 
containing mRNA (Huez et al., 1 9 7 5, 1 9 78). The
minimal length of the poly(A) tail required for 
ensuring the stability of the mRNA was demonstrated to 
be at least 20 adenylate residues (Nudel et al., 
1976).
Besides of the 3'-0H poly(A) segment of the 
eukaryotic mRNA, the 5 ’-end "cap" also plays an 
important role in stabilizing the mRNA in the 
cytoplasm (Furuichi et al., 1 977) as well as its role 
in the initiation of translation (Paterson and 
Rosenberg, 1979; Revel and Groner, 1978; Shatkin, 
1976). The 5*-end "cap" was formed by adding post- 
transcriptionally a 7-methy1guanosine to the mRNA 
nuclear precursor and linked by a 5* to 5f bond to the 
first 5' nucleotide of the transcribed RNA molecule. 
The work of Furuichi et al. (1977) showed that the 
presence of a "cap" or even 5’-blocking of mRNA with 
unraethylated guanosine protects reovirus against 
degradation after injection into X e n o p u s 1 a e v i s 
oocytes. However, for the initiation of translation a 
complete 5’-end "cap" is required.
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( i i i )  The  f i d e l i t y  o f  t r a n s l a t i o n  o f  i n j e c t e d  mRNA.
I n  a d e t a i l e d  s t u d y  c o n c e r n e d  w i t h  t h e  
t r a n s l a t i o n  o f  r a b b i t  g l o b i n  mRNA i n  X e n o p u s  o o c y t e s  
( L a n e  e t  a l . , 1 9 7 1 ;  M a r b a i x  a n d  L a n e ,  1 9 7 2 ) ,  i t  w a s
d e m o n s t r a t e d  t h a t  t h e  o o c y t e - d e r i v e d  g l o b i n  c h a i n s  
w e r e  v e r y  s i m i l a r  t o  r a b b i t  r e t i c u l o c y t e  g l o b i n  c h a i n s  
a s  j u d g e d  by c a r b o x y m e t h y l  c e l l u l o s e  c h r o m a t o g r a p h y  o f  
t h e  w h o l e  c h a i n s  a n d  b y  c a t i o n - e x c h a n g e  
c h r o m a t o g r a p h y ,  p a p e r  c h r o m a t o g r a p h y  a n d  p a p e r  
e l e c t r o p h o r e s i s  o f  t r y p t i c  p e p t i d e s  d e r i v e d  f r o m  t h e  
s e p a r a t e d  a -  a n d  3 - c h a i n s .  I t  t h e r e f o r e  s e e m s  l i k e l y  
t h a t  mRNAs f r o m  d i f f e r e n t  s p e c i e s  a r e  f a i t h f u l l y  
t r a n s l a t e d  i n  X e n o p u s  o o c y t e s .
T h e  f i d e l i t y  o f  t h e  o o c y t e  s y s t e m  i s  a l s o  
c o n f i r m e d  b y  t h e  f a c t  t h a t  i n j e c t e d  mRNAs  a r e  
t r a n s l a t e d  t o  b i o l o g i c a l l y  a c t i v e  p r o d u c t s ,  f o r  
e x a m p l e  m o u s e  3 - g l u c u r o n i d a s e  ( L a b a r c a  a n d  P a i g e n  
1 9 7 7 ) ;  h u m a n  i n t e r f e r o n s  ( C a v a l i e r i  e t  a l . ,  1 9 7 7 ) ;  
h u ma n  i n t e r l e u k i n - 2  ( T a n i g u c h i  e t  a l . ,  1 9 8 3 ) .
( i v )  T r a n s l a t i o n  e f f i c i e n c y  o f  t h e  o o c y t e  s y s t e m .
I t  i s  n o w  g e n e r a l l y  b e l i e v e d  t h a t  t h e  
t r a n s l a t i o n a l  m a c h i n e r y  i n  X e n o p u s  o o c y t e s  i s  f u l l y  
s a t u r a t e d  a n d  t h a t  a n y  i n j e c t e d  mRNA h a s  t o  c o m p e t e  
a g a i n s t  e n d o g e n o u s  mRNA f o r  t r a n s l a t i o n .
At  l o w  c o n c e n t r a t i o n s  o f  i n j e c t e d  mRNA ( l e s s  t h a n
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lOng per o o c y t e  for g l o b i n  mRNA), a l i ne a r 
r e l a t i o n s h i p  is o b s e r v e d  b e t w e e n  the m R N A 
concentration and the translation rate; at higher 
concentrations, a sort of "saturation” is reached 
(Moar et al., 1971; Marbaix and Gurdon, 1 9 7 2).
Independent of the concentration of mRNA, the maximal 
rate of translation of the injected mRNA is reached 
after 7 to 20 hours (Asselbergs et al., 1979).
The rate of translation of rabbit 3-globin mRNA 
at 19P C in X e n o p u s oocytes was estimated to be about 
30 3-globin molecules synthesized per molecule of mRNA 
per hour (Gurdon et al., 1973). Although the 
translation rate of injected oocytes is approximately 
one quarter the rate observed in reticulocytes at the 
same temperature, 110 molecules of 3-globin per 
molecule of mRNA per hour (Hunt et al., 1969), the 
injected mRNA can be translated in the Xenopus oocytes 
for 4 to 15 days (Gurdon et al., 1973) as compared 
with one or two hours in the reticulocyte lysate 
system. Thus the mRNA is translated about 100 times 
more efficiently in X enopus oocytes than in a 
reticulocyte lysate. It is possible to detect 
picogram quantities of mRNA using oocytes (Gurdon et 
al., 1971) while the cell-free system requires much 
larger amounts (1 to lOng) of mRNA (Pelham and 
Jackson, 1976). Even though most of the eukaryotic 
mRNAs are efficiently translated in the Xenopus
oocytes, several other mRNA are only translated with a
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r e l a t i v e l y  l o w  y i e l d  i n  Xe n o pu s o o c y t e s ,  s u c h  a s  
t  h y r  o g 1 o b u 1 i  n raRNA ( V a s s a r t  e t  a l .  , 1 9 7 5 ) ,  a n d  t h e  a -  
g l o b i n  raRNA i n  t h e  a b s e n c e  o f  h a e m i n  ( G i g l i o n i  e t  a l . ,  
1 9 7 3 )  .
( v )  P o s t - t r a n s 1 a t i o n a  1 m o d i f i c a t i o n s  o f  t h e  
t r a n s l a t i o n  p r o d u c t s .
A n o t h e r  a d v a n t a g e  o f  t h e  Xe no  pu s o o c y t e  s y s t e m  
f o r  t h e  t r a n s l a t i o n  o f  h e t e r o l o g o u s  raRNAs i s  t h a t  a 
w i d e  r a n g e  o f  s e c o n d a r y  m o d i f i c a t i o n s  t h a t  t a k e  p l a c e  
i n  t e r m i n a l l y  d i f f e r e n t i a t e d  c e l l s  c a n  a l s o  o c c u r  i n  
o o c y t e s  ( r e v i e w e d  by A s s e l b e r g s ,  1 9 7 9 ) .  Some e x a m p l e s  
o f  t h e  s e c o n d a r y  m o d i f i c a t i o n s  o f  t h e  t r a n s l a t i o n  
p r o d u c t s  o f  mRNAs i n j e c t e d  i n t o  X e n o p u s  o o c y t e s  a r e :
( a )  N - A c e t y l a t i o n  o f  t e r m i n a l  m e t h i o n i n e  i n  c a l f  l e n s  
e p i t h e l i u m  a A 2 c r y s t a l l i n  ( B e r n s  e t  a l . ,  1 9 7 2 ) ,
( b )  p r o l i n e  h y d r o x y l a t i o n  o f  mo u s e  c o l l a g e n  ( L a n e  a n d  
K n o w l a n d ,  1 9 7 5 ) ,
( c )  p h o s p h o r y l a t i o n  o f  t e s t i s  p r o t a m i n e s  ( Ge d a mu  e t  
a l . ,  1 9 7 8 ) ,
( d )  g l y c o s y l a t i o n  o f  P h a s e o l u s  v u l g a r i s  L. p h a s e o l i n  
( M a t t h e w s  e t  a l . ,  1 9 8 1 ) ,
( e )  g 1 y c o s y 1 a t i o n  o f  h u m a n  i n t e r f e r o n ,  a s e c r e t e d  
p o l y p e p t i d e  ( R e y n o l d s  e t  a l . ,  1 9 7 5 ) ,
( f )  p r o t e o l y t i c  c l e a v a g e  o f  r a b b i t  p r e - u t e r o g l o b i n  t o  
u t e r o g l o b i n ,  a s e c r e t e d  p o l y p e p t i d e  ( B e a t o  a n d  
R u n g g e r ,  1 9 7 5 ) ,
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(g) assembly of multimeric proteins bound by S-S 
bonds, like rabbit uteroglobin (Beato and 
Rungger, 1975),
(h) assembly of multimeric proteins with non-covalent 
bonds between subunits, like bovine a-crystallin 
(Asselbergs et al., 1978), and also
(i) proteolytic processing of viral polyproteins like 
the processing of the precursor polypeptides of 
Avian Myeloblastosis Virus to virion structural 
proteins (Ghysdael et al., 1977).
It thus appears that the post- trans1ationa 1 
modifications which occur in Xenopus oocytes are not 
cell-type specific and are probably determined by the 
a va ilability of amino acid sequences of the 
translational product (Gurdon, 1974). However some 
post-translational modifications are not performed by 
Xenopus oocytes:
(a) the carp proinsulin is not converted to insulin 
(Rapoport, 1981), (b) the C-terminal amide of the
honey bee promitellin is not synthesized (Kindas-Mugge 
et al., 1974; Kreil et al., 1977), (c) bovine
thyroglobulin is not iodinated (Vassart et al., 1975), 
and (d) the mouse 3-glucuronidase probably does not 
undergo post-synthetic cleavage (Labarca and Paigen, 
1977) .
Apart from p o s t - t r a n s 1 ationa 1 modification,
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another great advantage of Xenopus oocyte translation 
system is that the foreign protein translated in the 
oocyte is directed to its own original destination. 
For example the m e mb ra ne  proteins like murine 
immunoglobulin E receptor (Liu and Orida, 1984), human 
serotonin receptor and sodium channel (Gundersen et 
a 1., 1984) and Semliki Forest virus envelope proteins 
(Huth et al., 1984) are also transported to the oocyte 
membrane after translation in the Xenopus oocyte. 
Secreted proteins such as murine inter1eukin-2 and 
bacterial 3-lactamase are secreted outside the oocyte 
after translation (Bleackley et al., 1981; Wiedmann et 
al., 1984) and appear to have their signal peptides 
processed normally.
Thus the Xenopus laevis oocyte translation system 
is an efficient and c omplete system for the 
t r a n s l a t i o n  of f o r e i g n  mRNA. S i nce m u r i n e  
inter1eukin-3 is a secretable glycoprotein (Ihle et 
al., 1981), this system appeared to be the system of 
choice for the assay of the murine interleukin-3 mRNA 
and for the screening of the cDNA library in the 





1. G u a n i d i n e - H C 1 , an ultra pure reagent, was 
obtained from Bethesda Research Laboratories, 
Inc. (No. 5502).
2. Guanidine thiocyanate, purum, was obtained from 
Fluka (No. 50990).
3. Sarcosyl, NL 97; was a gift from CIBA-GEIGY Pty. 
Ltd.
4. Phenol, Anala R, was obtained from BDH Chemicals 
Australia Pty. Ltd. (No. 10188) and stored at - 
20°C.
5. Sucrose, ultra pure density gradient grade, was 
obtained from S c h w a r z / M a n n  Pty. Ltd. (No. 
821721 ) .
6. Oligo (dT)-cellulose type 7 was obtained from P-L 
Biochemicals, Inc. (No. 5543).
7. Calcium chloride, Anala R, was obtained from BDH 
Chemicals Australia Pty. Ltd. (No. 10067).
8. 2-Mercaptoethanol, 90%, was obtained from Eastman 
Kodak Co. (No. 4196).
9. Urea, ultra pure reagent, was obtained from 
Bethesda Research Laboratories Inc. (No. 5505- 
UA) .
10. SDS (Sodium dodecyl sulfate), specially pure, was 
obtained from BDH Chemical Australia Pty. Ltd. 
(No. 4244).
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11. Penicillin G, potassium, was obtained from Sigma 
(No. PEN-K).
12. Streptomycin, was obtained from Glaxo (No. 
325794) .
13. [methyl-^H] thymidine, was obtained from Amersham 
(No. TRA120).
14. Trypan blue, was obtained from Sigma (No. T6146).
15. DTT (DL-Dithiotheritol), was obtained from Sigma 
(No. D-0632) .
All other chemicals used were of the highest purity 
commercially available.
Cell lines
WEHL-3B and EL-4 cells were provided by Dr. 
Andrew J. Hapel.
Xenopus laevis
X e n o p u s laevis was obtained from Xenopus Ltd., 
151 Frenches Road, Red Hill, Surrey RM1 2HZ, England.
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III. Solutions.
1. Guanidine thiocyanate buffer: 4M guanidine
thiocyanate, 0.1M Tris-HCl pH7.5 in sterile 
water. The solution was millipore filtered and 
stored at room temperature in a sealed sterile 
bottle. 0.143ml 2-mercaptoethano1 (14M stock 
solution, Eastman Kodak Co., No. 4196) was added 
to 20ml of the guanidine thiocyanate buffer 
before use.
2. Guanidine-HCl buffer: 6M guanidine-HCl, lOmM EDTA 
pH7.0 in sterile water. It was stored at room 
temperature. 0.1ml 1MDTT was added to 10ml of 
this buffer before use.
3. Urea buffer: 7M urea, 0.1M Tris-HCl pH8.5, O.lmM 
EDTA, 0.1% SDS. (This solution was made up 
immediately before use.
4. Oocyte incubation medium: (Cavalier et al.,
1977). 88mM NaCl, ImM KC1, 2.4mM NaHC03 , 0.82mM
M g S 0 4 .7H20, 0.3 3 m M C a (N O 3 ) 2 .4 H 20, 0 . 41 m M
C a C l 2.6H20, 7.5mM Tris-base, Penicillin G,
potassium, 11 pi g / m 1, Streptomycin, 18ug/ml. The 
final pH was adjusted to pH7.6 with HC1 and the 
solution was sterilized by filtration.
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5. Phenol: Solid phenol from the freezer was melted
in equal volume of 200mM Tris-HCl pH9, lOOmM 
NaCl, ImM EDTA. It was vortexed well and two 
phases allowed to separate. The aqueous phase 
was removed by aspiration. The neutralized 
phenol was then used for phenol extraction of 




2.1 Isolation of RNA by centrifugation through CsCl. 
This method is modified from C h i r g w i n ’s method 
(Chirgwin et al., 1979).
WEHI-3B cells were cultured in RPMI-1640 medium 
supplemented with 10% he at-inactivated fetal calf 
serum to a density of 2xl0^/ml. 10^ cells were then 
collected by centrifugation in an MSE centrifuge at 
300xg for 10 min and resuspended in 2ml of serum-free 
RPMI-1640 medium. The suspension was added dropwise 
to 40ml guanidine thiocyanate buffer (4M guanidine 
t h i o c y a n a t e ,  0.1M T r i s - H C l  pH7.5, 0.1M 2 - 
mercaptoethanol) with continuous stirring. The cell 
lysate was stored at -70°C until it was processed 
further.
l/20th volume of 10% sarcosyl was added to the 
thawed cell lysate. After adding 0.5g CsCl/ml, the 
light-brown solution was heated at 65°C for 5 min, 
quick-cooled in ice, layered on top of a 2.5ml cushion 
of 5.7M CsCl, 25mM NaOAc pH5 in a sterilized SW41 
centifuge tube (Beckman No. 331372, polyallomer) and 
centrifuged in an S W 4 1 rotor at 28,000rpm for 18 hr at 
18°C. The overlaying solutions were removed by 
aspiration, and the tubes were inverted quickly and 
drained for 15 min. The tubes were aspirated dry
whilst still inverted and the bottom 0.5cm of the
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tubes containing the clear RNA pellet were cut off 
with a sterile scalpel blade. The RNA pellet was 
rinsed out very carefully from the bottom of the tube 
4 times with 200yl lOmM Tris-HCl pH7.5, ImM EDTA, 5% 
sarcosyl, 5% phenol. The RNA suspension was vortexed 
for about 5 min to ensure it was completely dissolved. 
It was then extracted twice with 10ml phenol, 
chloroform and isoamylalcohol mixture (50:48:2). The 
aqueous phase was brought to 0.3M NaOAc pH5.5 and the 
RNA precipitated with 2.5 volumes of absolute ethanol 
in a dry ice-ethanol bath for 1 hr. The tube was 
centrifuged in a Sorvall SS34 rotor at 20,000 rpm for 
30 min at -15°C. The RNA pellet was washed with cold 
absolute ethanol and dried under vacuum. It was 
resuspended in lOmM Tris-HCl pH7.5, O.lmM EDTA.
2.2 Isolation of RNA by ethanol precipitation (Brooker 
et al., 1980).
The guanidine thiocyanate cell lysate was 
prepared as in Method 2.1. The cell lysate was 
centrifuged in an SS34 rotor at 15,000rpm for 10 min 
at 0°C. The supernatant containing the RNA and other 
cellular components was acidified to pH5 by the 
addition of 0.04 volume of IN acetic acid, and the RNA 
was precipitated by the addition of 0.5 volume of 
absolute ethanol. After mixing, the solution was kept 
in dry-ice ethanol bath for 1 hr and centrifuged in an
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SS34 rotor at 20,000rpra for 30 min at -15°C. The 
pellet was dissolved in approximately 0.5 volume 
(relative to the original volume of the lysate) of 
guanidine-HC1 buffer (6M guanidine-HC1, lOmM EDTA 
pH7.0, lOmM DTT). The solution was again acidified to 
pH5 by the addition of 0.04 volume of IN acetic acid 
and precipitated with 0.5 volume of ethanol. The 
mixture was kept in a dry-ice ethanol bath for 30 min 
and centrifuged in an SS34 rotor at 20,000rpm for 30 
min at -15°C. The p recipitation of the RNA in 
guanidine-HCl buffer was repeated once, reducing the 
volume to one third relative to that of the first 
precipitation. The final pellet was resuspended in 
0.5 volume of 0.24M sodium acetate pH5.5. 2.5 volumes
of absolute ethanol were added, mixed well and the 
mixture held in a dry-ice ethanol bath for 1 hr. It 
was centrifuged in an SS34 rotor at 20,000rpm for 30 
min at -15°C. The RNA pellet was resuspended in the 
same volume of urea buffer (7M urea, 0.1M Tris-HCl 
pH8.5, O.lmM EDTA, 0.1% SDS). It was extracted twice 
with equal volume of phenol, chloroform and 
i soamy1 acoho 1 mixture (50:48:2). The SDS was raised 
to 1% in the second extraction. The nucleic acid was 
precipitated with 2.5 volumes of absolute ethanol in a 
dry-ice ethanol bath for 1 hr and centrifuged in a 
SS34 rotor at 20,000rpm for 30 min at -15°C. The 
pellet was suspended again in 10ml 30mM potassium 
acetate, 70% ethanol, held in a dry-ice ethanol bath
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for 1 hr and c e n t r i f u g e d  in a SS34 rotor at 20,000rpra 
for 30 min at -15°C. The final pellet was dried under 
v a c u u m  and r e s u s p e n d e d  in lOraM T r i s - H C l  p H 7.5, 0.1mM 
E D T A .
2.3 Isolation of poly(A)+-RNA from total RNA.
Pol y ( A ) + -RNA was is o l a t e d  from the total RNA by 
chromatography on oligo(dT)-cellulose (Bantle, J.A. et 
a 1., 1976). About 4 to 5mg total RNA was ad j u s t e d  to 
0.5M NaCl and applied to a c o l u m n  c o n t a i n i n g  lg of 
o l i g o ( d T ) - c e l l u l o s e  in buffer (0.5 M NaCl, 1 0 m M  Tris- 
HCl pH7.5, I m M  EDTA) at a flow rate of about 20ml/hr. 
The column was washed with the same buffer until the 
optical density was < 0.08 A 9 ^ q unit/ml. The c o l u m n  
was w a s h e d  again w i t h  10ml 0.1M NaCl, l O m M  T r i s - H C l  
pH7.5, ImM EDTA. Pol y ( A ) + -RNA was then eluted with 
10mM Tris-HCl pH7.5, ImM EDTA. 500u 1 fractions were 
collected. F r a c t i o n s  c o n t a i n i n g  RNA were pooled 
together. 0.1 volume of 3M K0AC pH5.5 and 2.5 volumes 
of a b s o l u t e  ethanol were added and mixed well. The 
m i x t u r e  was held in a dry - i c e  ethanol bath for 1 hr 
and c e n t r i f u g e d  in an SS34 rotor at 2 0 , 0 00rpm for 30 
min at -15°C. The RNA pellet was w ashed with cold 
a b s o l u t e  ethanol and dried under vacuum. It was 
resuspended in lOmM Tris-HCl pH7.5, O.lmM EDTA.
The oligo(dT)-cellulose column was regenerated by 
w a s h i n g  wit h  10ml 0.1M K0H. The o 1 i g o ( d T ) - c e 11 u 1 o s e
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was then neutralized with 0.5M NaCl, lOmM Tris-HCl, 
pH7.5, ImM EDTA and stored at 4°C in the same buffer 
containing 0.2g/l NaN^.
2.4 Preparation of injection needles.
F i v e - m i c r o 1 iter microd i spenser tubes (DADE 
Diagnostics, Inc. P4518-5X) were pulled out using a 
needle puller (Leitz, Typ 027-035.002). The needles 
were cut with fine scissors under a dissecting 
microscope to form a needle with a tip of 15-20nm in 
diameter. The microdispenser capillaries consist of 
uniform bore tubing (15mm equivalent to 1 y 1). The 
needles were sterilized at 180°C overnight before use.
2.5 Preparation of oocytes.
A Xenopus laevis female was cooled in ice water 
for 30 min, sacrificed by quickly removing the head 
with a scalpel and paralysed by pithing. The 
abdominal area was swabbed with 0.5% w/v hibitane in 
70% v/v ethanol and the skin of the abdomen removed. 
The abdomen was cut open and the oocytes were removed 
and immediately placed in 150ml of oocyte incubation 
medium in a sterile beaker. Individual oocytes were 
obtained by gently teasing apart the oocyte sacs with 
2 pairs of watchmakers forceps. Individual oocytes 
were transferred with a sterile pasteur pipette (1mm 
internal diameter) to another petri dish and washed 
with the oocyte incubation medium. The oocytes could
- 3 1 -
b e  k e p t  i n  t h e  o o c y t e  i n c u b a t i o n  m e d i u m  i n  a 
s t e r i l i z e d  p e t r i  d i s h  i n  c o l d  r o o m  a t  4 ° C  f o r  a t  l e a s t  
t w o  w e e k s  w i t h  a c h a n g e  o f  m e d i u m  e v e r y  2 d a y s .
2 . 6  I n j e c t i o n  o f  mRNA.
mRNA ( l y g / y l  i n  lOmM T r i s - H C l  pH7 . 5 ,  O. l mM EDTA) 
w a s  h e a t e d  a t  8 0 ° C  f o r  2 m i n  a n d  r a p i d l y  c o o l e d  i n  i c e  
b e f o r e  i n j e c t i o n .  The  i n j e c t i o n  n e e d l e  wa s  c l a m p e d  t o  
t h e  h a n d l e  o f  t h e  m i c r o m a n i p u 1 a t o r  ( L e i t z )  a n d  
a t t a c h e d  t o  t u b i n g  c o n n e c t e d  t o  a s u c t i o n - p r e s s u r e  
s y s t e m  ( F i g u r e  2 . 1 ) .  The  i n j e c t i o n  n e e d l e  wa s  r i n s e d  
w i t h  s t e r i l e  w a t e r  1 . 5  y 1 o f  t h e  t r e a t e d  mRNA w a s  
p l a c e d  i n  t h e  b o t t o m  o f  a s t e r i l e  p e t r i  d i s h .  T h e  
i n j e c t i o n  n e e d l e  w a s  f i l l e d  f r o m  t h e  d r o p  u s i n g  
s u c t i o n .  A s i n g l e  o o c y t e  o f  a b o u t  1mm i n  d i a m e t e r  wa s  
p i c k e d  up u s i n g  s t e r i l e  g l a s s  s p o o n  a n d  p l a c e d  f a c i n g  
t h e  i n j e c t i o n  n e e d l e .  T h e  i n j e c t i o n  n e e d l e  w a s  
p u n c h e d  i n t o  t h e  o o c y t e  a t  a n  a n g l e  o f  a b o u t  4 5 ° .  
P o s i t i v e  p r e s s u r e ,  2 0 1 b s / i n z wa s  a p p l i e d  t o  t h e  s y s t e m  
u s i n g  c o m p r e s s e d  N2 a n d  a b o u t  5 0 n l  mRNA, e q u i v a l e n t  t o  
a p p r o x i m a t e l y  0 . 75mm d i s p l a c e m e n t  o f  t h e  m e n i s c u s ,  wa s  
i n j e c t e d  p e r  o o c y t e .  The  n e e d l e  wa s  r e m o v e d  f r o m  t h e  
o o c y t e .  T h e  i n j e c t e d  o o c y t e s  w e r e  k e p t  i n  a d r o p  o f  
o o c y t e  i n c u b a t i o n  m e d i u m .  A f t e r  i n j e c t i o n ,  t h e  
i n j e c t e d  o o c y t e s  w e r e  o b s e r v e d  u n d e r  t h e  d i s s e c t i n g  
m i c r o s c o p e .  Any l e a k i n g  o o c y t e s  w e r e  d i s c a r d e d .  The  






F i g u r e  2 . 1  S c h e m a t i c  d i a g r a m  s u m m a r i z i n g  t h e  
e q u i p m e n t  u s e d  f o r  m i c r o i n j e c t i o n  i n t o  Xe nopus  l a e v i s  
o o c y t e s .  F u l l  d e t a i l s  o f  t h e  p r o c e d u r e s  u s e d  a r e  
g i v e n  i n  Me t h o d  2 .6 .
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medium (10/100pl) in a loosely capped sterilized 
Eppendorf tube at 20°C for 48 hrs. After incubation, 
the incubation medium was transferred to another 
sterile Eppendorf tube and centrifuged in an Eppendorf 
centrifuge for 15 min. The supernatant was stored at 
-70°C until assayed.
2.7 Assay for Interleukin-3 activity.
All the assays for IL-3 activity were done by Dr. 
Andrew Hapel's laboratory. Samples to be examined 
were diluted in RPMI-1640 containing 10% FCS. Two 
fold dilutions were prepared in 96-well microtiter 
plates containing 0.05ml/well. Log phase, washed 
32Dcl-23 or FDC-P1 IL-3-dependent cells (10^) were 
subsequently added in 0.05ml and were incubated for 24 
hrs at 37°C. After the initial incubation, lpCi of 
H-thymidine was added and the cells were further 
incubated for approximately 6 hr at 37°C. The cells 
were then harvested with an automated cell harvester 
unit onto filter paper. The level of thymi d in e  
incorporation was determined by liquid scintillation 
counting .
2.8 Sucrose gradient centrifugation of IL-3 mRNA.
Linear gradients were made by mixing equal 
volumes of 5% and 20% (w/v) sucrose in 0.02M sodium 
acetate, pH5, in the chamber of a Buchler gradient
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maker which had been treated with 0.1% py r ocar bona t e 
in 70% ethanol. Gradients were made in sterilized 
Beckman SW41 centrifuge tubes by running the heavy 
sucrose solution into the tube first and lowering the 
tube very slowly. IL-3 mRNA in lOmM Tris-HCl, pH7.5, 
0.1mM EDTA was heated at 80°G for 2 min and quick- 
cooled in an ice bath to reduce aggregation. The 
sample was layered over one gradient (500yg/gradient). 
The gradients were centrifuged at 30,000rpm, 4°C for 
20 hr. After centrifugation, gradients were carefully 
pierced at the bottom with a gauge 25 needle. 
Fractions (20 drops per fraction) were collected. 
20yl of samples from each fraction were taken to 
measure the absorbance at 260nra. 0.1 volume of 3M KC1 
and 2.5 volumes of absolute ethanol were added and 
mixed well. The mixture was kept in dry-ice ethanol 
bath overnight and centrifuged in an Eppendorf 
centrifuge for 30 min at 4°C. The mRNA pellet was 
washed with cold absolute ethanol and dried under 




1. Isolation of total RNA and poly(A)+ RNA from 
WEHI-3B cells.
It was previously shown that the WEHI-3B cell line 
constitutive1 y produces IL-3 at high titers (Lee et 
a 1., 1982). Therefore the WEHI-3B cell line was used 
as the main source of IL-3 mRNA. WEHI-3B cells were 
cultured in RPMI-1640 medium supplemented with 10% 
heat-inactivated fetal calf serum, 20mM glutamine, and 
antibiotics to a titer of 2xl0^/ml. 10^ cells were 
then collected by centrifugation and lysed in 
guanidine thiocyanate buffer (Method 2.1). The RNA 
was purified by pelleting through a CsCl step gradient 
(Method 2.1). In this method, since DNA and protein 
do not pellet with the RNA and care was taken to 
completely remove these contaminants from the RNA 
pellet. The pellet was then dissolved in buffer, 
phenol extracted and the RNA precipitated (Method 
2.1). Four preparations of the total RNA from 10^ 
WEHI-3B cells were made and yields ranged from 2.5mg 
to 5.4mg (Table 2.2).
In addition to the WEHI-3B cell line, the EL-4 
cell line is also another source of IL-3 mRNA since it 
can be induced to produce IL-3 by stimulation with 
phorbol esters (Lee et al., 1 982). One batch of RNA 
was prepared from induced EL-4 cells. The cells were 
grown to a cell density of about 10° cells per ml in
T a b l e  2 . 2  P r e p a r a t i o n  o f  I L - 3  mRNA
prepa ra t i on y i e l d  of t o t a l  RNA/ y i e l d  of poly(A)+ RNA/ 
109 c e l l s  109 c e l l s
00260/280 0°260/280
WEH 1—3 1 2 . 70mg 1.90 370yg 1.77
2 5 . 40mg 1.72 950pg 1.64
3 2 . 80mg 1.70 353pg 1.84
4 2 . 47mg 1.71 384pg 1.75
induced 1 4 . 61mg 1.71 480pg 1.75
EL-4
The  y i e l d  o f  t o t a l  RNA a n d  p o l y ( A ) + RNA f r o m  e a c h  
p r e p a r a t i o n  w a s  m e a s u r e d  by o p t i c a l  d e n s i t y  a t  2 60 nm. 
P o l y ( A )  + RNA w a s  i s o l a t e d  f r o m  t o t a l  RNA b y  
c h r o m a t o g r a p h y  on  o 1 i g o ( d T ) - c e 1 1 u 1 o s e  ( M e t h o d  2 . 3 ) .
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spinner culture in DM EM medium supplemented with 10% 
heat-inactivated fetal calf serum. 2x10^ cells were 
collected by centrifugation, resuspended in serum-free 
medium containing lOOng per ml phorbol myristic
oacetate and subcultured into lbOcra^ culture flasks at 
5x10® cells per flask. The cells were incubated for 
10 hr before collection. The viability of the cells 
after induction was checked by staining with 0.0625% 
of Trypan blue. 90% of the induced cells were still 
viable.
2 x 1 0 ^ cells were collected by centrifugation 
and resuspended in 4 m 1 PBS. The resuspended cells 
were lysed in 4M guanidine thiocyanate buffer (Method 
2.2). The RNA was purified by the guanidine HC1 
precipitation technique (Method 2.2). 9.2 mg of total
RNA was obtained from 2x10^ induced EL-4 cells.
Poly(A) + -RNA was isolated from the total RNA by 
chromatography on oligo (dT)-cellulose (Method 2.3). 
In a typical preparation, 3.5mg of total RNA was 
c h ro m a t o g r a p h e d  on a column containing lg of 
oligo(dT)-cellulose. The RNA was applied in 0.5M NaCl 
buffer and washed with the same buffer and then 0.1M 
NaCl buffer. The RNA was eluted in buffer containing 
no salt. The optical densities of the c olumn 
fractions are shown in Table 2.3. Fractions 4-9 
containing the eluted RNA were pooled and the RNA 
recovered by ethanol precipitation.
T a b l e  2 . 3  O l i g o  ( d T ) - c e l l u l o s e  c h r o m a t o g r a p h y  o f  t h e  
WEHI-3 t o t a l  RNA.
A b s o r b a n c e  o f  f r a c t i o n s  (260mm)
F r a c t i o n  no. 0.5M NaCl 0.1M NaCl E l u t i o n
1 0 . 0 0 2 0 . 0 0 3 0 . 0 0 1
2 0 . 5 8 5 0 . 0 0 3 0 . 0 0 1
3 1 . 240 0 . 0 1 4 0 . 0 0 3
4 0 . 1 8 0 0 . 0 0 9 0 . 1 1 4
5 0 . 0 2 4 0 . 0 0 6 0 . 2 2 3
6 0 . 0 1 0 0 . 0 0 4 0 . 0 8 9
7 0 . 0 0 7 0 . 0 0 4 0 . 0 3 1
8 0 . 0 0 6 0 . 0 0 3 0 . 0 1 0
9 0 . 0 0 5 0 . 0 0 3 0 . 0 0 5
10 0 . 0 0 5 0 . 0 0 3 0 . 0 0 4
11 0 . 0 0 5 0 . 0 0 3
12 0 . 0 0 4 0 . 0 0 3
13 0 . 0 0 3
14 0 . 0 0 4
15 0 . 0 0 4
16 0 . 0 0 3
17 0 . 0 0 3
18 0 . 0 0 3
19 0 . 0 0 3
20 0 . 0 0 3
3 . 7 m g  t o t a l  RNA w a s  a d j u s t e d  t o  0 . 5M N a C l  a n d  
l o a d e d  o n t o  a l g  o 1 i  g o ( dT ) -  c e 11 u 1 o s e c o l u m n .  I t  w a s  
f i r s t l y  w a s h e d  w i t h  0.5M Na Cl ,  lOmM T r i s - H C l  pH7. 5 and  
t h e n  w a s h e d  w i t h  0 . 1M N a C l ,  lOmM T r i s - H C l  p H 7 . 5 .  I n  
t h e  f i r s t  a n d  s e c o n d  w a s h ,  1 m l  f r a c t i o n s  w e r e  
c o l l e c t e d  a n d  5 0 )il s a m p l e s  w e r e  t a k e n  o u t  f r o m  e a c h  
f r a c t i o n  t o  m e a s u r e  t h e  a b s o r b a n c e  a t  2 6 0 n m .  A f t e r  
w a s h i n g ,  t h e  p o l y ( A ) + RNA wa s  e l u t e d  u s i n g  lOmM T r i s -  
H C l ,  p H 7 . 5 .  F r a c t i o n s  o f  5 0 0 y l  w e r e  c o l l e c t e d  a n d  
2 0 ]J 1  s a m p l e s  w e r e  t a k e n  o u t  f r o m  e a c h  f r a c t i o n  t o  
m e a s u r e  t h e  a b s o r b a n c e  a t  260nm.
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A summary of the RNA preparations from WEHI-3B 
and EL-4 cells is given in Table 2.2.
2. Translation of IL-3 mRNA in oocytes.
Attempts were made to translate the poly(A)+ 
mRNAs from WEHI-3B and EL-4 by microinjection into 
Xenopus 1aevis oocytes. mRNAs from EL-4 or WEHI-3B 
were diluted to lyg/yl and heated at 80°C for 2 min 
then c o o l e d  in ice b e f o r e  i n j e c t i o n .  The 
microinjection system is shown schematically in Figure 
2.1 and the technique is described in detail in Method 
2.6. After injection, the oocytes were observed under 
the microscope and any leaking oocytes were discarded. 
10 injected oocytes were incubated in lOOyl of oocyte 
incubation medium in a loosely capped sterilized 
Eppendorf tube at 20°C for 48 hr. After incubation, 
the incubation m e d i um  was removed to another 
sterilized Eppendorf tube and was centrifuged in an 
Eppendorf centrifuge for 15 min. The supernatant was 
stored at -70°C. For the oocyte extract, 20
incubated oocytes were homogenized manually in lOOyl 
fresh incubation medium using a sterile glass rod. 
The extract was then centrifuged for 15 min in an 
Eppendorf centrifuge. The supernatant was carefully 
removed to avoid contamination by the lipid layer 
formed at the top. The oocyte extract was also stored 
at -70°C. For the total extract the incubated oocytes
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were homogenized in the same tube without changing the 
incubation medium. The incubation medium, oocyte 
extract and total extract were assayed for IL-3 
activity using the IL-3 dependent cell line 32Dcl-23 
(Ihle et al., 1982, Method 2.7). It was found that 
mRNA from EL-4 and WEHI-3B cells could be translated 
in the oocytes to give readily detectable levels of 
IL-3 after 48 hr incubation (Table 2.4). Most of the 
detectable activity was present in the incubation 
medium indicating that the oocytes were secreting 
mature IL-3. Comparison of the activities of the 
total extracts and the activities in the incubation 
media showed that the oocyte extracts were inhibitory. 
mRNA from WEHI-3B cells regularly gave higher levels 
of IL-3 in the translation assays than preparations 
from EL-4 (Table 2.4), in keeping with the higher 
levels of IL-3 found in culture supernatants of the 
WEHI-3B cell line.
The effect of incubation time on the levels of 
IL-3 activity in the incubation medium was examined 
(Table 2.5). It was found that the level of IL-3 
activity only marginally increased over the period of 
48 hr to 96 hr of incubation. Thus 48 hr incubation 
time was routinely used.
The effect of the age of the oocytes after 
harvesting from the toad on their ability to translate 
IL-3 mRNA was also examined. It was found that the
Table 2.4 Translation of IL-3 mRNA in Xenopus laevis
oocytes
IL-3 activity ( c . p . m . )
mRNA Incubation
time
oocyte medium total extract
EL-4 24h 0 3,100 3,700
48h - 20,000 5,600
WEHI-3 48h 6,000 47,000 28,700
WEHI-3B conditioned medium 70,000
raRNA from EL-4 or WEHI-3B at lyg/yl was heated at 80°C 
for 2 min and cooled on ice. 50nl of the treated mRNA 
was injected per oocyte. 10 injected oocytes were 
incubated in 100]il oocyte incubation medium at 20°C 
for 24 hr or 48 hr. After incubation, the medium was 
withdrawn and an extract of the oocytes prepared as 
described in the text. The incubation medium, oocyte 
extract and total extract were assayed for IL-3 
activity using the IL-3 dependent cell line 32Dcl-23 
(Method 2.7) measuring incorporation of JH-thymidine 
as an index of cell growth.
Table 2.5 T r a n s l a tion_of_W EHI-3B mRNA in Xenopus
laevis oocytes





WEHI-3B conditioned medium 21,000
WEHI-3B mRNA was translated in Xenopus oocytes and the
incubation medium assayed for IL-3 activity (see Table 
2.4) after different lengths of incubation.
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isolated oocytes could be stored in a sterile petri- 
dish in the oocyte incubation medium at 4° for 2 weeks 
with a change of fresh medium every two days. The 
oocytes still looked healthy after 2 weeks storage. 
In order to study the effect of oocyte age on the 
translation efficiency of IL-3 mRNA. WEHI-3B mRNA was 
injected into the oocytes after different times of 
storage. The results indicated that there was no 
significant drop in the ability to translate IL-3 mRNA 
with up to 14 days storage (Table 2.6).
There was a linear relationship between the 
amount of IL-3 mRNA injected into oocytes and the 
level of IL-3 activity secreted into the incubation 
medium between 0 to 12.5ng per oocyte. As more IL-3 
mRNA was injected per oocyte the relationship between 
the amount of IL-3 mRNA injected into the oocyte and
the level of IL-3 activity secreted into the
incubation medium was no longer linear. However, up
to 5 0 n g o f IL-3 mRNA injected per oocyte, the
t r a n s l a t i o n rate had still not r e a c h e d the
"saturation" state (Figure 2.2).
3. Enrichment of IL-3 mRNA by sucrose gradient 
centrifugation.
In order to enrich the IL-3 mRNA, WEHI-3B mRNA 
was fractionated on a sucrose gradient. A linear 
sucrose gradient was prepared in a Beckman SW41 tube
Table 2.6 Effect of oocyte age on their ability to 
translate IL-3 mRNA
age of the oocytes IL-3 activity (c.p.m.)
day 0 16,000 
day 4 13,000 
day 8 14,000 
day 14 14,000
WEHI-3B conditioned medium 21,000
The IL-3 mRNA was microinjected into Xenopus oocytes 
and the incubation medium assay for IL-3 activity as 
described in Table 2.4.
70
i I I ■
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Figure 2.2 Relationship between the amount of IL-3 
mRNA injected and the IL-3 activity produced in 
oocytes. Twofold dilutions of WEHI-3B mRNA were 
prepared in lOmM Tris-HCl pH7.5, O.lmM EDTA. 50nl of 
each diluted sample, which had been heated at 80°C and 
chilled in ice was microin jected into each of 10 
oocytes and the secreted IL-3 activity determined as 
described in Table 2.4.
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(Method 2.8). 500yg WEHI-3B poly(A+ ) RNA in 150yl of
lOraM Tris-HCl pH7.5, O.lmM EDTA, was heated at 80° for 
2 rain and cooled rapidly in an ice bath to reduce 
aggregation. The sample was layered over the 
gradient. The gradient was centrifuged for 20 hr at 
30,000rpra at 4°C using the Beckman SW41 rotor. After 
centrifugation, the gradient was fractionated into 15 
fractions of about 600yl. 20yl samples from each 
fraction were taken to measure the absorbance at 
260nm. Two distinct peaks at 28S and 18S were 
observed (Figure 2.3). Each fraction was divided into 
two parts and to each tube 33yl of 3MKC1 and 825yl 
absolute ethanol were added and mixed well. The tubes 
were kept in dry-ice ethanol bath overnight and were 
centrifuged in an Eppendorf centrifuge at 4°C for 30 
min. The RNA pellets were washed with cold absolute 
ethanol and dried under vacuum. The pellets were 
suspended in 20yl of 10 m M Tris-HCl pH7.5, O.lmM EDTA 
and samples of each fraction were injected into 
X e no p u s 1 a e vis oocytes as described in Method 2.6. 
The major peak of IL-3 activity sedimented at ~ 1 2 S , 
that is fraction 8 and 9 (Figure 2.3). This procedure 








F i g u r e  2 . 3
S e d i m e n t a t i o n  o f  I L - 3  mRNA t h r o u g h  a s u c r o s e  d e n s i t y  
g r a d i e n t .  ^ , A 9 5 o » h a t c h e d  a r e a s ,  I L - 3  a c t i v i t y .  
P o l y ( A ) + -RNA ( 5 0 0 u g ) f r o m  W E H I - 3  w a s  h e a t e d  a t  8 0 ° C  
f o r  2 m i n ,  c h i l l e d  i n  i c e  a n d  a p p l i e d  t o  a 5 - 2 0 %  
s u c r o s e  g r a d i e n t  p r e p a r e d  i n  a B e c k m a n  S W4 1  
p o l y a l l o m e r  t u b e .  T h e  g r a d i e n t  w a s  c e n t r i f u g e d  a t  
3 0 , OOOr  pm f o r  2 0  h r  a t  4 ° C  a n d  d i v i d e d  i n t o  15  
f r a c t i o n s  by t h e  c o l l e c t i o n  o f  d r o p s .  T h e  RNA w a s  
r e c o v e r e d  by  e t h a n o l  p r e c i p i t a t i o n  a n d  s a m p l e s  
i n j e c t e d  i n t o  o o c y t e s  a s  d e s c r i b e d  i n  T a b l e  2 . 3 .  On e  
u n i t  o f  I L - 3  a c t i v i t y  i s  t h a t  r e q u i r e d  t o  g i v e  50% o f  
t h e  m a x i m u m  i n c o r p o r a t i o n  o f  ^ H - t h y m i d i n e  i n  t h e  
a s s a y .
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VI. Discussion
In the work described in this chapter a sensitive 
assay for IL-3 mRNA was developed using microinjection 
of Xenopus oocytes. The WEHI-3B cell line was used as 
the main source of IL-3 mRNA. On average, 3.34mg of 
total RNA and 514pt g poly(A)+RNA were isolated from 10^ 
WEHI-3B cells.
Although the ribosomal RNAs cannot be completely 
eliminated from the poly(A)+RNA after one oligo(dT)- 
cellulose c h r o m at o gr ap hy  (data not shown), the 
poly(A)+ IL-3 mRNA was translated efficiently and the 
IL-3 secreted into the oocyte incubation medium. 48 
hr of incubation for the injected oocytes gave a high 
enough level of IL-3 activity. There was only a 
marginal increase in the IL-3 activity when the 
incubation time was increased to 96 hr and so 48 hr 
incubation time was routinely used. At low
concentrations of injected mRNA (smaller than 12.5ng 
per oocyte for IL-3 mRNA (Figure 2.2); lOng per oocyte 
for globin mRNA (Moar et al. , 1971)) a linear
relationship was observed between the amount of mRNA
injected and the IL-3 appearing in the incubation 
medium. It was previously reported that injection of 
about 30ng of globin in RNA gave "saturation" of 
translation per oocytes (Moar et al., 1971). In
contrast, the "saturation" state was not reached even 
up to 50ng per oocyte for IL-3 mRNA (Figure 2.2),
- 41-
alt hough this could be due to a lower degree of purity 
for the IL-3 mRNA preparations. Since the translation 
efficiency remained high with up to 14 days of storage 
of the oocytes (Table 2.6), a single batch of oocytes 
could be used for a number of successive assays.
Using the oocyte translation assay the IL-3 mRNA 
was partially purified 10-20 fold on sucrose density 
gradients. The purified IL-3 mRNA was then used for 
the construction of the cDNA library. By this means 
the degree of enrichment of IL-3 cDNA clones in the 
library was significantly increased. This strategy 
was believed to be essential since it was expected 
that the IL-3 mRNA would be present in low abundance 
in the poly(A)+RNA preparations.
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Chapter 3 Molecular cloning of cDNA for murine 
interleukin-3.
I . Introduction.
Although their isolation can s o m e ti m es  be 
difficult and time consuming, cDNA clones provide an 
extremely powerful tool for analyzing the structure, 
organization and expression of eukaryotic genes 
(Breathnach et al., 1977; Catterall et al., 1979; 
Fujita et al., 1983). The cDNA can be used as a 
hybridization probe to enable the isolation of the 
corresponding genes from chromosomal DNA of the same 
species (Breathnach et al., 1977) or of different 
species (Maki et al., 1984). By comparing the DNA 
sequence of cDNA clone and the corresponding genomic 
clone, one can identify the intervening sequences 
(Tilghman et al., 1978a), study the splicing of the 
mRNA (Tilghman et al., 1978b) and discover whether 
genomic rearrangements have occurred (Brack et al.,
1978) . The cloned cDNA can also be expressed in 
bacterial cells (Itoh et al., 1984; Rosenberg et al., 
1984). cDNA cloning of RNA viruses such as vesicular 
stomatitis virus (Rose, 1980), polio virus (Kitamura 
et al., 1981) and influenza viruses (Sleigh et al.,
1979) has provided an important route for studying 
their structure, replication, and expression and for 
the development of antiviral vaccines (Heiland and
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Get h i n g , 1981; Panicali and Paoletti, 1982; Smith et 
al., 1983; Moss et al., 1984).
The method used for the synthesis and cloning of 
cDNAs have been progressively refined since the first 
demonstration that avian myeloblastosis virus reverse 
transcriptase can be used to synthesis a DNA copy of 
an RNA molecule (Temin and Mizutani, 1970; Baltimore, 
1970). The strategies for cloning double strand cDNA 
can be divided into five steps: (i) first strand cDNA 
synthesis, (ii) second strand cDNA synthesis, (iii) 
insertion of the double strand cDNA into a cloning 
vector, (iv) transformation of the host cell, and (v) 
screening of the cDNA library.
(i) First strand cDNA synthesis.
The first strand cDNA synthesis is a primer 
requiring step. Oligo(dT) polynucleotide is generally 
used as a primer for synthesis of cDNA from a 
poly(A)+RNA (Rougeon and Mach, 1976). This ensures 
that the cDNA synthesis is initiated near the 3’ 
terminus of the RNA. For the nonpolyadenylated RNAs a 
poly(A) tail can be added to their 3’ terminus using 
poly(A) polymerase from Escherichia coli (Hell et al., 
1976; Emtage et al., 1980). Alternatively, a specific 
primer can be used to synthesise a particular pure 
cDNA from a heterogeneous population of mRNA sequences 
(Chan et al., 1979). The optimal conditions for
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producing full-length first strand have been studied 
by several laboratories (Efstratiadis et al., 1976; 
Buell et al., 1978; Retzel et al., 1980). It was 
found that the optimal conditions are to some extent 
dependent on the particular mRNA. However, the 
general recommendations are (1) the use of highly 
purified reverse transcriptase at pH8.3 and 42°C; (2) 
about 4 units/ug of mRNA; (3) 140-150mM KC1, 6-10mM 
MgCl2 » and O.lmM-lmM dNTPs.
(ii) Second strand synthesis.
The first method used for the synthesis of the 
second strand cDNA relied on the hairpin formation at 
the 3* terminus of the first single strand cDNA and 
acted as a primer (Maniatis et al., 1976; Rougeon and 
Mach, 1976). This reaction requires an initial 3f to 
5’ exonucleolytic digestion of unpaired nucleotides on 
the 3* side of a partially mis-matched loop. It has 
been demonstrated that the second strand cDNA can be 
synthesized by the Klenow fragment of DNA polymerase I 
but not by avian m y e 1 obastosis virus reverse 
transcriptase, which does not possess the 3’ to 5 f 
exonuclease activity (Rougeon and Mach, 1976). 
However, when using this method, it is necessary to 
digest the single strand hairpin loop of the double 
strand cDNA with SI nuclease. This invariably results 
in the loss of sequences corresponding to the extreme 
5’-terminal region of the mRNA (Maniatis et al., 1976;
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Si p p e1 et a 1., 1978; Humphries et a 1., 1977; Ullrich 
et al., 1977; Seeburg et al., 1977).
To overcome this difficulty Zain et al. (1979) 
inserted cDNA-mRNA hybrids into a plasmid vector and 
were able to clone a complete copy of the leader 
segments of adenovirus 2 fiber mRNA. However, this 
technique gave only low yields of recombinants.
Another method designed to obtain the complete 
5T-end sequence complementary to the mRNA was using 
artificial priming on sequences generated by terminal 
transferase at the 3f-end of the first single strand 
cDNA. This was first demonstrated by Rougeon et al. 
(1975) u s ing t e r m i n a l  t r a n s f e r a s e  to add a 
h o m o p o 1 y ra e r i c dT tail at the 3'-end of the first 
strand cDNA. Oligo(dA) was subsequently used as a 
primer to synthesise the second strand cDNA. Later 
Cooke et al. (1980) and Land et al.(1981) varied this 
procedure slightly by adding a homopolymeric dC tail 
at the 3'-end of the f i r s t  s t r a n d  cD N A  and 
subsequently using oligo(dG) as a primer to synthesis 
the second strand cDNA. The artificial priming 
methods described above require the generation of a 
single strand cDNA by alkaline hydrolysis of the mRNA 
template. This procedure might nick the first strand 
cDNA. In addition, even highly purified preparations 
of terminal transferase may be contaminated with 
single-strand-specific nucleases, which might also
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nick the first single strand cDNA. These two problems 
can be circumvented by tailing the first cDNA strand 
as a DNA-RNA hybrid and sizing the double-strand cDNA 
before insertion into the plasmid vector.
Recently a very powerful vector-primer cDNA 
cloning system was developed by Okayama and Berg 
(1982) and modified by Alexander et al. (1984). In 
this system the vector used (pARC7) was a derivative 
of a dimer of p8V. The vector was linearized and a dT 
tail added to each end. Each dT tail of the 
linearized vector was used as a primer for the 
synthesis of first strand cDNA. The cDNA-mRNA hybrid 
was then dG tailed. This hybrid plasmid was then cut 
into half by BamHI restriction endonulease. A linker 
with BamHI "sticky end" and a dC tail at the other end 
was used to join up the linearized hybrid plasmid. 
RNaseH, E_^_ c o 1 i DNA polymerase I and _E^_ c o 1 i DNA 
ligase were used to replace the mRNA with DNA and to 
covalently close the remaining nicks. This system 
generated full length cDNA with intact 5'-ends with 
the high efficiency of > 1 0 transformants per y g of 
mRNA (Alexander et al., 1984).
(iii) Insertion of double stranded cDNA into the 
cloning vector.
Apart from the vector-primer cDNA cloning system, 
the other methods of cDNA synthesis require the
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double-ended cDNA to be inserted into the vector. For 
this step several different methods have been used. 
The double strand cDNA has been cloned as a blunt- 
ended fragment (Cochet et al., 1979) or after adding 
synthetic linkers containing a specific endonuclease 
recognition sequence (Heyneker et al., 1976; Bolivar 
and Backman, 1979). To overcome the problem of the 
double strand cDNA being cut during the cleaving of 
linkers by the restriction endonuclease, the double 
strand cDNA can be protected by s i t e - specific 
methylation (Maniatis et al., 1978). In addition, the 
background of nonrecombinant plasmids caused by self­
ligation of the vector can be easily overcome by 
dephosphorylation of the linearized vector.
The third method, which has been widely used, 
involves the addition of dG tails to the plasmid and 
complementary dC tails to the double strand cDNA 
(Villa-Komaroff et al., 1978; Rowekarap and Firtel, 
1980; Land et al., 1981) or addition of dT tails to 
the plasmid and complementary dA tails to the cDNA 
(Wensink et al., 1974). However, it was found that 
the efficiency of cloning using poly dG-poly dC tails 
of 10-20 nucleotides in length was 10-100 fold higher 
than that using poly dA-poly dT tails of 50-100 
nucleotides in length (Nelson and Brutlag, 1979). A 
reasonably high cloning efficiency, 100 to 200 
recombinant transformants per ng of cDNA, can be
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obtained by this method (Maeda, 1981).
(iv) Transformation of the hybrid plasmid into E . 
coli .
For a very low abundance mRNA a cDNA library may 
need to consist of 100,000 clones. The transformation 
efficiency of the hybrid plasmids, therefore, can 
govern the success of construction of a cDNA library. 
The most c o m m o n l y  used method has been calcium 
chloride treatment of the cells (Mandell and Higa, 
1970). M o r e  r e c e n t l y ,  a high e f f i c i e n c y  
transformation method was developed (Hanahan, 1983)
O  Owhich gives 1x10° to 5x10° transformants per yg of 
plasmid DNA.
(v) Screening of the cDNA library.
The choice of methods used to screen the cDNA 
library for a specific gene is mainly dependent on the 
abundance of the mRNA and the available information 
concerning the gene or gene product.
(a) Hybridization-translation method.
This method is a positive screening method 
suitable for use with cDNA libraries made from an 
enriched mRNA source. The cloned cDNA is immobilized 
on a nitrocellulose filter and hybridizedto mRNA in 
solution. After extensive washing, the mRNA is
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released from the hybrid and translated either in 
cell-free protein- synthesizing system (Goldkerg et 
a 1., 1979; Parnes et a 1., 1981) or by microinjection 
into X e n o p u s 1a e vis oocytes (Devos et al., 1982; 
Taniguchi et al., 1983). The appropriate protein can 
be detected by immunoprecipitation (Parnes et al., 
1981; Lomedico et al., 1984) or by biological assays 
(Devos et al., 1982; Taniguchi et al., 1983).
(b) Hybrid-arrested translation method.
This is a negative selection method which is also 
suitable for cDNA libraries made from an enriched mRNA 
source. It relies on the observation that mRNA-DNA 
hybrid is not translated in an in vitro translation 
system (Paterson et al., 1977). The cDNA clone of 
interest is detected by the reduction of a translation 
product as a result of hybridization with the plasmid 
DNA. It is a rapid method because there was no step 
designed to remove unhybridized mRNA. However, this 
method is not well suited to short cDNA or those with 
AT rich sequences (Hentschel et al., 1979).
(c) Screening by specific hybridization with 
synthetic oligodeoxynucleotides.
The hybridization-translation or hybrid-arrested 
screening methods are tedious and time consuming. 
When a partial or complete amino acid sequence of the 
protein of interest is available, a very powerful
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method is to use synthetic oligodeoxynucleotides based 
on the protein sequence as probes to screen a large 
cDNA library (Wallace et a 1., 1981b; Suggs et a 1. , 
1981). The nucleotide sequence of suitable synthetic 
o l i g o d e o x y n u c l e o t i d e s  can be deduced from short 
protein sequences for areas rich in amino acids 
specified either by a single codon (e.g., methionine, 
AUG; tryptophan, UGG) or by two codons (e.g., 
histidine, CAU, CAC; phenylalanine, UUU, UUC; 
t y r o s i n e ,  U A U ,  U A C ) .  A m i x t u r e  of 
oligodeoxynucleotides that represents all possible 
codon combinations can be chemically synthesized and 
used as a probe to screen the cDNA library by colony 
hybridization (Grunstein and Hogness, 1975). Using 
hybridization conditions of appropriate stringency 
only the perfectly matched duplex will be stable 
(Wallace et a 1. , 1979; Wallace et a 1., 1981b). A 
human 02~raicr°gl°bulin cDNA clone was isolated using 
this approach (Suggs et al., 1981).
(d) Differential hybridization.
Some genes are inducible by drugs, hormones, or 
heat shock. The mRNA preparationsfrora non-induced and 
induced cells would contain many sequences in common 
but are different from each other in the presence and 
absence of a few species of interest. Thus the cDNA 
clone for an inducible gene can be isolated from a 
cDNA library constructed from mRNA extracted from the
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induced cell population by screening with probes made 
from mRNA of induced and non-induced cells. Examples 
of inducible genes cloned in this way include the 
ga1actose-inducib1e genes of yeast (St. John and 
Davis, 1979) and human fibroblast interferon 
(Taniguchi et al., 1980). This procedure has also 
been used to identify cDNA clones of developmentally 
regulated mRNAs from X e n o p u s 1 a e vis (Dworkin and 
David, 1980), Dictyostelium discoidum (Williams and 
Lloyd, 1979; R o w e k a m p  and Firtel, 1980) and sea 
urchins (Laskey et al., 1980).
(e) In-situ colony screening with labelled 
antibodies.
The method requires an antibody that can bind 
specifically to the protein of interest and involves 
the expression of the cDNA clones in bacterial cells. 
The doub1e-strand cDNA is usually cloned within a 
structural gene present in the plasmid and under the 
control of a bacterial promoter. To ensure that a 
proportion of the cDNA will be joined in phase with 
the reading frame, the doub1e-strand cDNA can be 
joined to the vector using the oligo(dG)-oligo(dC) 
tailing method or joined with linkers to a set of 
vectors that provide all 3 possible reading frames 
(Stanley and Luzio, 1984). This method does not 
require that a full-length clone be present in the 
cDNA library, since immunological detection techniques
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re q u i r e only that a polypeptide be expressed of 
sufficient length to constitute an antigenic 
determinant. Recently, some vectors were constructed 
for this in situ immunological screening method, like 
Agtll, Agtll-Amp3 (Kemp et a 1., 1983) and pEXl, pEX2, 
pEX3 (Stanley and Lugio, 1984).
(f) Directed expression of cDNA clones in 
mammalian cells and bacteria.
Recently several eukaryotic cloning vectors have 
been developed which can express full-length cDNAs in 
m a m m a l i a n  cells to give biologically active 
polypeptides (Gheysen and Fiers, 1982; Okayama and 
Berg, 1983). In theory the cDNA of interest can be 
i d e n t i f i e d  in the cDNA l i b r a r y  by s c r e e n i n g  
transfected cells for the production of the protein of 
interest, or by gene complementation in a defective 
cell line (Jolly et al., 1983). Recently a mouse IL-2 
cDNA clone was isolated by direct expression of the 
cDNA clones in monkey COS cells (Yokota et al., 1985). 
This is a very powerful direct screening approach for 
the cDNAs of rare raRNAs.
In addition, cDNAs cloding for mammalian proteins 
that are highly conserved during evolution can also be 
isolated by complementation of the appropriate Eh_ coli 
mutant (Goddard et al., 1983; Chang et al., 1978).
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Strategy for cloning murine interleukin-3.
It was necessary to establish a very sensitive 
assay for IL-3 mRNA since it was expected to be a low- 
abundance mRNA. This was feasible since there was a 
very sensitive biological assay for IL-3 using the IL- 
3 dependent line 32Dcl-23 (Ihle et al., 1982a). What 
was therefore required was a translation system which 
would yield biologically active IL-3 and this was 
achieved using Xeno pus 1 a e vis oocytes (Chapter 2). 
Therefore, the hybridization-trans1ation screening 
method could be used as the cloning strategy.
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I I . M a t e r i a l s .
R e a g e n t s
1 .  d A T P  ( 2 ' - D e o x y - a d e n o s i n e - 5 '  -  t r i p h o s p h a t e ,  
d i s o d i u r n  s a l t )  w a s  o b t a i n e d  f r o m  P h a r m a c i a  P - L  
B i o c h e m i c a l  (No.  1 0 3 9 8 5 ) .
2 .  dTTP ( T h y m i d i n e - 5 ’ - 1 r i p h o s p h a t e  , t e t r a s o d i u m  
s a l t )  wa s  o b t a i n e d  f r o m  P h a r m a c i a  P - L  B i o c h e m i c a l  
( No .  1 0 4 2 7 2 ) .
3 .  dCTP ( 2 ’ - D e o x y - c y t i d i n e - 5 f - t r i p h o s p h a t e , d i s o d i u r n  
s a l t )  wa s  o b t a i n e d  f r o m  P h a r m a c i a  P - L  B i o c h e m i c a l  
( No .  1 0 4 0 4 3 ) .
4 .  d G T P  ( 2 * - D e o x y - g u a n o s i n e - 5 ’ - t r i p h o s p h a t e ,  
d i s o d i u r n  s a l t )  w a s  o b t a i n e d  f r o m  P h a r m a c i a  P - L  
B i o c h e m i c a l  (No.  1 0 4 1 0 8 ) .
5 .  ddATP ( 2  ' ,  3 ' - D i d e o x y a d e n o s i n e - 5 ' - 1 r i p h o s p h a t  e ,
s o d i u m ) ,  w a s  o b t a i n e d  f r o m  P h a r m a c i a  P - L
B i o c h e m i c a l  (No.  P - L  2 7 - 4 8 1 9 - X X ) .
6 .  d d C T P  ( 2 ’ , 3 ’ -  D i  d e o x y c y t  i  d i n e - 5 T- 1 r i p h o s p h a t e  , 
s o d i u m )  w a s  o b t a i n e d  f r o m  P h a r m a c i a  P - L  
B i o c h e m i c a l  (No.  P - L  2 7 - 4 8 2 3 - X X ) .
7 .  ddGTP (2  ’ , 3 ’ - D i d e o x y g u a n o s i n e - 5 ’ - 1 r i p h o s p h a t  e ,
s o d i u m ) ,  w a s  o b t a i n e d  f r o m  P h a r m a c i a  P - L
B i o c h e m i c a l  (No.  P - L  2 7 - 4 8 1 7 - X X ) .
8 .  d d T T P  ( 2 ’ , 3 f - D i d e o x y t h y m i d i n e - 5 ’ - 1 r i p h o s p h a t e  ,
s o d i u m ) ,  w a s  o b t a i n e d  f r o m  P h a r m a c i a  P - L
B i o c h e m i c a l  (No.  P - L  2 7 - 4 8 3 1 - X X ) .
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9 .  [ a - 3 3 P ] d A T P .  ( D e o x y a d e n o s i n e  5 ’ - [ a - 3 3 P ]  
t r i p h o s p h a t e  t r i e t h y l a m m o n i u m  s a l t )  wa s  o b t a i n e d  
f r o m  A m e r s h a m  (No.  P B 1 0 2 0 4 ) .
1 0 .  [ 3 H ] d C T P ( D e o x y  [ 1 ’ , 2 ’ , 5 - 3 H ] c y t i d i n e  5 r -  
t r i p h o s p h a t e  a m m o n i u m  s a l t ) ,  5 1 C i / m m o l e ,  w a s  
o b t a i n e d  f r o m  A m e r s h a m  (No.  TRK625) .
1 1 .  [ 3 H] d GT P  ( D e o x y [ 8 - 3 H] g u a n o s i n e  5 f- t r i p h o s p h a t e ,  
a mmo n i u m s a l t ) ,  1 2 . 3 C i / m m o l e ,  wa s  o b t a i n e d  f r o m  
A m e r s h a m  (No.  TRK350) .
1 2 .  01 i  go(  dT^ 2 _ i g)  > w a s  o b t a i n e d  f r o m  P h a r m a c i a  P - L  
B i o c h e m i c a l  (No.  P - L  7 8 5 8 ) .
1 3 .  C a l f  t h y m u s  DNA,  w a s  o b t a i n e d  f r o m  S i g m a  ( No .  
D 8 8 9 9 ) .
1 4 .  TCA ( T r i c h l o r o a c e t i c  a c i d ) ,  a n a l y t i c a l  r e a g e n t ,  
wa s  o b t a i n e d  f r o m  AJAX C h e m i c a l s  (No.  5 5 8 ) .
1 5 .  DTT ( D L - D i t h i o t h e r i t o l )  wa s  o b t a i n e d  f r o m  S i g m a  
( No .  D - 0 6 3 2 ) .
1 6 .  AMV r e v e r s e  t r a n s c r i p t a s e ,  wa s  o b t a i n e d  f r o m  L i f e  
S c i e n c e  I n c .
1 7 .  T e r m i n a l  d e o x y n u c 1 e o t i d y 1 t r a n s f e r a s e ,  w a s  
o b t a i n e d  f r o m  P h a r m a c i a  P - L  B i o c h e m i c a l  ( No .  
0 7 3 0 )  .
1 8 .  O l i g o ( d G - ^ g ) ,  w a s  o b t a i n e d  f r o m  P h a r m a c i a  P - L  
B i o c h e m i c a l  (No.  P - L  7 8 8 9 ) .
1 9 .  T e t r a c y c l i n e ,  w a s  o b t a i n e d  f r o m  B o e h r i n g e r  
M a n n h e i m  (No.  1 5 5 3 9 ) .
2 0 .  L y s o z y m e ,  wa s  o b t a i n e d  f r o m  S i g m a  (No.  L - 6 8 7 6 ) .
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21. Ribonuclease A, was obtained from Sigma (No. 
R4875).
22. Ethidium bromide, was obtained from Sigma (No. 
E8751).
23. PIPES [ P i p e r a z i n e - N , N’-b i s ( 2-e t han e s u 1 f o ni c 
acid)] was obtained from Calbiochem-Behring Corp. 
(No. 528132).
24. Formamide, puriss, was obtained from Fluka (No. 
47670).
2 5. E^ co_li_ t R N A , was obtained from B oehringer 
Mannheim (No. 109541).
26. Calf intestinal alkaline phosphatase, was 
obtained from Sigma (No. P5521).
27. PEG6000 (polyethylene glycol 6000), laboratory 
reagent, was obtained from BDH C h e m i c a l s  
Australia Pty. Ltd. (No. 29577).
28. Silane (Methacrylic acid 3-Trimethoxy-Silylpropyl 
Ester), was obtained from Tokyo Kasei (No. M725).
29. Dimethyldichlorosilane LABCHEM, was obtained from 
AJAX Chemical Company (No. 664).
30. TEMED ( N ,N ,N ’, N T-Tetramethy1ethy1ene-diamine) , 
was obtained from BDH Chemical Ltd. (No. 30385).
31. Ammonium persulfate, laboratory reagent, was 
obtained from BDH Chemicals Ltd. (No. 27195).
32. [y-^^P]ATP (Adenosine 5’-[y-^"P] triphosphate, 
triethylammoniura salt), 5 0 00 Ci /m mo l e,  was 
obtained from Amersham (No. PB10128).
- 57-
33. T4 polynucleotide kinase, was obtained from 
Pharmacia P-L Biochemicals (No. P-L 0734).
34. Salmon sperm DNA, was obtained from Sigma (No. D- 
1626) .
35. Low melting point agarose, electrophoresis grade, 
was obtained from Bethseda Research Laboratories 
Inc. (No. 5 51 7 4 A) .
36. Partisil-IOSAX, was obtained from Watraan (No. 
4126-010).
37. Ampicillin, was obtained from Beecham Research 
Laboratories.
38. Ficoll 400, was obtained from Pharmacia Fine 
Chemicals. (No. 17-0400-01).
39. P o l y v i n y l - p y r r o li d on e  (av. MW 360,000) was 
obtained from Sigma (No. DVP-360).
40. Bovine serum albumin (Bovine albumin powder, 
faction V from bovine plasma) was obtained from 
Armour-Pharmaceutical Company Ltd.
41. Acrylamide, was obtained from BDH Chemicals Ltd. 
(No. 44299).
42. N ,N ’ - Methy1enebisacry1a m i d e , was obtained from 
BDH Chemicals Ltd. (No. 15213).
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Plasmids, bacteriophages and bacteria strains.
1. pAT153 (Twigg and Sherratt, 1980).
2. M13rap8 (Messing, 1981).
3. M13mp9 (Messing, 1981).
4. pBR322 (Bolivar et al., 1977).
5. E. coli HB101 (Bolivar and Backman, 1979).
6. JM103 (Messing, 1983).
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III. Solutions.
1. Scintillation fluid: 2,5-dipheny1oxazo1e in
Xylol-Triton X-100 (2:1 vol/vol).
2. High-salt buffer: lOOmM NaCl, 50mM Tris-HCl
pH7.5, lOmM MgCl2> ImM 2-mercaptoethanol.
3. Medium-salt buffer; 50mM NaCl, 10mM Tris-HCl 
p H 7.5 , lOmM M g C12 > ImM 2-mercaptoethanol.
4. Low-salt buffer: lOmM Tris-HCl pH7.5, lOmM MgCl2, 
ImM 2-mercaptoethanol.
5. Smal buffer: 20mM KCl, lOmM Tris-HCl pH8.0, lOmM
M g C12 > ImM 2-mercaptoethanol.
6. LB medium: 10g Bacto-tryptone, 5g Bacto-yeast
extract, 10g NaCl, 1 litre H 2 0, pH7.5.
7. LB agar: 10g Bacto agar in 500ml LB medium.
8. Tetracycline agar: LB agar plus 25ug/ml
tetracycline.
9. Ampicillin agar: LB agar plus 50yg/ml Ampicillin.
10. STET buffer: 8% sucrose, 5% Triton X-100, 50mM 
EDTA, 50mM Tris-HCl pH8.0.
11. BPB dye mix: 29gm sucrose, 0.09gm Broraophenol
blue, 1.86gra EDTA in 100ml H20, pH8.0.
12. SSC: 0.15M NaCl, 0.015M Na citrate, pH7.
13. STE buffer: lOmM NaCl, lOmM Tris-HCl ph7.5, ImM 
EDTA.
14. 56 medium: 10g (NH^^SO^, lg MgS04, 30.5g
NaH2PC>4, 53g K2HPO4 in 1 litre H20.
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15. 56 culture medium: 1 litre 56 medium with 0.02g
Ca(N03)2.4H20, 0.0001% FeS04 , 0.03M glucose,
0.0015mM Vitamin B1 and 0.5% Casamino acid.
16. YT medium: 8g tryptone, 5g yeast extract, 5g
NaCl, 1 litre H 20, pH7.5.
17. Tris-acetate buffer: 0.04M Tris-acetate 0.002M 
EDTA, p H7.8 .
18. TBE buffer: 0.089M Tris-borate, 0.089M Boric
acid, pH8.
19. Denhardt's solution: O.lg Ficoll, O.lg
polyvinylpyrrolidone, 0.1g BSA (brovin serum 
albumin) in 10ml H20.
20. Annealing buffer: lOmM Mg G12, 10m M Tris-HCl
pH8.5.
21. 40% acrylamide stock: 38g acrylamide, 2g bis-
acrylamide in 100ml H20, deionized and millipore 
filtered.
22. Colony storage medium: LB medium with the
following compounds (g/litre): K 2 H P 0 4 (6.3),
K H 2P04 (1.8), Na Citrate (0.45), M g S 0 4.7H20
(0.09), (NH4)2S04 (0.9), glycerol (44).
23. H agar: 10g bacto-agar, 10g tryptone, 8g NaCl in 
11. H20, pH7.5.
24. H top agar: 7g bacto-agar, 10g tryptone, 8g NaCl 
in 11. H20, pH7.5.
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IV. Methods.
3.1. Construction of the WEH1-3B cDNA library.
a. First strand cDNA synthesis.
Synthesis of first-strand cDNA was carried out in 
a reaction volume of 5 0 y 1 containing 5 0mM Tris-HCl, 
pH8.3, lOmM MgCl2 > 140mM KC1, 30mM 2-mercaptoethanol, 
2 0 0 y M each of dATP, dTTP, dCTP, dGTP, lyCi [ct-32P] 
dATP (- 3000 Ci/mmole), 5yg poly(A)+ RNA, 5 y g
o ligo (dT 2 2_l 8^> and 50 units reverse transcriptase at 
42°C for I hr.
Samples were taken out at 30 min and 60 min to 
check the extent of incorporation. 2yl of reaction 
mixture was mixed with 28yl 0.02M EDTA, pH8. To 
determine the total count, lOyl of the mixture was 
diluted with 10ml of 50% ethanol in a scintillation 
vial and the radioactivity determined by Cerenkov 
counting. To determine TCA precipitable counts a lOyl 
sample was added to lOOyl of sonicated calf thymus DNA 
(500yg/ml in lOmM Tris-HCl, pH7.5, O.lmM EDTA) in a 
5ml disposible plastic tube. 5ml of ice-cold 10% TCA 
was added and chilled on ice for 15 min. The 
precipitate was collected by filtering the solution 
through a GF/C glass-fiber disc (Whatman) using a 
suction filter apparatus. The filter was washed six 
times with 5 m 1 ice-cold 10% TCA folio wed by 5 m 1 of
95% ethanol. The radioactivity of the filter was
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determined in 10ml 50% ethanol by Cerenkov counting. 
The reaction was stopped by adding 1/10 volume ( 5 y 1) 
of 0.2 M EDTA, pH8. 5yl of 5M NaCl and lyl of 10% SDS 
were added and mixed well. The solution was then 
extracted with an equal volume of phenol, chloroform 
and isoamylalcohol mixture (50:48:2). 2.5 volumes of
absolute ethanol was added to the aqueous phase and 
mixed well. It was kept in dry-ice ethanol bath for 1 
hr and centrifuged in Eppendorf centrifuge for 30 min 
at 4°C. The pellet was washed with cold absolute 
ethanol and dried under vacuum.
b. Hydrolysis of the RNA.
The pellet was dissolved in 200yl of fresh 0.1M 
NaOH and incubated at 70°C for 20 min. The solution 
was then neutralized with 10 y 1 of 1M Tris-HCl, pH7.5, 
and 20yl of 1M HC1. The first strand cDNA was then 
separated from the unincorporated dNTPs and the 
products of alkaline hydrolysis of the template by 
chromatography on a 5m 1 Sephadex G-75 column in 10mM 
Tris-HCl, pH 7, 1 m M EDTA, lOOmM NaCl. 5 drops
f r a c t i o n s  we r e  c o l l e c t e d  and the a m o u n t  of 
radioactivity determined by Cerenkov counting. The 
fractions in the excluded volume that contained 
radioactivity were pooled. 1/10 volume of 5M NaCl and 
2.5 volumes of absolute ethanol were added and the 
mixture kept in a dry-ice ethanol bath for 1 hr. It 
was centrifuged in an SS34 rotor at 20,000rpm, -15°C
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for 30 min. The DNA pellet was washed with cold 
absolute ethanol and dried under vacuum.
c. dC tailing of the first-strand cDNA.
The dC tailing or dG tailing of DNA was performed 
according to the method of Michelson and Orkin (1982).
5 y C i of [ ^  H ] dCTP (51 Ci/mmole; ie 98 pmoles) was 
dried in a siliconized Eppendorf tube under vacuum.
1 0 y 1 of 10X TdT buffer, lyl of 10m M DTT 
(dithiothreitol), lyl of 5 0 0m M dCTP, 5 y 1 of 10mg/ml 
BSA (bovine serum albumin), 49yl of first-strand cDNA 
(16.4ng/yl in lOmM Tris-HCl, pH7.5 , O.lmM EDTA) and 
31.4yl of water were added to the dried [^H] dCTP and 
mixed well. The solution was equilibrated at 12°C for 
5 min. A lyl s a m p l e  was w i t h d r a w n  for the 
determination of the TCA precipitable counts (see 
below) .
The reaction was started by adding 3.6yl of 15 
units/yl terminal deoxynuc1eotidy1 transferase and 
incubated at 12°C. lyl samples were taken out at 15 
min and 30 min to measure the % incorporation of dCTP. 
The lyl samples were diluted in 29yl ice cold 0.02M 
EDTA, pH8. lOyl of the diluted sample was spotted on 
a GF/C glass-fiber filter and dried under a lamp and 
counted in 10ml of scintillation fluid for the 
determination of total counts. Another lOyl of the 
diluted sample was added to lOOyl sonicated calf
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t h y m u s  DNA ( 5 0 0 y g / m l  in l O m M  Tris-HCl, pH7.5, O.lmM 
EDTA) in a d i s p o s a b l e  p lastic tube. 5 ml ice cold 10% 
TCA was added and chilled in ice for 15 min. The 
precipitate was collected by filtering through a GF/C 
g l a s s - f i b e r  f i l t e r  u s i n g  a s u c t i o n  f i l t e r i n g  
apparatus. The filter was w a s h e d  6 t i mes w i t h  ice- 
cold 10% TCA and once w i t h  5ml of 95% ethanol. The 
filter was dried under a lamp and counted in 10ml of 
scintillation fluid.
The r e a c t i o n  m i x t u r e  was t e m p o r a r i l y  chilled on 
ice to stop the reaction while checking the length of 
the added tail. The i n c u b a t i o n  was c o n t i n u e d  until 
the tail length reached about 15 residues per molecule 
of cDNA and the re a c t i o n  was stopped by adding 0.1 
v o l u m e  of 0.2M EDTA, p H 8, f o l l o w e d  by rapid c h i l l i n g  
on ice. T h e  r e a c t i o n  m i x t u r e  wa s  i m m e d i a t e l y  
e x t r a c t e d  w i t h  a n  e q u a l  v o l u m e  o f  
c h 1 o r o f o r m : i s o a m y 1 a 1 c o h o 1 (48:2). The organic phase 
was r e e x t r a c t e d  wit h  20]il l O m M  Tris-HCl, pH7, I m M  
EDTA, l O O m M  NaCl. 0.1 v o l u m e  of 3M so d i u m  acetate, 
pH5.5, and 2.5 volumes of absolute ethanol were added 
to the pooled aqu e o u s  phase and m i x e d  well. The 
solut i o n  was kept in a d r y - i c e  e thanol bath for 1 hr 
and centrifuged in an Eppendorf centrifuge for 30 min 
at 4°C. The cDNA pellet was washed with cold absolute
ethanol and dried under vacuum.
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d.  D o u b 1 e - s t r a n d e d  cDNA s y n t h e s i s  ( L a n d  e t  a l . , 
1 9 8 1 )  .
T h e  p r i m e r ,  o l i g o ( d G ^ Q )  w a s  f i r s t  a n n e a l e d  w i t h  
t h e  dC t a i l e d  s i  n g 1 e - s  t  r  a n d cDNA i n  a v o l u m e  o f  a 6 5 y l  
c o n t a i n i n g  5 3 5 n g  o f  dC t a i l e d  s i n g l e - s t r a n d  cDNA, 3 y g  
o f  o l i g o ( d G - L o ) , 50mM T r i s - H C l ,  p H 8 . 3 ,  30mM KC1 a n d  
10mM Mg Cl 2 . The  a n n e a l i n g  m i x t u r e  wa s  h e a t e d  a t  68° C 
f o r  5 m i n  t h e n  c o o l e d  a t  4 3 ° C  f o r  15 m i n  a n d  f i n a l l y  
c o o l e d  a t  0°C f o r  2 m i n .
A f t e r  a n n e a l i n g ,  1 . 8 y l  o f  1M T r i s - H C l ,  p H 8 . 3 ,  
l . l l i l  o f  IM KC1,  3 . 5  y 1 o f  0 . 1M M g C l 2 , l y l  o f  1M D T T , 
8 y 1 o f  d N T P s  ( 2 . 5  m M e a c h ) ,  2 y 1 o f  [ a - ^ ^ P ] d A T P  
( l y C i / y l )  a n d  1 6 . 7 y l  o f  w a t e r  w e r e  a d d e d  t o  t h e  
a n n e a l i n g  m i x t u r e  a n d  m i x e d  w e l l .  l y l  o f  t h e  m i x t u r e  
wa s  t a k e n  o u t  t o  m e a s u r e  t h e  b a c k g r o u n d  r a d i o a c t i v i t y  
a s  b e f o r e .  The  r e a c t i o n  wa s  s t a r t e d  by a d d i n g  2 y l  o f  
r e v e r s e  t r a n s c r i p t a s e  ( 1 5 u n i t s / y l )  a n d  t h e  r e a c t i o n  
m i x t u r e  i n c u b a t e d  a t  4 2 ° C. l y l  s a m p l e s  w e r e  t a k e n  o u t  
a t  3 0  m i n  a n d  6 0  m i n  t o  c h e c k  t h e  p e r c e n t a g e  
i n c o r p o r a t i o n  o f  l a b e l .  A f t e r  t h e  m a x i m u m  
i n c o r p o r a t i o n  wa s  r e a c h e d  ( u s u a l l y  1 h r )  t h e  r e a c t i o n  
w a s  s t o p p e d  by a d d i n g  l O y l  o f  0 . 2M EDT A, pH8 ,  l O y l  o f  
5M N a C l  a n d  2 y l  o f  10% SDS.  I t  w a s  t h e n  e x t r a c t e d  
w i t h  a n  e q u a l  v o l u m e  o f  p h e n o l ,  c h l o r o f o r m  a n d  
i s o a m y l a l c o h o l  m i x t u r e  ( 5 0 : 4 8 : 2 ) .
T h e  d o u b 1 e - s  t  r  a n d cDNA i n  t h e  a q u e o u s  p h a s e  w a s  
s e p a r a t e d  f r o m  t h e  u n i n c o r p o r a t e d  d N T P s  b y
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chromatography on a 5ml Sephadex G-75 column in lOmM 
Tris-HCl, pH7, ImM EDTA, lOOmM NaCl. Fractions in the 
excluded volume containing radioactivity were pooled. 
1/10 volume of 3M NaCl, and 2.5 volumes of absolute 
ethanol were added and the mixture kept in a dry-ice 
ethanol bath for 1 hr. The precipitated cDNA was 
centrifuged in an Eppendorf centrifuge for 30 min at 
4°C. The pellet was washed with cold absolute ethanol 
and dried under vacuum.
e. dC tailing of double-stranded cDNA.
5yCi of [^H]dCTP (51Ci / mmole, ie 98 pmoles) was 
dried down in a siliconized Eppendorf tube under 
vacuum. lOyl of 10X TdT buffer, lyl of lOmM DTT, lyl 
of 500yM dCTP (ie. 500 pmoles), 5 y 1 of 10mg/ml BSA, 
50yl of double-strand cDNA (718ng) and 29.6yl of water 
were added to the dried [^HjdCTP and mixed well. It 
was equilibrated at 20°C for 5 min. A lyl sample was 
taken out for checking the background radioactivity by 
acid precipitation as in Method 3.1c. The reaction 
was started by adding 3.2yl of 15 units/y1 terminal 
deoxynuc1eotidy1 transferase ('12 units/pmole of 3’ 
end) and incubated at 20°C. After 20 min of 
incubation the reaction mixture was chilled on ice. A 
lyl sample was taken out to determine the average 
number of residues added per 3* end as in Method 3.1c. 
When the tail length reached the required size, the 
reaction was topped by adding lOyl of 0.2M EDTA, pH8,
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and the mixture was immediately extracted with an 
equal volume of chloroform:isoamylalcohol (48:2). The 
aqueous phase was chromatographed on a 5ml Sephadex 
G75 column in lOmM Tris-HCl, pH7, ImM EDTA, 100mM 
NaCl. Fractions in the excluded volume containing 
radioactivity were pooled. 1/10 volume of 3M sodium 
acetate, pH5.5, and 2.5 volumes of absolute ethanol 
were added and mixed well. The mixture was kept in a 
dry-ice ethanol bath for 1 hr and centrifuged in an 
Eppendorf centrifuge for 30 min at 4°C. The DNA 
pellet was washed with cold absolute ethanol and dried 
under vacuum. It was finally resuspended in lOmM 
Tris-HCl, p H 7.5 , 0.25mM EDTA, lOOmM NaCl.
f. dG tailing of linearized pAT153.
5 0 y g of pAT153 DNA was digested in 1 5 0 y 1 of IX 
high salt buffer containing 250 units of P s 1 1 
restriction endonuclease at 37°C for 3 hr. In order 
to ensure the complete digestion of pAT153, 10 times 
excess Ps 11 restriction endonuclease was used in the 
digestion. After digestion the reaction mixture was 
extracted with an equal volume of phenol, chloroform 
and isoamyl alcohol mixture (50:48:2). 1/10 volume of 
3M sodium acetate, pH5.5, and 2.5 volume of absolute 
ethanol were added and mixed well. The mixture was 
kept in a dry-ice ethanol bath for 1 hr and 
centrifuged in an Eppendorf centrifuge for 15 min at 
4°C. The pellet was washed with cold absolute ethanol
- 68-
and dried under vacuum. It was resuspended in water.
In the dG tailing of PstI linearized pAT153, two 
parallel experiments were carried out under the same 
conditions. One reaction was followed by the 
incorporation of [^H]dGTP and the other was not. To 
9 8 jj 1 of 0.07 5y g/y1 PstI digested pAT153, 20yl of 10X 
TdT buffer, 2yl of lOmM DTT, 2yl of 500yM dGTP, lOyl 
of 10mg/ml BSA and 60yl of water were added and mixed 
well. The reaction mixture was equilibrated at 20°C 
for 5 min. 8 y 1 of 15 u n i t s / y l  t e r m i n a l  
deoxynucleotidyl transferase was added to the reaction 
mixture and mixed well. 18 0 y 1 of the mixture was 
transferred to another Eppendorf tube containing lyl 
of 81yM dGTP and incubated at 20°C. Another 20yl of 
the mixture was transferred to an Eppendorf tube 
containing lyCi of dried [^H]dGTP (12.3Ci/mmole) and 
incubated at 20°C. After 5 min of reaction both tubes 
were chilled on ice. A lyl sample was taken from the
Otube containing [ HjdGTP to determine the length of 
the dG tail as in Method 3.1c. When the dG tail 
reached the optimal length, the reaction without 
[^HjdGTP was stopped by adding 18yl of 0.2M EDTA, pH8. 
It was immediately extracted with an equal volume of 
chloroform:isoaraylalcohol (48:2). 1/10 volume of 3M
sodium acetate, pH5.5, and 2.5 volumes of absolute 
ethanol were added and mixed well. The mixture was 
kept in a dry-ice ethanol bath for 1 hr and
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centrifuged in an Eppendorf centrifuge for 15 min at 
4°C. The DNA pellet was washed with cold absolute 
ethanol and dried under vacuum. It was resuspended in 
lOmM Tris-HCl, pH7.5, 0.25mM EDTA, lOOmM NaCl.
g. Anealing of the dC tailed doub1e-stranded 
cDNA with dG tailed pAT153.
39.1ng of dG tailed pAT153 (0.016 pmoles) and 
5.29ng of dC tailed doub1e-stranded cDNA (ie. 0.016 
pmoles, assuming an average size of 500 base pair) 
were mixed in 9 0 y 1 of lOmM Tris-HCl, pH7.5, 0.25 mM 
EDTA, lOOmM NaCl. The annealing mixture was heated at 
70°C for 10 min in a water bath then the whole water 
bath was transferred into a polystyrene foam box. The 
annealing mixture was allowed to cool down very slowly 
to room temperature for 24 hr.
h. Transformation (Dagert and Ehrlich, 1979).
HB101 was grown to 1x10^ cells/ml (ie. Klett 
value of 40) in 30ml LB medium at 37°C. The cells 
were collected by centrifugation in a Sorvall SS34 
rotor at 5,000rpm, 4°C for 5 min. The cell pellet was 
resuspended in 30ml of cold lOmM Tris-HCl, pH7.3, 50mM 
CaCl2 . The cells were pelleted again and resuspended 
in 30ml of cold lOmM Tris-HCl, pH7.3, 50mM CaC^, and 
kept in ice for 30 min. They were pelleted again and 
resuspended in 1ml of cold lOmM Tris-HCl, pH7.3, 50raM 
C a C12 •
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After the annealing mixture had cooled to room 
temperature it was chilled in ice for 2 min. 310]il of 
C a C l 2 treated HB101 were added to 90yl of the 
annealing mixture and kept in ice for 1 hr with gentle 
mixing every 10 min. The cells were then heat shocked 
at 39° for 2 min. The transformed cells were plated 
(lOOy1/plate) on tetracycline plates and incubated at 
37°C for 36 hr.
Pools of ten transformants were transferred to a 
sterilized vial with 1ml of colony storage medium 
(Gergen et al., 1979). The vials were incubated at 
37°C for 24 hr and then stored at -20°C.
3.2. Screening the W EH I- 3 B cDNA library by the 
hybridization-translation assay (Parnes et al., 1981; 
Taniguchi et al., 1983).
a. Small scale preparation of plasmid DNA 
(Holmes and Quigley, 1981).
50yl of cells carrying the recombinant plasmids 
was inoculated into 40ml LB medium and grown at 37°C 
for 18 hr. Cells were harvested by centrifugation and 
resuspended in 2.8ml STET buffer at room temperature. 
200yl of lysozyme (10mg/ml in 250mM Tris-HCl, pH8) was 
added to the cell suspension and kept in a boiling 
water bath for 2 min and centrifuged in a Sorvall SS34 
rotor at 20,000rpm, 4°C, for 15 min. The supernatant
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w a s  t r a n s f e r r e d  t o  a n o t h e r  c e n t r i f u g e  t u b e  a n d  a n  
e q u a l  v o l u m e  o f  c o l d  i s o p r o p a n o l  a d d e d  a n d  m i x e d  w e l l .  
The  t u b e  wa s  k e p t  a t  - 2 0 ° C  f o r  30 mi n  a n d  c e n t r i f u g e d  
i n  a S S 3 4  r o t o r  a t  1 0 , 0 0 0 r p m ,  0 ° C  f o r  10 m i n .  T h e  
p e l l e t  w a s  w a s h e d  w i t h  e t h e r  a n d  d r i e d  u n d e r  v a c u u m .  
The  p e l l e t  w a s  f i n a l l y  r e s u s p e n d e d  i n  4 0 0 y l  lOmM T r i s -  
HC1,  pH7 . 5 ,  O. lmM EDTA a n d  i n s o l u b l e  m a t e r i a l  r e m o v e d  
by c e n t r i f u g a t i o n  i n  an  E p p e n d o r f  c e n t r i f u g e  f o r  5 mi n  
a t  4 ° C .  T h e  c l e a r  s u p e r n a t a n t  w a s  t h e n  s t o r e d  i n  a 
s i l i c o n i z e d  E p p e n d o r f  t u b e  a t  - 2 0 ° C .
b.  B i n d i n g  o f  t h e  p l a s m i d  DNA on n i t r o c e l l u l o s e  
f i l t e r s .
The  p l a s m i d  DNA w a s  f i r s t  l i n e a r i z e d  w i t h  Bam HI 
r e s t r i c t i o n  e n d o n u c l e a s e .  4 0 0 y l  o f  c r u d e  p l a s m i d  DNA 
( e q u i v a l e n t  t o  4 0 ml  c u l t u r e )  wa s  a d d e d  t o  4 0 0 y l  o f  2X 
h i g h  s a l t  b u f f e r  c o n t a i n i n g  5 0  u n i t s  o f  B a m H I  
r e s t r i c t i o n  e n z y m e  a n d  w a s  i n c u b a t e d  a t  3 7 ° C  f o r  20  
h r .  D i g e s t i o n  o f  t h e  p l a s m i d  DNA w a s  c h e c k e d  by  g e l  
e l e c t r o p h o r e s i s .  A l O y l  s a m p l e  f r o m  t h e  d i g e s t i o n  
m i x t u r e  was  t r e a t e d  w i t h  l y l  RNAaseA ( 1 0 r a g / m l  i n  0.1M 
s o d i u m  a c e t a t e ,  p H5 ,  p r e - b o i l e d  f o r  10  m i n )  a t  3 7 ° C  
f o r  15 m i n .  5 y l  o f  BPB d y e  m i x  w a s  a d d e d  t o  t h e  
RNAaseA t r e a t e d  s a m p l e s  a n d  l o a d e d  t o  a 1% a g a r o s e  g e l  
c o n t a i n i n g  e t h i d i u m  b r o m i d e  0 . 5 y g / m l .  E l e c t r o p h o r e s i s  
w a s  c a r r i e d  o u t  i n  T r i s - a c e t a t e  b u f f e r  c o n t a i n i n g  
0 . 5 y  g / m l  o f  e t h i d i u m  b r o m i d e  f o r  1 h r  a t  1 0 0 m A
c o n s t a n t  c u r r e n t .
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T h e Bam HI digested crude plasmid DNA was 
extracted with an equal volume of phenol, chloroform 
and isoamyl alcohol mixture (50:48:2). 1/10 volume of 
3M sodium acetate, pH5.5, and 2.5 volumes of absolute 
ethanol was added to the aqueous phase and mixed well. 
The mixture was kept in a dry-ice ethanol bath for 1 
hr, then centrifuged in an SS34 rotor at 20,000rpm, - 
15°C for 15 min. The DNA pellet was washed with cold 
absolute ethanol and dried under vacuum.
The dry DNA pellet was dissolved in 1ml of fresh 
0.1M NaOH and kept at 70°C for 20 min. It was then 
diluted into 20ml of 2M NaCl (20ml for 2.5cm diam. 
filter, 10ml for 1.3cm diam.) and filtered through a 
nitrocellulose filter (Schleicher and Schuell BA85, 
0.45mm pore) as shown in Figure 3.1. The filter was 
washed with 10ml 6XSSC and blotted dry between two 
sheets of sterilized Whatman No. 1 filter paper. It 
was then baked at 80°C in a vacuum oven for 2 hr.
c. Hybridization and elution of mRNA.
Hybridization was carried out in a sterilized and 
siliconized glass vial which was just larger than the 
nitrocellulose filters used.
Hybridization fluid (1ml for 2.5cm diam. filter, 
250yl for 1.3cm diam.) containing 50% deionized 




(10ml syringe for 
smaller filter)
20ml of 2M NaCI 






F i g u r e  3 . 1  B i n d i n g  o f  d e n a t u r e d  p l a s m i d  DNA on t o  t h e  
n i t r o c e l l u l o s e  f i l t e r .  T h e  a p p a r a t u s  w a s  s e t  u p  
w i t h o u t  t h e  g a u g e  2 0  n e e d l e .  T h e  n i t r o c e l l u l o s e  
f i l t e r  w a s  w e t  by  f i l t e r i n g  5 m l  o f  s t e r i l i z e d  
d i s t i l l e d  w a t e r  a n d  t h e n  w i t h  5 m l  o f  2M N a C I .  T h e  
o u t l e t  o f  t h e  f i l t e r  h o l d e r  wa s  s e a l e d  w i t h  p a r a f i l r a  
a n d  t h e  a p p a r a t u s  wa s  f i l l e d  w i t h  2 0 ml  ( 1 0 m l  f o r  s m a l l  
f i l t e r )  o f  2M N a C I .  1 m l  ( o r  5 0 0 j j1 f o r  s m a l l  f i l t e r )  
o f  NaOH d e n a t u r e d  p l a s m i d  DNA w a s  t h e n  a d d e d  t o  t h e  2M 
Na C I  a n d  m i x e d  w i t h  a p a s t e u r  p i p e t t e .  T h e  s o l u t i o n  
w a s  f i l t e r e d  s l o w l y  ( 0 . 5 m l / m i n )  t h r o u g h  t h e  
n i t r o c e l l u l o s e  f i l t e r  by c o n n e c t i n g  a g a u g e  20 n e e d l e  
t o  t h e  o u t l e t  o f  t h e  f i l t e r  h o l d e r .  T h e  f i l t e r  w a s  
t h e n  w a s h e d  w i t h  1 0 ml  ( 5 m l  f o r  s m a l l  f i l t e r )  6XSSC.
- 73-
0.1% SDS and 400yg of WEHI-3B mRNA was heated at 70°C 
for 10 min then chilled in ice. 10 filters were then 
immersed in the hybridization fluid. The glass vial 
was sealed and incubated at 37°C for 18 hr.
The filters were transferred to a 500ml 
sterilized and siliconized glass bottle and washed 3 
times with 200ml (50ml for small filters) washing 
buffer I (lOmM PIPES, pH6.4, 0.15M NaCl, 1 mM EDT A , 
0.2% SDS) at 65° by shaking and aspiration. They were 
then washed another 3 times with 50ml (10ml in a 20ml 
sterilized and siliconized glass bottle for small 
filters) washing buffer II (ImM PIPES, pH6.4, lOmM 
NaCl) at room tempe r at ur e by vortex mixing and 
aspiration.
After washing, the filters were transferred 
separately into sterilized siliconized glass vials (or 
sterilized and siliconized Eppendorf tubes for small 
filters). 3 0 0 y 1 of water and 4 y g E_^_ co 1 i tRNA were 
added. The glass vials (or Eppendorf tubes) were 
placed in a boiling water bath for 90 seconds, quick 
frozen in a dry-ice ethanol bath, and thawed at room 
temperature. The 3 0 0 y 1 water with eluted mRNA was 
transferred to a sterilized and siliconized Eppendorf 
tube. 12 y 1 of 5M NaCl and 800yl of absolute ethanol 
were added and mixed well. The tubes were kept in a 
dry-ice ethanol bath for 2 hr and centrifuged in an 
Eppendorf centrifuge for 15 min at 4°C. The mRNA
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pellet (hardly visible) was washed with cold absolute 
ethanol and dried under vacuum.
The mRNA pellet was resuspended in 5ul lOmM Tris- 
HC1, pH7.5, O.lmM EDTA. The mRNA samples were assayed 
by translation in Xenopus laevis oocytes as described 
in Method 2.6.
3.3. Digestion of DNA with restriction endonucleases.
In a typical reaction lug of DNA was digested in 
10ul containing IX the appropriate digestion buffer 
and 1 unit of restriction enzyme at the appropriate 
t em p er a t u r e  for 1 hr or longer in a sterilized 
siliconized Eppendorf tube. Since the manufacturers’ 
units are based on the digestion of lambda DNA the 
number of units used was varied according number of 
restriction sites in the DNA to be digested.
The reaction was stopped by addition of 1/10 
volume of 0.2M EDTA, pH8. If the DNA was to be 
analyzed directly by electrophoresis, 5ul of BPB dye 
mix was added, and the mixture loaded onto the gel. 
If the restricted DNA was to be purified, it was 
e x t r a c t e d  once w i t h  p h e n o l ,  c h l o r o f o r m  and 
isoamylacohol mixture (50:48:2) and precipitated with 
ethanol.
Most of the restriction enzymes were purchased 
from New England Biolabs. The restriction enzymes
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were used at the temperature recommended by the 
manufacturers and in either high, medium or low salt 
buffer (see Solutions) according to their NaCl 
requirement. However, a particular Smal buffer was 
used for the Smal restriction enzyme (see Solutions).
3.4. Dephosphorylation of DNA fragments.
Dephosphorylation of DNA fragments was carried 
out in 50yl containing 50mM Tris-HCl, ImM MgCl2» 5yg 
(up to lOyg) linear DNA and 5 units of calf intestinal 
alkaline phosphatase. To dephosphory1 ate protruding 
5’ termini, the reaction mixture was incubated at 37°C 
for 30 min. Another 5 units of calf intestinal
alkaline phosphatase was added and the reaction 
mixture incubated for a further 30 min.
To dephosphorylate DNA fragments with blunt ends 
or recessed 5’ termini, the reaction mixture was 
incubated for 15 min at 37°C and 15 min at 56°C. Then 
a n o t h e r  5 u ni t s of calf i n t e s t i n a l  a l k a l i n e  
phosphatase was added and the incubation repeated at 
both temperatures.
After incubation, 2yl of 0.5M EDTA, pH8, was 
added and the reaction mixture was extracted with 
phenol, chl o r o fo r m  and i s o a m y 1 a 1 c o h o 1 mixture 
(50:48:2). 1/10 volume of 3M sodium acetate, pH5.5,
and 2.5 volumes of absolute ethanol were added and
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raixed well. The mixture was kept in a dry-ice ethanol 
bath for 1 hr and centrifuged in an Eppendorf 
centrifuge for 15 min at 4°C. The DNA pellet was 
washed with cold absolute ethanol and dried under 
vacuum. It was then resuspended in lOmM Tris-HCl, 
p H 7.5 , O.lmM EDT A.
Since the calf intestinal alkaline phosphatase 
was supplied as a suspension in ammonium sulfate, the 
enzyme was pretreated before use. An aliquot of calf 
intestinal alkaline phosphatase was centrifuged in an 
Eppendorf centrifuge for 10 min at 4°C. The 
supernatant was removed and the pellet was resuspended 
in sterile distilled water.
3.5 Ligation of DNA.
cDNA or DNA fragments were ligated to the vector 
DNA in a molar ratio of 1:1 in 66mM Tris-HCl, pH7.5, 
6.6mM MgCl2, 50yg/ml BSA, ImM ATP, 20mM DTT and 1 unit 
of T4 DNA ligase. Reaction mixtures were incubated at 
16°C, 15 hr for sticky ends and 20 hr for blunt ends. 
After ligation, the ligated DNA in the reaction 
mixture was directly used for transformation without 
any purification.
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3.6 DNA sequencing by the chain termination method 
(Sanger et al., 1977; Sanger et al., 1982).
a. Preparation of the template.
A drop of overnight culture of JM101 was added to 
25ml of 2XYT medium. A single plaque of the 
recombinant M13 phage was picked with a sterile 
toothpick and transferred to 1ml of the diluted JM101 
culture in a 5ml disposable plastic tube. The tube 
was shaken at 37°C for 6-9 hr. The culture was 
centrifuged in an Eppendorf centrifuge for 5 min at 
4°C. 8 0 0 u 1 of the supernatant was carefully
transferred to another Eppendorf tube. 200yl of 2.5M 
NaCl, 20% PEG 6000 was added, mixed well and kept at 
room t e m pe r at u r e  for 15 min. The mixture was 
centrifuged in an Eppendorf centrifuge for 5 min at 
4°C. Supernatant was carefully removed and the tube 
was recentrifuged briefly and the supernatant again 
removed. The PEG pellet was resuspended in 100yl lOmM 
Tris-HCl, pH6.5, O.lmM EDTA. It was extracted with 
50yl of neutralized phenol. The aqueous phase was 
extracted with 0.5ml diethyl ether. lOyl of sodium 
acetate, pH5.5, and 250yl of absolute ethanol were 
added and mixed well. The mixture was kept in a dry- 
ice ethanol bath for 1 hr and centrifuged in an 
Eppendorf centrifuge for 15 min at 4°C. The pellet 
was washed with cold absolute ethanol and dried under 
vacuum. It was resuspended in 50]il of lOmM Tris-HCl,
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pH7.5, O.lraM EDTA.
b. Preparation of 6% acrylamide sequencing gel.
The acrylamide gels were covalently bonded to one 
of the glass plates to facilitate subsequent drying of 
the gel prior to autoradiography. Before setting up 
the gel apparatus, one glass plate was treated with 
Silane and the cut-out glass plate was siliconized. 
5ml of Silane mixture (50yl Silane, 10ml ethanol and 
330]_il 10% acetic acid) was spread evenly on the clean
back glass plate using a tissue and allowed to dry for 
3 min. The plate was then washed with ethanol and 
dried. 5 m 1 of s i l i c o n i z i n g  s o l u t i o n  (2% of 
dimethyldichlorosilane in CCl^) was spread evenly on 
the cut-out glass plate and dried for 3 min. The cut­
out plate was then rinsed with distilled water. The 
Silane treated back glass plate was then taped 
together with the siliconized cut-out glass plate and 
appropriate spacers. For a 36.5cm x 20cm and 0.4mm 
thick gel, 40ml of urea-acrylamide mix was used. 
19.2g of ultra pure urea was dissolved in 6ml 40% 
acrylamide stock, 2ml 10X TBE and 10ml distilled water 
at 37°C. The solution was made up to 40ml with 
distilled water. 4 0 u 1 of TEMED was added and then 
filtered through a millipore filter (Schleicher and 
Schuell, BA85, 0.45mm). 240|il of 10% fresh ammonium
persulfate was added to the solution and mixed well 
and the mixture immediately dispensed into the cavity
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bet w e e n the two glass plates using a 60ml syringe. 
The gel was allowed to set for 1 hr. The gel could be 
prepared a day before the DNA sequencing experiment.
c. Preparation of 2X N termination mix and N*
mix .
The 2X N termination mix was prepared according 
to the following table:










dTTP ( ImM) 4 80 80 80
dCTP ( ImM) 80 4 80 80
dGTP ( 1 mM ) 80 80 4 80
2 x dNTP buffer 20 20 20 20
d dTTP (0.8mM) 184 - - -
ddCTP (0.2mM) - 184 - -
d dGTP (0.2mM) - - 184 -
dd ATP (O.lmM) - - - 184
total 368 368 368 368
stored at -20°C
2 x dNTP buffer: O.lmM Tris-HCl, pH8, 2mM EDTA.
- 8 0 -
The  N* w a s  ma de  up j u s t  b e f o r e  u s e  a c c o r d i n g  t o  t h e  
f o l l o w i n g  t a b l e :
dN* mi x
c o n t e n t  
2 x dATP mi x  
2 x dGTP mi x  
2 x dTTP mi x  
2 x dCTP mi x
[ a - P 3 2 ] dATP
( l O y l s / u l )
dATP( 5mM)
dA* mi x  dG* mi x
( H i )  ( H i )
6
6
1 . 2  1 . 2
1 . 2  1 . 2
d T * mi x  dC* mi x  







s t e r i l i z e d
d i s t i l l e d  w a t e r  3 . 6  3 . 6  3 . 6  2 . 4
t o t a l 12 12 12 12
d .  S e q u e n c i n g  r e a c t i o n .
( i )  A n n e a l i n g .
5 u 1 o f  M13 t e m p l a t e ,  1 ]i 1 10X a n n e a l i n g
b u f f e r ,  l u l  s e q u e n c i n g  p r i m e r  ( 5 n g )  a n d  3 p l  s t e r i l i z e d  
d i s t i l l e d  w a t e r  w e r e  m i x e d  w e l l  a n d  s e a l e d  i n  a 
c a p i l l a r y  t u b e .  T h e  u n i v e r s a l  p r i m e r  d e s c r i b e d  by
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Duckworth et al. (1981) (5 'GTA A AACGACGGCCAGT3 ’) was 
used in the sequencing reaction unless otherwise 
specified. The capillary was placed in a boiling 
water bath for 3 min then cooled to room temperature.
(ii) Preparation of the reaction matrix.
The s e al e d  glass c a p i l l a r y  c o n t a i n i n g  the 
annealed primer-template was dried with tissue and cut 
open by a diamond pen. 0.3]il of Klenow (~1.5 units) 
was added to the capillary. The annealed template and 
enzyme were mixed well by sucking up and down and 
expelled to the bottom of a sterilized Eppendorf tube. 
2yl of the enzyme and template mixture was distributed 
to the bottom of each sterilized capless Eppendorf 
tube using an automatic pipette with siliconized tips. 
The tubes were inclined at an angle of 45°. 2]il of N* 
mix ( d A * , d G *, d C *, d T * ) was added to the top of each 
corresponding Eppendorf tube.
(iii) Initiating the reaction.
The reactions were started by centrifuging the 
tube briefly to mix the drops and the tubes incubated 
at 37°C for 10 min.
(iv) dNTP chase.
The whole rack was taken out from the 37°C water 
bath and inclined at an angle of 45°. 2yl containing 
0.5mM of each dNTPs was added to the top of each tube.
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Drops were mixed by brief centrifugation and the tubes 
placed in a metal rack at 37°C for another 10 min.
(v) Termination of the reaction.
The metal rack was taken out from the 37°C water 
bath and inclined at an angle of 4 5°. 4 ji 1 of 
formamide dye mix was added to the top of each tube. 
The drops were mixed by centrifugation and the tubes 
placed in a boiling water bath for 5 min prior to 
loading on a 6% acrylamide sequencing gel.
e. Electrophoresis of the samples.
About 2.5ul of each reaction mixture was loaded 
onto the 6% acrylamide gel. Electrophoresis was 
initially carried out at 50 Watts constant power and 
then reduced to 30 Watts after the temperature of the 
gel reached to 57°C.
Electrophoresis was stopped when the bromophenol- 
blue dye reached the bottom of the gel. The two glass 
plates were separated leaving the acrylamide gel on 
the back glass plate. The gel was fixed in 10% acetic 
acid for 30 min with occasional mixing. The gel was 
then completely dried in a drying cupboard (“70°C) and 
cooled to room temperature. 'Scotch gard’ (3M, Scotch 
gard) was sprayed evenly on top of the gel and dried 
for 5 min.
An X-ray film (Fuji, RX) was placed directly on
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top of the dried gel and covered by a glass plate to 
ensure good contact. The film was exposed for several 
hours and developed in a Kodak X-OMAT processor.
The DNA sequence data was assembled and analyzed 
using the computer programs described by Standen 
(1980, 1982a).
3.7 Labelling restriction fragments using [a-^^P] dATP.
DNA fragments with protruding 5 ’ end were 
labelled with [a-^PjdATP using the Klenow fragment of 
E, co1i DNA polymerase I.
In a typical reaction, lug of pBR322 DNA was
digested in 20yl of IX high salt buffer, with 5 units
of Hin fI restriction endonuclease at 37°C for 1 hr.
The reaction mixture was diluted with 20yl of IX low
salt buffer. lyl of [a-^P] dATP (lOyCi/yl) and 0.5yl
of the Klenow fragment of EL_ c o 1i DNA polymerase I
(~2.5 units) were added and incubated at 37°C for 10
min. In some cases, the radioactive restriction
fragments were separated from the unincorporated [a- 
3 2P]dATP by chromatography on a Sephadex G-75 column 
in 1 OmM Tris-HCl, pH7, ImM EDTA, lOOmM NaCl.
3.8 5'-end labelling of synthetic primers.
The reaction was carried out in 50yl containing 
20 pmoles of the synthetic oligonucleotide. 20pmoles
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of [y-32p]dATP (Amersham 10218, 2pmoles/yl), 70mM 
Tris-HCl, pH7.6, lOmM MgCl2, 5mM DTT and 5 units of T4 
polynucleotide Kinase (P-L 0734) at 37°C for 1 hr. 
The reaction mixture was heated at 65°C for 10 min and 
then chromatographed on a 1ml Sephadex G-10 column in 
lOmM Tris-HCl, pH7, ImM EDTA, lOOmM NaCl, to separate 
the labelled primer from unincorporated label.
3.9. Colony hybridization.
a. Growth of the colonies on the nitrocellulose 
filter.
Colonies of recombinant plasmid were transferred 
to an agar plate containing the appropriate antibiotic 
in a grid pattern using sterile toothpicks. The 
plates were incubated at 37°C overnight and kept as a 
master plate. The nitrocellulose filter (Schleicher 
and Schuell, BA85, 401116) was marked with a black 
marker pen and lowered onto a second agar plate using 
2 pairs of sterilized forceps and allowed to wet 
completely. The replica plating tool was sterilized 
by soaking in 70% ethanol for 5 min, in 100% ethanol 
briefly and the excess ethanol flamed. A print was 
made from the master plate to the agar plate with the 
nitrocellulose filter. The plate was then incubated 
at 37°C overnight and the master plate was stored at 
4°C.
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b. Binding the DNA to the filters.
The nitrocellulose filter was peeled off the agar 
plate and placed colony side up for 10 min on top of 
two sheets of 3MM paper, which were saturated with 
denaturing solution (0.5M fresh NaOH, 1.5M NaCl). The 
filter was dried briefly on a 3MM paper and placed 
colony side up for 10 min on top of two sheets of 3MM 
paper, which were saturated with neutralizing solution 
(1.5M NaCl, 0.5M Tris-HCl, pH7.5). Excess liquid was 
removed from the filter on a 3MM paper. The filter 
was then placed colony side up for 10 min on top of 2 
sheets of 3MM paper, which was saturated with 2XSSC. 
The filter was air dried, place between 2 sheets of 
3MM paper and baked at 80°C in a vacuum oven for 2 hr. 
After baking, the filter could be stored in a vacuum 
dessicator for at least 2 weeks at room temperature 
prior to use.
c. Prehybridization.
The filters still placed between 2 sheets of 3MM 
paper were wet with 6XSSC. Filters were then 
separated from the paper, placed in 300ml prewashing 
solution (50mM Tris-HCl, pH8, 1M NaCl, ImM EDTA, 0.1% 
SDS) and incubated at 42°C for 2 hr with shaking. The 
prewash step was to remove from the filter any 
absorbed medium, frag me nt s  of agarose or loose
bacterial debris.
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After the prewash, the filters were prehybridized 
in 10ml prehybridization fluid (5XSSC, 5X Denhardt's 
solution, 200yg/ml of denaturated sonicated Salmon 
sperm DNA) in a sealed plastic bag (up to 10 
filters/bag) at the hybridization temperature for 4 
hr .
The hybridization temperature was dependenton the 
probe size. For probe size larger than 200 base pairs 
the hybridization temperature was 65°C. For synthetic 
oligonucleotide probes the hybridization temperature 
was 5 to 10° below the melting temperature (Tm).
Approx. Tm of a synthetic primer = (2X no. of AT + 4X no.
(up to 20-mer) of GC)
(Singer-Sam et a l ., 1983)
d. Hybridization.
The prehybridization fluid was removed from the
plastic bag. 5m 1 of hybridization fluid (5XSSC, 5X
Denhardt’s solution) was added to the bag. Double-
stranded probes were denatured by heating at 100°C for
3 min then quick chilled on ice-water. The denatured
probe was added to the hybridization fluid to a final
concentration of 15-20ng/ml. The plastic bag was
of
sealed carefully avoiding the trapping^any air bubbles 
inside the hybridization fluid. Hybridization was 
c a r r i e d  out at the p a r t i c u l a r  h y b r i d i z a t i o n  
temperature for 12 to 16 hr.
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Time of hybridization = 3 x Cotl/2
number of hr to achieve Cotl/2 = 1 Y Z „ 9
X 5 1Ö
where X = the weight of probe added (in pig)
Y = its complexity (in Kb)
Z = the volume of the reaction (in ml)
e. Washing of the filters.
The filters were washed briefly in 300ml 5XSSC at 
room temperature then washed in 11. of 5XSSC at the 
hybridization temperature with agitation for 1 hr. 
The background was checked by the hand monitor (Mini­
instrument Ltd. model 5-10E). If the count was over 
50 counts per sec, the filters were washed for a 
longer time until the background dropped to <_ 10 
counts per sec. The filters were blotted dry between 
3MM papers and covered with Saran wrap. The filters 
were then exposed to X-ray film (Kodak, XAR-5 or Fuji, 
RX) at -70°C with an intensifying screen overnight. 
The X-ray films were developed in a Kodak X-OMAT 
processor.
3.10. Isolation of DNA fragments from low melting 
point agarose gels.
D NA  f r a g m e n t s  w e r e  s e p a r a t e d  by gel 
e l e c t r o p h o r e s i s  u s i n g  low m e l t i n g  a g a r o s e . 
Electrophoresis was carried out at 4°C in a cold room.
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After electrophoresis the agarose gel was stained with 
0.5]_il ethidiura bromide in fresh Tris-acetate buffer. 
The DNA bands were visualized using a 300ram UV 
transilluminator with a plastic sheet placed under the 
gel. The DNA band of interest was cut out from the 
gel with a sterilized scalpel blade and transferred 
into a graduated centrifuge tube. The gel volume was 
measured by the displacement method. An equal volume 
of lOmM Tris-HCl, pH7.5, O.lmM EDTA was added to the 
gel fragment. The gel was melted at 70°C for 2 min 
with brief shaking. The solution was extracted 4 
times with phenol and then 4 times with diethyl ether, 
1/10 volume of 5M NaCl (and 1/100 volume of 1M M gC l 2 
for the DNA fragment < 200bp), 2.5 volumes of absolute 
ethanol were added and mixed well. The mixture was 
kept in a dry-ice ethanol bath for 1 hr and 
centrifuged in a SS34 rotor at 20,000rpm, -15°C for 
30 min. The DNA pellet was washed with cold absolute 
ethanol and dried under vacuum. It was finally 
resuspended in lOmM Tris-HCl, pH7.5, O.lmM EDTA.
3.11. Deoxyoligonucleotide synthesis.
All the synthetic primers used in this thesis 
were prepared by Dr. I.G. Young and Mr. G. Mayo.
Deoxyo1igonuc1eotides were synthesized by the 
phosphite phosphotriester route (Tanaka and Letsinger, 
1982; McBride and Caruthers, 1983). After cleavage
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from the silica supports the oligonucleotides were 
purified by HPLC using a Partisi1-10SAX ion exchange 
column. The column was packed and equilibrated in 
buffer A (ImM K P O 4 , pH6.3, 60% f o r m a m i d e  v/v). 
Samples were loaded and eluted using a linear gradient 
from 100% buffer A, 0% buffer B (0.3 M KPO4, pH6.3, 
60% formamide v/v) to 30% buffer A, 70% buffer B, at a 
flow rate of lml / min. The elution was monitored by 
measuring the absorbance at 270nm. Peak fractions 
were pooled, diluted 1 in 2 in buffer A, reloaded on 
the column, and eluted using a steep linear gradient 
from about 20% to 70% of buffer B. The peak fraction 
was collected and desalted using a Sephadex G25 
column. 1.5ml fractions were collected and absorbance 
at 270nm was measured. The peak was collected and 
evaporated to dryness by rotary evaporation. The 
sample was finally resuspended in 0.1ml lOmM Tris-HCl, 
pH7.5, O.lmM EDTA. All glassware was siliconized and 
all plastic apparatus was sterilized.
3.12. Size- fractionation of DNA on Sepharose CL-4B 
column.
A Sepharose CL-4B column was prepared in a 
disposable lml plastic pipette plugged with sterile 
siliconized glass wool. The column was equilibrated 
with lOmM Tris-HCl, pH8, ImM EDTA, 0.3M NaCl.
DNA sample (about 6 0 u 1) was applied to the
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column. After the DNA sample had completely run into 
the column, the reservoir was topped up with the above 
buffer. A 6 drop fraction was collected for the first 
fraction and then thirty 1 drop fractions were 
collected. The radioactivity of each fraction was 
measured by Cerenkov counting of the whole tube inside 
a scintillation vial.
The same column was calibrated using as size 
marker HinfI restriction fragments derived from PBR322 
and labelled with [a-^PjdATP. The fractions were 
c o l l e c t e d  in t he s a m e  w a y  as b e f o r e  and 
e1ectrophoresed on a 1.4% agarose gel. The gel was 
dried on a glass plate and covered with Saran wrap. 
The gel was then exposed to X-ray film (Kodak XAR-5) 
at room temperature for 5 hr. The X-ray film was 
developed using a Kodak X-OMAT processor.
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V . Results.
1. Preparation of WEHI-3B cDNA library.
The myelomonocytic leukemia line WEHI-3B (Warner 
et al. , 1969) was chosen as the source of mRNA which
was prepared from the WEHI-3B cells by the guanidine 
thiocyanate method. The mRNA preparation was purified 
by chromatography on o 1 igo(dT)-ce11u 1 ose and then 
fractionated on a sucrose density gradient. The 
fractions were assayed by microinjection into Xenopus 
oocytes. RNA from the peak fraction was used as 
template to synthesize double-stranded cDNA.
a. First-strand cDNA synthesis.
4.6ug of IL-3 mRNA from fraction 8 of the sucrose 
density gradient was used as template to synthesize 
the first-strand cDNA using oligo(dT 2_ g )  as primer. 
The percentage of incorporation of dNTPs reached
the maximum of 10.3% after 30 min reaction (Table 3.1) 
and it was calculated that 1.35yg of first-strand cDNA 
was synthesized.
b. Hydrolysis of RNA.
The RNA was hydrolyzed in 2 0 0 li 1 of freshly 
prepared 0.1M NaOH at 70°C for 20 min. It was then 
neutralized and the cDNA separated from the 
unincorporated dNTPs and the products of alkaline 
hydrolysis by chromatography on a Sephadex G-75
Table 3.1 First-strand cDNA synthesis
Time of 
reaction
% of incorporation of 
[ 32P ]dATP
cDNA synthesised
30 min 10.3 1.35yg 29%
60 min 10.3 1.35yg 29%
First strand cDNA was synthesized from partially 
purified IL-3 mRNA as described in Method 3.1a. lyl 
of sample was taken out after 30 min and 60 min ofr o nreaction and assayed for the incorporation of [a- ^P] 
dATP by TCA precipitation.
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column. The cDNA was then ethanol precipitated giving 
a recovery of 820ng of first-strand cDNA.
c. dC tailing of the first-strand dNA.
The method of Land et al. (1981) was used for 
second strand synthesis and cloning in order to try 
and obtain a cDNA carrying a complete copy of the 
original mRNA. 804ng of s i ng1e-strand cDNA was used 
as a template for dC tailing using terminal 
deoxynucleotyidy1 transferase. It was assumed that the 
average size of the cDNA was 500 base pairs long. The 
enzyme to substrate ratio used was about 11 units per 
pmole of 3' ends. After 30 min the length of the dC 
tail reached an average of 11.1 residues per 3 ’
end of cDNA (Table 3.2). About 590ng cDNA was 
recovered after the tailing reaction.
d. double-strand cDNA synthesis.
Oligo(dG^g) was hybridized to the dC tailed 
single-strand cDNA and second strand synthesis carried 
out using reverse transcriptase. The percentage of 
dNTPs incorporated reached a maximum after 30 min and 
about 630ng of second-strand cDNA were synthesized. 
After phenol extraction and chromatography on Sephadex 
G75 about 718ng of double-stranded cDNA was recovered.
e. dC tailing of double-strand cDNA.
The cDNA was then tailed with dC residues using
Table 3.2 dC tailing of the first-strand cDNA
Reaction
time
% of [3H]dCTP pmoles of dCTP 
incorporated incorporated
(minus background)











The dC tailing reaction was carried out using 
terminal transferase as described in Method 3,1c.
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terminal deoxynuc1eotidy1 transferase. After 20 min 
the average size of dC tail was about 11 residues per 
3' end of doub1e-stranded cDNA. After chloroform 
extraction and chromatography on Sephadex G-75 about 
464ng of dC tailed double-stranded cDNA was recovered.
e. dG tailing of pAT153.
pAT153 was converted into a linear form by 
digestion with PstI restriction endonuclease. 7.4 ug 
of the linearized pAT153 (i.e. 6 pmoles of 3 ’ ends)
was t a i l e d  w i t h  dG r e s i d u e s  u s ing t e r m i n a l  
deoxynucleotidy1 transferase. A parallel experiment 
was conducted using [^H] dGTP to determine the length 
of the dG tails. After 5 min of reaction the length of 
the dG tail was about 12 residues per 3' end and the 
reaction was terminated by the addition of EDTA. 
Following chloroform extraction the dG tailed vector 
was recovered by ethanol precipitation.
f. Annealing and transformation.
The dC tailed doub1e-strand cDNA and dG tailed 
pAT153 were annealed in a molar ratio of 1:1 and 
transformed into HB101 (Method 3.1g and h). In the 
t r a n s f o r m a t i o n ,  t h ree d i f f e r e n t  heat s h o c k  
temperatures were tested (37°C, 39°C and 42^C). The 
transformation efficiency was almost the same using 
heat shock temperatures of 39°C and 42°C but was very 
low using 3 7 0 C (Table 3.3). M o s t  of the












dC tailed double-strand cDNA was annealed to dG 
tailed P s 11 linearized pAT153 as in Method 3,lg. To 
each 90yl of annealed mixture, 310yl of CaCl2 treated 
HB101 was added. After standing on ice for 60 min 
with gentle mixing every 10 min, the cells were heat 
shocked at 37°C, 39°C or 42°C. The transformed cells
w e r e  then p l a t e d  on agar p l a t e s  c o n t a i n i n g  
tetracycline. Number of transformants were counted 
after incubation at 37°C for 36 hr.
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transformation experiments were therefore carried out 
using 39°C. The average transformation efficiency was 
65 transformants per ng of cDNA. The transformants 
(6720) were grown as a pool of ten colonies in 
glycerol broth (colony storage medium) and stored at 
-20°C. A small sample of 57 individual transformants 
were tested for sensitivity to ampicillin. About 90% 
were sensitive indicating that they contained cDNA 
inserts .
2. S c r e e n i n g  the W E H I - 3 B  cDNA l i b r a r y  by 
hybridization-translation .
a. Preparation of plasmid DNA.
Recombinant plasmids were grown in pools of 10 on 
a small scale and crude plasmid DNAs were prepared by 
the method of Holmes and Quigley (1981) generally 
yielding about 3 0 p g of plasmid DNA per 40ml of 
culture.
The plasmid DNA was linearized using B> a _ in HI 
r e s t r i c t i o n  e n d o n u c l e a s e  and c h e c k e d  by 
electrophoresis on 1% agarose gel (Figure 3.2). After 
phenol extraction and ethanol precipitation the DNA 
preparations were treated with 0.1M NaOH at 70°C for 
20 min to hydrolyse contaminating RNA.
Figure 3.2 Plasmid DNAs prepared from hybrid plasmid 
pools. Plasmid DNAs were prepared on a small scale, 
digested with B a m HI restriction endonuclease and 
checked by gel electrophoresis as described in Method 
3.2b. Lanes 1, 8 and 15, A-HindIII standards; lanes 
2-7 and 9-14, plasmid DNAs. The direction of 
electrophoresis is from top to bottom.
1 2 3 4  5 6 7 89101112131415
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b. Binding of plasmid DNA to nitrocellulose.
Following alkaline hydrolysis to DNA preparations 
were diluted with 2M NaCl giving a final pH of about 9 
and s l o w l y  p a s s e d  t h r o u g h  2.5cm d i a m e t e r  
nitrocellulose filters to allow binding (Figure 3.1). 
The filters were then washed with 10ml 6XSSC, blotted 
dry and baked at 80°C in a vacuum oven for 2 hr.
The binding efficiency was studied by adding [a-
dATP labelled linear pBR322 DNA to the crude 
plasmid DNA prior to hydrolysis of the RNA. The 
binding efficiency for the procedure above was 72%. 
The binding exper i m e n t s  established that the 
efficiency was much lower if protein was not removed 
by phenol extraction, or if the phenol itself was not 
removed by ethanol precipitation and washing. In 
addition, the binding efficiency reduced to about half 
if the DNA preparation was neutralized after alkaline 
hydrolysis.
c. Hybridization-translation.
The recombinant plasmids were firstly screened by 
the hybridization-trans1ation assay in pools of 10. 
10 nitrocellulose filters each containing plasmid DNA 
from 10 recom b i n a n t  clones were used in each 
h y bridization- t r a n s 1 ation assay. Therefore 100 
different clones could be screened in each experiment. 
The 10 filters were hybridized with 400)ig of WEHI-3B
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mRNA and the bound mRNA subsequently eluted and 
recovered by ethanol precipitation using 4pg of E . 
c o 1 i tRNA as carrier. The mRNAs were then translated 
in oocytes (Method 2.6). The E_^_ c o 1 i tRNA does not 
interfere with translation of WEHI-3B mRNA in Xenopus 
laevis oocytes.
One positive pool of 10 clones was detected among 
the screening of 45 pools. This positive pool was 
verified by repeating the hybridization-1rans1 ation 
assay 3 times. The activity observed in translates 
derived from this positive pool was quite low but was 
consistently 2 to 3 times above the background and the 
values of the other negative clone pools.
DNA was therefore prepared from the individual 
clones of the positive pool and the hybridization- 
translation assay repeated. In screening the 
individual clones, half the amount of plasmid DNA 
("15u g) was used and bound to 1.3cm diameter 
nitrocellulose filters. 10 of these small filters were 
hybridized with 100pg of WEHI-3B mRNA in 250]Jl of 
hybridization fluid in a small glass vial. From the 
hybr i d i z a t i o n - t r a n s 1 ation assay one of the ten 
individual clones (pILMl) was clearly positive (Table 
3.4). The IL-3 activity detected showed the same 
titration curve as oocyte translates of WEHI-3B mRNA 
(Figure 3.3).
Table 3.4 mRNA hybridization translation assay for 
detection of IL-3 cDNA clones











DNA samples ( ~ 1 5 y g ) were prepared from each clone by 
the rapid boiling method and were bound to the 
nitrocellulose filters as described in Method 3.2. 
The 10 filters were hybridized with 1 0 0 y g of WEHI-3B 
mRNA and the bound mRNA was eluted as described in 
Method 3.2c. The eluted mRNA was translated in oocyte 
as in Method 2.6. A unit of IL-3 activity is that 
required to give 50% of the maximum incorporation of 










3 4 5 6 7
Sample dilution ( 2 n)
8 9
F i g u r e  3 . 3 .  T i t r a t i o n  c u r v e s  f o r  t h e  I L - 3  a c t i v i t y  
p r e s e n t  i n  o o c y t e  t r a n s l a t e s .  ▲ , T r a n s l a t e s  o f  mRNA 
h y b r i d i z i n g  t o  p I L M l ;  • ,  t r a n s l a t e s  o f  WE H I - 3 B  mRNA.  
T w o f o l d  d i l u t i o n s  o f  t h e  o o c y t e  t r a n s l a t e s  w e r e  ma de  
i n  m i c r o t i t r e  t r a y s  a n d  t h e  I L - 3  a c t i v i t y  p r e s e n t  wa s  
m e a s u r e d  u s i n g  t h e  I L - 3  d e p e n d e n t  c e l l  l i n e  32D c l - 2 3  
a s  d e s c r i b e d  i n  Me t h o d  2 . 7 .  The  s t i m u l a t i o n  o f  g r o w t h  
o f  t h e  i n d i c a t o r  c e l l s  i s  e x p r e s s e d  i n  t e r m s  o f  ^ H -  
t h y m i d i n e  i n c o r p o r a t i o n .  The  d o t t e d  l i n e s  d e s i g n a t e d  
a ,  b a n d  c r e p r e s e n t  i n c o r p o r a t i o n s  o f  1 0 0 %,  50% a n d  
b a c k g r o u n d  p l u s  t h r e e  s t a n d a r d  d e v i a t i o n s  
r e s p e c t i v e l y  .
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3. Characterization of pILMl.
a. Size of pILMl cDNA insert.
Since even short cDNA clones would be active in 
the hybridization-translation assay, the cDNA used to 
construct the library was not size fractionated and 
was expected to contain some short cDNA. Indeed the 
size of the pILMl cDNA insert was found to be about 
160 to 170 base pairs (Figure 3.4).
b. subcloning of the pILMl cDNA insert into 
M13mp8 and M13rap9.
pILMl plasmid DNA was digested with _P s__t I 
restriction endonuclease and the mixture fractionated 
by electrophoresis on a low melting agarose gel. The 
gel was stained with ethidium bromide and the insert 
DNA was recovered by phenol extraction and ethanol 
precipitation.
M13mp8 (or M13mp9) was completely digested with 
P s 11 restriction endonuclease and dephosphory1 ated 
with calf intestinal alkaline phosphatase (Method 
3.4). The pILMl cDNA insert was ligated with the 
M 1 3 m p 8 (or M 1 3 m p 9 ) u s i n g  T4 DNA l i g a s e  and 
transfected into CaCl 9 treated competent cells of 
JM103 (Method 2.1h). The cells were plated on H top 
agar containing X-gal and IPTG so that the recombinant 
phage (colorless plaques) could be distinguished from 
the parental phage (blue plaques).
Figure 3.4 Size of the cDNA insert in pILMl. 1 0 y g 
of pILMl plasmid DNA was digested with 30 units of 
Ps11 restriction endonuclease in 30yl of IX high salt 
buffer at 37°C for 1 hr. It was treated with 20yg of 
RNAaseA at 37°c for 15 min before being loaded to a 
2.5% agarose gel. The gel was electrophoresis at 70mA 
for 3.5 hr and then was stained with 0.5yg/ml ethidium 
bromide and photographed. Lanes (a) Hinfl-digested 
pBR322; (b) Pstl-digested pILMl. The direction of 
electrophoresis is from top to bottom. The sizes of 
standards are indicated in base pairs.
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c. Nucleotide sequence analysis.
The nucleotide sequence analysis was carried out 
in collaboration with Dr. H.D. Campbell. Single 
stranded DNA was prepared from the templates of M13mp8 
and M13mp9 recombinants and the inserts sequenced 
(Method 3.6) using the chain termination method.
This yielded the sequence of both strands of the 
cDNA insert in pILMl (Figure 3.5). The cDNA insert in 
pILMl was quite short. It was only 139 base pairs 
excluding the G-C tails. There were 12 G-C pairs at 
one end at 19 G-C pairs at the other end. Since the 
3' end of the first-strand cDNA was dC tailed twice in 
making the cDNA library, the end with the longer G-C 
tail should represent the 5!-end of the original mRNA.
4. Construction of the second cDNA library.
To isolate a clone carrying the entire IL-3 
coding sequence, a second cDNA library was prepared, 
but in this case the doub1e- stranded cDNA was size- 
fractionated using Sepharose CL-4B to enrich for cDNA 
fragments larger than 500 base pairs.
2.9]jg of WEHI-3B mRNA from the fraction 8 of the 
sucrose gradient (see above) was used as a template to 
synthesize the first-strand cDNA. 665ng of first- 
strand cDNA was synthesized (i.e. 22.9%) after 60 min
5
G AACGAGACAATGGTTCTTGCCAGCTCTACCACCAGCATCCACACCATGCTGCTCCTGCTCCT 
30 40 50 60 70 80
GATGCTCTTCCACCTGGGACTCCAAGCTTCAATCAGTGGCCGGGATACCCACCGTTTAAC
100 110 120 130
( 12)
F i g u r e  3 . 5  N u c l e o t i d e  s e q u e n c e  o f  t h e  cDNA i n s e r t  i n  
p I L M l .  T h e  cDNA i n s e r t  i n  p I L M l  w a s  s u b c l o n e d  i n t o  
t h e  P s 1 1 s i t e  o f  M1 3 mp 8  a n d  M 1 3 m p 9 .  DNA s e q u e n c i n g  
w a s  c a r r i e d  o u t  by  t h e  c h a i n  t e r m i n a t i o n  m e t h o d .
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of reaction.
After hydrolysis of the mRNA template and 
purification of the first-strand cDNA on a Sephadex G- 
75 column (Method 3.1b). 380ng of single-strand cDNA
was recovered.
A h o m o p o 1 y m e r i c dC tail was added to the 3’ end 
of the first single-strand cDNA (Method 3.1c). After 
45 min of reaction, the tail length reached an average 
of 11.6 residues per 3* end of the cDNA, assuming the 
average size of the cDNA to be 500 base pairs. 311ng 
of dC tailed first sing1e- strand cDNA was recovered 
after chloroform extraction and ethanol precipitation.
The second-strand of the cDNA was synthesized 
using Oligo(dG-^Q) as primer yielding 219ng of the 
s e c o n d - strand cDNA from 311ng of the dC tailed 
template. 310ng of the doub1e-stranded cDNA was 
recovered after phenol extraction, chromatography on a 
Sephadex G-75 column and ethanol precipitation.
This was then used as template for the dC 
tailing reaction and after 30 min of reaction, it was 
found that the dC tail had reached an average size of 
15.4 residues per 3’ end of the cDNA. After phenol 
extraction, the sample was chromatographed on a 
Sepharose CL-4B column and 30 fractions were collected 
(Figure 3.6).
The same column was calibrated using as size
5Figure 3.6 Size fractionation of the dC-tailed double 
stranded cDNA on a Sepharose CL-4B column. (a) Column 
profile for size fractionation of [ ^  ^  P ] -1 a b e 11 e d 
double stranded cDNA (Method 3.11) . (b) Column
profile for size fractionation of [^Pj-labelled HinfI 
digested pBR322 size standards (Method 3.7). The 
individual frac t i o n s  from this sep a r a t i o n  were 
analyzed by agarose gel electrophoresis (see Figure 
3.7) .
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m a r k e r s  H i  n f  I  f r a g m e n t s  d e r i v e d  f r o m  p BR3 2 2  a n d  
l a b e l l e d  w i t h  [ a - ^ ^ P j d A T P .  T h e  f r a c t i o n s  w e r e  
c o l l e c t e d  a n d  e 1 e c t r o p h o r e s e d  on  a 1. 4% a g a r o s e  g e l  
( F i g u r e  3 . 7 ) .  The  dC t a i l e d  d o u b l e - s t r a n d e d  cDNA f r o m 
f r a c t i o n s  5 t o  8 w h i c h  w e r e  e x p e c t e d  t o  c o n t a i n  cDNA 
f r a g m e n t s  o f  s u f f i c i e n t  s i z e  w e r e  p o o l e d  a nd  e t h a n o l  
p r e c i p i t a t e d .  5 7 n g  o f  DNA w a s  r e c o v e r e d ,  a n n e a l e d  
w i t h  dG t a i l e d  p A T 1 5 3  a n d  t r a n s f o r m e d  i n t o  HB1 0 1 .  
A p p r o x i m a t e l y  32 t r a n s f o r m a n t s  p e r  ng  cDNA w e r e  
o b t a i n e d  a n d  92% o f  t h e s e  w e r e  a m p i c i l l i n  s e n s i t i v e .
5.  S c r e e n i n g  o f  t h e  s e c o n d  cDNA l i b r a r y  by c o l o n y  
h y b r i d i z a t i o n .
An o l i g o n u c l e o t i d e  p r i m e r  T T GAAGCTTGGAG-  
TCCCAGGT^ ) c o r r e s p o n d i n g  t o  n u c l e o t i d e s  9 2 - 1 1 2  o f  t h e  
s h o r t  cDNA i n s e r t  o f  p I L M l  w a s  s y n t h e s i z e d  a n d  
l a b e l l e d  u s i n g  [ y -  P]  dATP a n d  p o l y n u c l e o t i d e  k i n a s e  
( M e t h o d  3 . 8 ) .  T h e  l a b e l l e d  p r i m e r  w i t h  a s p e c i f i c  
a c t i v i t y  o f  7 . 6  x 1 0 ® c p m / u g ,  w a s  u s e d  t o  e x a m i n e  t h e  
r e m a i n i n g  c l o n e s  i n  t h e  f i r s t  cDNA l i b r a r y  a n d  t h o s e  
i n  t h e  s e c o n d  cDNA l i b r a r y  by c o l o n y  h y b r i d i z a t i o n  a t  
5 5 ° C ( M e t h o d  3 . 9 ) .
No o t h e r  c l o n e s  c o n t a i n i n g  t h i s  s e q u e n c e  w e r e  
d e t e c t e d  f r o m  t h e  f i r s t  l i b r a r y .  One c l o n e ,  p I LM3,  i n  
t h e  s e c o n d  l i b r a r y  h y b r i d i z e d  s t r o n g l y  t o  t h e  l a b e l l e d  
p r i m e r  ( F i g u r e  3 . 8 ) .
Figure 3.7 Autoradiograph of the calibration of the 
Sepharose CL-4B column with [^^P ]-1 abe11ed size 
markers. [ ^ P ] - l a b e l l e d  H i n fl digested pBR322 
fragments were size- fractioned on a Sepharose CL-4B 
column (see Figure 3.6) and the fractions analyzed by 
electrophoresis on a 1.4% agarose gel. The gel was 
dried and autoradiographed. The lane numberings
correspond with the fraction numbers in Figure 3.6(b). 
The direction of electrophoresis is from top to 
bo t tom.
1 3 2 2 / F ra c tio n s
Hint I 7 8 9 10 11 12 13 14 15 16 17 18 1920 21 22
Figure 3.8 Autoradiograph of colony screening of IL-3 
cDNA library. T,he oligonucleotide primer (-^TTGAAG- 
CTTGGAGTCCCAGGT^ ) complementary to portion of the IL- 
3 cDNA sequence of pILMl was labelled using [y-32pj 
ATP and T4 polynucleotide kinase (Method 3.8). The 
labelled probe had a specific activity of 7.6 x 10^ 
cpm/yg was used for screening the IL-3 cDNA library by 
colony hybridization as described in Method 3.9. 
A positive clone (pILM3) is indicated.
plLM3
- 1 0 1 -
6 .  C h a r a c t e r i z a t i o n  o f  p I LM3.
P l a s m i d  DNA w a s  p r e p a r e d  f r o m  p I L M3  on  a s m a l l  
s c a l e  a n d  a p a r t i a l  r e s t r i c t i o n  map p r e p a r e d  ( Me t h o d  
3 . 3 ) .  As  s h o w n  i n  F i g u r e  3 . 9 ,  o n e  o f  t h e  P s 1 1 c l o n i n g  
s i t e s  w a s  l o s t .  T h e  cDNA i n s e r t  w a s  a b o u t  6 0 0  b a s e  
p a i r s  l o n g  w i t h  o n e  s i t e  f o r  b o t h  H i  n d 1 1 1  a n d  Ba mH I 
r e s t r i c t i o n  e n d o n u c l e a s e s .  T h e r e  w e r e  no P v u l , E c o RI  
o r  P s 1 1 s i t e s  i n  t h e  cDNA i n s e r t .
7 .  N u c l e o t i d e  s e q u e n c e  o f  t h e  cDNA i n s e r t  i n  p I LM3.
The  DNA s e q u e n c e  o f  c l o n e  pI LM3 wa s  d e t e r m i n e d  on 
b o t h  s t r a n d s  u s i n g  t h e  c h a i n  t e r m i n a t i o n  m e t h o d  
( Me t h o d  3 . 6 )  a f t e r  s u b c l o n i n g  i n t o  M13mp8 a n d  9.  The  
s e q u e n c i n g  s t r a t e g y  i s  g i v e n  i n  F i g u r e  3 . 1 0 a .  T h e  
s u b c l o n i n g  wa s  c o m p l i c a t e d  by t h e  f a c t  t h a t  o n e  o f  t h e  
P s t l  s i t e s  f l a n k i n g  t h e  cDNA i n s e r t  h a d  b e e n  l o s t  du e  
t o  e x o n u c l e o l y t i c  r e m o v a l  o f  o n e  n u c l e o t i d e  d u r i n g  t h e  
G t a i l i n g  o f  t h e  v e c t o r .
F i r s t  t h e  2 . 8  Kb Ba mHI  f r a g m e n t  f r o m  p I L M3  w a s  
i s o l a t e d  u s i n g  l o w  m e l t i n g  p o i n t  a g a r o s e  g e l  
e l e c t r o p h o r e s i s  ( M e t h o d  3 . 1 0 )  a n d  s u b c l o n e d  i n t o  
M1 3 mp 9 .  T h e  s e q u e n c e  o f  t h e  cDNA f r o m  t h e  B a m HI  s i t e  
t o  t h e  G- C t a i l  w a s  d e t e r m i n e d  b y  t h e  c h a i n  
t e r m i n a t i o n  m e t h o d  ( M e t h o d  3 . 6 ) .  An o l i g o n u c l e o t i d e  
p r i m e r ,  P2 ( ~* TAGATAAATTGATAAGA^ ) wa s  s y n t h e s i z e d  
( M e t h o d  3 . 1 1 )  a n d  u s e d  w i t h  t h e  M13 t e m p l a t e s  t o
Eco RI







F i g u r e  3 . 9  T h e  r e s t r i c t i o n  ma p  o f  t h e  p I L M 3 .  T h e  
s o l i d  l i n e  d e p i c t s  t h e  v e c t o r  s e q u e n c e  ( p A T 1 5 3 )  a n d  
t h e  h a t c h e d  s e c t i o n  t h e  cDNA i n s e r t .  Th e  map i s  b a s e d  
on  t h e  r e s u l t s  o f  s i n g l e  a n d  d o u b l e  d i g e s t i o n s  w i t h  
P s t I ,  H i  n d 1 1 1  , B a m H I , P v u I  a n d  Ec  o R1 r e s t r i c t i o n  
e n d o n u c l e a s e s  ( M e t h o d  3 . 3 ) .  T h e  s i z e s  o f  t h e  
r e s u l t a n t  f r a g m e n t s  w e r e  d e t e r m i n e d  by a g a r o s e  g e l  
e l e c t r o p h o r e s i s .
a









H V L A S S T T S  I H T M L L L L L M L F  
AACCCCTTGGAGGACCAGAACGAGACAATGGTTCTTGCCAGCTCTACCACCAGCATCCACACCATGCTGCTCCTGCTCCTGATGCTCTTC 
10 20 30 4 0  50 60  70 80 90
D T H R L T R T L X X S S 1 V
H L G L Q A S I  S G R D T H R L T R T L N C S S  I V K E I  I 
CACCTGGGACTCCAAGCTTCAATCAGTGGCCGGGATACCCACCGTTTAACCAGAACGTTGAATTGCAGCTCTATTGTCAAGGAGATTATA
100 1 10 120 130 140 150 160  170 180
G K L P E P E L K T D D E G P S L R N K S F R R V N L S K F
GGGAAGCTCCCAGAACCTGAACTCAAAACTGATGATGAAGGACCCTCTCTGAGGAATAAGAGCTTTCGGAGAGTAAACCTGTCCAAATTC
190 2 00 2 10 22 0 230 2 40 2 5 0  260 270
V E S Q G E V D P E D R Y V I K S N L Q K L N C C L P T S A
GTGGAAAGCCAAGGAGAAGTGGATCCTGAGGACAGATACG1'!  ATCAAGTCCAATCTTCAGAAACTTAACTGTTGCCTGCCTACATCTGCG
280 29 0 3 0 0 31 0 320 3 3 0 34 0  350 360
N D S A L P G V F I  R D L D D F R K K L R F Y M V H L N D L
AATGACTCTGCGCTGCCAGGGGTCTTCATTCGAGATCTGGATGACTTTCGGAAGAAACTGAGATTCTACATGGTCCACCTTAACGATCTG
370 3 8 0 3 9 0 4 0 0 41 0 42 0 4 3 0  4 4 0  45 0
E T V L T S R P P Q P A S G S V S P N R G T V E C
GAGACAGTGCTAACCTCTAGACCACCTCAGCCCGCATCTGGCTCCGTCTCTCCTAACCGTGGAACCGTGGAATGTTAAAACAGCAGGCAG
4 6 0 4 7 0 4 8 0 4 9 0 500 51 0 5 2 0  530 540
AGCACCTAAAGTCTGAATGTTCCTCATGGCCCATGGTCAAAAGGATTTTACATTCCTTTATGCCATCAAATGTCTTA1CAATTTATCTA
55 0  5 6 0  5 7 0  5 8 0  590  6 0 0  6 1 0  620
F i g .  3 . 1 0  ( a )  T h e  cDNA i n s e r t  i n  p I L M3  s h o w i n g  t h e  
r e l e v a n t  s i t e s  o f  r e s t r i c t i o n  e n d o n u c l e a s e  c l e a v a g e .  
The  r e a d i n g  f r a m e  i s  d e l i n e a t e d  f r o m  t h e  u n t r a n s l a t e d  
r e g i o n s  by  h a t c h i n g  a n d  t h e  f l a n k i n g  G- C t a i l s  a r e  
s h o w n  a s  s h o r t  b a r s .  One  o f  t h e  e x p e c t e d  P s 1 1 s i t e s  
w a s  l o s t  d u r i n g  G - t a i l i n g  o f  t h e  v e c t o r  p A T 1 5 3 .  T h e  
s e q u e n c i n g  s t r a t e g y  i s  s u m m a r i z e d  b e n e a t h  t h e  cDNA 
i n s e r t .  DNA s e q u e n c i n g  w a s  c a r r i e d  o u t  by  t h e  c h a i n  
t e r m i n a t i o n  m e t h o d  a f t e r  s u b c l o n i n g  f r a g m e n t s  o f  pI LM3 
i n t o  M 1 3 m p 8  a n d  M 1 3 m p 9 .  T h e  c o m p u t e r  p r o g r a m s  
d e s c r i b e d  by S t a d e n  ( 1 9 7 8 ,  1 9 8 0 )  w e r e  u s e d  t o  a s s e m b l e  
a n d  a n a l y s e  t h e  s e q u e n c e  d a t a .  To a v o i d  i n t e r f e r e n c e  
f r o m  t h e  l o n g e r  G- C t a i l s ,  w h i c h  w a s  e n c o u n t e r e d  
u s i n g  t h e  u n i v e r s a l  p r i m e r  o f  D u c k w o r t h  e t  a l .  ( 1 9 8 1 ) ,  
t w o  i n t e r n a l  p r i m e r s  ( P a n d  P 2 ) 17 n u c l e o t i d e s  i n  
l e n g t h  w e r e  s y n t h e s i z e d  a n d  u s e d  w i t h  t h e  M13 
t e m p l a t e s .  ( b )  N u c l e o t i d e  s e q u e n c e  o f  t h e  cDNA i n s e r t  
o f  pI LM3 a n d  p r e d i c t e d  a m i n o  a c i d  s e q u e n c e  o f  m u r i n e  
I L - 3 .  The  N - t e r m i n a l  s e q u e n c e  o f  m u r i n e  I L - 3  ( I h l e  e t  
a l . ,  1 9 8 3 )  i s  b o x e d  i n  a b o v e  t h e  p r e d i c t e d  a m i n o  a c i d  
s e q u e n c e .  P o t e n t i a l  s i t e s  f o r  N - g 1 y c o s y 1 a t i o n  a r e  
u n d e r l i n e d .  T h e  a r r o w  i n d i c a t e s  a p o s s i b l e  s i t e  o f  
c l e a v a g e  f o r  r e m o v a l  o f  t h e  s i g n a l  p e p t i d e .
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d e t e r r a i n e  t h e  DNA s e q u e n c e  o f  t h e  o p p o s i t e  s t r a n d .  An 
N c o I  r e s t r i c t i o n  s i t e  w a s  f o u n d  i n  t h e  DNA s e q u e n c e  
c l o s e  t o  t h e  G- C t a i l  o f  t h e  2 . 8  Kb B a m HI  f r a g m e n t .  
T h e r e f o r e  t h e  P s t l - N c o l  f r a g m e n t  o f  t h e  cDNA w a s  
i s o l a t e d  u s i n g  l o w  m e l t i n g  a g a r o s e  g e l  e l e c t r o p h o r e s i s  
( M e t h o d  3 . 1 0 ) ,  m a d e  b l u n t - e n d e d  u s i n g  t h e  K l e n o w  
f r a g m e n t  o f  E , c o 1 i  DNA p o l y m e r a s e  I  ( M e t h o d  4 . 2 )  a n d  
s u b c l o n e d  i n t o  S_ ni a_ X d i g e s t e d  M 1 3 m p 9 . An 
o l i g o n u c l e o t i d e  p r i m e r ,  P I ,  ( ~* A ACCCCTTGG AGG ACCA ^ ) 
w a s  s y n t h e s i z e d  ( M e t h o d  3 . 1 1 )  a n d  w a s  u s e d  w i t h  t h e  
M13 t e m p l a t e  t o  d e t e r m i n e  t h e  DNA s e q u e n c e  f r o m  t h e  
P s 1 1 s i t e  t o  B a m HI  s i t e .  T h e  DNA s e q u e n c e  f r o m  P s 1 1 
s i t e  t o  t h e  H i n d I I I  s i t e  wa s  d e t e r m i n e d  u s i n g  p l a s m i d  
s e q u e n c i n g  m e t h o d  ( M e t h o d  4 . 7 ) .  F i n a l l y ,  t h e  f r a g m e n t  
f r o m  t h e  H i n  d 1 1 1  t o  t h e  B a mHI  s i t e  o f  p I L M3  w a s  
i s o l a t e d  u s i n g  l o w m e l t i n g  a g a r o s e  g e l  e l e c t r o p h o r e s i s  
( M e t h o d  3 . 1 0 ) ,  m a d e  b l u n t - e n d e d  u s i n g  t h e  K l e n o w  
f r a g m e n t  o f  E . c o  1 i  DNA p o l y m e r a s e  I  ( M e t h o d  4 . 2 )  a n d  
s u b c l o n e d  i n t o  S_ma_I d i g e s t e d  M 1 3 m p 9 .  T h e  DNA 
s e q u e n c e s  o f  b o t h  s t r a n d s  o f  t h i s  f r a g m e n t  w e r e  
d e t e r m i n e d  by t h e  c h a i n  t e r m i n a t i o n  m e t h o d .
U s i n g  t h e  a b o v e  s t r a t e g y  t h e  DNA s e q u e n c e  o f  b o t h  
s t r a n d s  o f  t h e  cDNA i n s e r t  i n  p I L M3  w a s  d e t e r m i n e d .  
The  u s e  o f  t h e  i n t e r n a l  o l i g o n u c l e o t i d e  p r i m e r s  s o l v e d  
t h e  i n t e r f e r e n c e  w i t h  t h e  c h a i n  t e r m i n a t i o n  m e t h o d  by 
t h e  G-C t a i l s .  T h i s  wa s  a p r o b l e m  whe n  c o p y i n g  t h e  G 
s t r a n d  o f  t h e  t a i l  a n d  h a s  b e e n  o b s e r v e d  p r e v i o u s l y .  
The  c o m p l e t e  DNA s e q u e n c e  o f  t h e  cDNA i n s e r t  i n  pI LM3
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i s  s h o w n  i n  F i g u r e  3 . 1 0 b .  T h e r e  w e r e  25 G- C b a s e  
p a i r s  a t  t h e  5* e n d  a n d  11 G- C b a s e  p a i r s  a t  t h e  3 ’ 
e n d  o f  t h e  c o n s e n s u s  s e q u e n c e  o f  t h e  cDNA.
C l o n e  p I L M3  w a s  f o u n d  t o  e x t e n d  b e y o n d  p I L M l  a t  
t h e  3* e n d  o n l y ,  b o t h  c l o n e s  p o s s e s s i n g  t h e  s a m e  5* 
e n d .  T h e  DNA s e q u e n c e  s h o w s  a s i n g l e  l a r g e  o p e n  
r e a d i n g  f r a m e  ( F i g u r e  3 . 1 0 b ) .  A s s u m i n g  t h a t  t h e  f i r s t  
ATG f r o m  t h e  5 ’ e n d  s e r v e s  a s  t h e  i n i t i a t i o n  c o d o n ,  
t h e  r e a d i n g  f r a m e  e x t e n d s  f r o m  n u c l e o t i d e s  2 8 - 5 2 5  
i n c l u s i v e  a n d  s p e c i f i e s  a p o l y p e p t i d e  o f  1 6 6  a m i n o  
a c i d s .  The  5 ’ u n t r a n s l a t e d  r e g i o n  i s  t h e r e f o r e  q u i t e  
s h o r t  ( 27  b p ) .  The  m e t h o d  o f  La nd  e t  a l .  ( 1 9 8 1 )  w h i c h  
w a s  u s e d  t o  g e n e r a t e  t h e  cDNA c l o n e s ,  i s  d e s i g n e d  t o  
p r o d u c e  a h i g h  p r o p o r t i o n  o f  cDNA c l o n e s  w i t h  c o m p l e t e  
5 ’ t e r m i n i i .  S i n c e  b o t h  cDNA c l o n e s  i s o l a t e d  i n  t h e  
c o u r s e  o f  t h i s  w o r k  h a d  t h e  s a m e  5 ’ e n d ,  i t  i s  
p o s s i b l e  t h a t  p I L M3  c a r r i e s  a c l o s e  t o  f u l l  l e n g t h  
c o p y  o f  t h e  5 ’ u n t r a n s l a t e d  r e g i o n  o f  I L - 3  mRNA.  
C l o n e  p I LM3,  h o w e v e r ,  d o e s  n o t  e x t e n d  t o  t h e  3* e n d  o f  
t h e  I L - 3  mRNA a n d  i s  p r o b a b l y  m i s s i n g  a s i g n i f i c a n t  
p o r t i o n  o f  t h e  3 ’ u n t r a n s l a t e d  r e g i o n .
T h e  r e a d i n g  f r a m e  s p e c i f i e s  a p r o t e i n  o f  MW 
1 8 , 5 4 0 .  T h e  s t r o n g l y  h y d r o p h o b i c  s t r e t c h  o f  9 a m i n o  
a c i d s  ( r e s i d u e s  1 3 - 2 1 )  i s  i n d i c a t i v e  o f  t h e  p r e s e n c e  
o f  a s i g n a l  p e p t i d e .  I n  t h e  c a s e s  s t u d i e d  t o  d a t e ,  
t h e  l a s t  r e s i d u e  o f  t h e  s i g n a l  s e q u e n c e  i s  i n v a r i a b l y  
a n  a m i n o  a c i d  w i t h  a s m a l l  u n c h a r g e d  s i d e  c h a i n .
- 1 0 4 -
A n a l y s i s  o f  t h e  s i g n a l  p e p t i d e  r e g i o n  s u g g e s t s  a 
n u m b e r  o f  p o t e n t i a l  s i t e s  f o r  c l e a v a g e  by t h e  s i g n a l  
p e p t i d a s e .  A p p l i c a t i o n  o f  t h e  e m p i r i c a l  r u l e s  
p r o p o s e d  by Von H e i j n e  ( 1 9 8 3 )  p r e d i c t s  t h e  e n d  o f  t h e  
s i g n a l  p e p t i d e  a t  r e s i d u e  27 ( A l a ) .  T h i s  p o t e n t i a l  
c l e a v a g e  s i t e  i s  s h o wn  w i t h  a n  a r r o w  i n  F i g u r e  3 . 1 0 b .
As t h i s  w o r k  w a s  p r o c e e d i n g  a s h o r t  s t r e t c h  o f
N - t e r m i n a l  a m i n o  a c i d  s e q u e n c e  w a s  p u b l i s h e d  f o r
m u r i n e  I L - 3  ( I h l e  e t  a l .  , 1 9 8 3 a ) .  T h i s  s e q u e n c e  i s
d e r i v e d  f r o m  I L - 3  p u r i f i e d  t o  a p p a r e n t  h o m o g e n e i t y
i n
f r o m  t h e  WEHI - 3B c e l l  l i n e  a n d  i s ^ c o m p l e t e  a g r e e m e n t  
w i t h  t h e  r e a d i n g  f r a m e  a n d  e x t e n d s  f r o m  r e s i d u e s  33 
( A s p )  t o  47 ( V a l ) .  I t  s e e m s  m o s t  u n l i k e l y  t h a t  t h e  
s i g n a l  p e p t i d e  w o u l d  e n d  a t  r e s i d u e  32 ( Ar g )  a n d  t h i s  
s u g g e s t s  t h a t  t h e  m u r i n e  I L - 3  i s o l a t e d  f r o m  t h e  WEHI -  
3B c e l l  l i n e  h a s  b e e n  f u r t h e r  p r o c e s s e d .
T h e  p r o t e i n  s e q u e n c e  o f  m a t u r e  p r o c e s s e d  I L - 3  
i n d i c a t e s  a MW o f  1 5 , 1 0 2  w i t h  f o u r  p o t e n t i a l  N-  
g 1 y c o s y 1 a t i o n  s i t e s  ( A s n - X - S e r  o r  A s n - X - T h r ) .  T h e  
f o u r  s i t e s  a r e  u n d e r l i n e d  i n  F i g u r e  3 . 1 0 b .  One  o f  
t h e s e  i s  i n  t h e  r e g i o n  o f  t h e  p u b l i s h e d  N - t e r m i n a l  
s e q u e n c e  a n d  g l y c o s y l a t i o n  a t  t h i s  s i t e  w o u l d  e x p l a i n  
t h e  i n a b i l i t y  t o  i d e n t i f y  t h e  As n r e s i d u e  d u r i n g  
a u t o m a t e d  E d m a n  d e g r a d a t i o n .  Whe n  t h e  a m i n o  a c i d  
c o m p o s i t i o n  f i g u r e s  f o r  m u r i n e  I L - 3  ( I h l e  e t  a l . ,  
1 9 8 3 a )  a r e  n o r m a l i z e d  t o  t h e  s i z e  p r e d i c t e d  by t h e  DNA 
s e q u e n c e  t h e y  g i v e  good  a g r e e m e n t  w i t h  t h e  p r e d i c t e d
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c o m p o s i t i o n  ( T a b l e  3 . 5 ) .
T h e  a m i n o  a c i d  s e q u e n c e  o f  m u r i n e  I L - 3  w a s  
c o m p a r e d  w i t h  t h e  s e q u e n c e s  o f  h u m a n  i n t e r 1 e u k i n - 2 
( T a n i g u c h i  e t  a l . ,  1 9 8 3 )  a n d  h u m a n  i m m u n e  i n t e r f e r o n  
( G r a y  e t  a l . ,  1 9 8 2 )  b o t h  o f  w h i c h  a r e  a l s o  p r o d u c e d  by 
a n t i g e n - a c t i v a t e d  T l y m p h o c y t e s .  No s i g n i f i c a n t  
s e q u e n c e  h o r m o l o g y  wa s  d e t e c t e d .  A l t h o u g h  h u ma n  I L - 2  
i s  o f  v e r y  s i m i l a r  s i z e  t o  I L - 3  i t  c a r r i e s  no  
p o t e n t i a l  s i t e s  f o r  N - g 1 y c o s y 1 a t i o n  a n d  d o e s  n o t  
a p p e a r  t o  be  c l o s e l y  r e l a t e d .













Glu, Gin 12 13.7
Asp, Asn 18 16.1
Ly s 9 9.5
Cy s 4 ND
Tr p 0 ND
Arg 11 9.5
Gly 6 8.3
The amino acid composition data are taken from Ihle et 
al. (1983). The composition was originally calculated 
for a MW of 23,722 and has been normalised to the size 
of mature IL-3 which is predicted from the DNA 
sequence. The normalization was done using the values 
for Glu and Asp. ND, not determined.
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IV. Discussion.
The de mo n s t ra t i on  that IL-3 mRNA can be 
efficiently translated in oocytes (see Chapter 2) to 
give biologically active factor provides a very 
sensitive and useful assay for this mRNA. This assay 
has enabled the identification of a cDNA clone 
carrying the entire coding sequence for murine IL-3 
using the mRNA hybridization translation method.
Sequence analysis of the cloned cDNA has shown 
that if codes for a polypeptide of 166 amino acids 
including a signal peptide of possibly 27 amino acids. 
Mature IL-3 has been purified to apparent homogeneity 
(Ihle et al., 1983a) from the same WEHI-3B cell line 
as was used as the source of the IL-3 mRNA in the 
present work. The N-terminal sequence of the mature 
IL-3 is in complete agreement with the reading frame 
but starts at residue 33 suggesting an additional 
proteolytic cleavage has occurred apart from the 
cleavage of the signal peptide. The proposed 
proteolytic cleavage could be catalysed by a number of 
serine-type proteases such as a member of the 
kallikrein family or plasmin and could provide another 
level of regulation if processing is required to 
generate biologically active IL-3. Whether this 
processing step occurs in vivo or simply represents 
adventitious proteolysis during purification is not 
clear at present.
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Apart from the agreement with the N-terminal 
sequence, the amino acid composition data for mature 
IL-3 also gives good agreement with the predicted 
sequence. Since it appears that WEHI-3B only produces 
one member of the group of colony stimulating factors 
(that is, IL-3), there seems no doubt that the cDNA 
clone encodes IL-3.
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C h a p t e r  4 E x p r e s s i o n  o f  t h e  I L - 3  cDNA i n  e u k a r y o t i c  
a n d  p r o k a r y o t i c  s y s t e m s .
I . I n t r o d u c t i o n .
A c o n v e n i e n t  way t o  c o n f i r m  t h e  i d e n t i f i c a t i o n  o f  
a c l o n e d  cDNA e n c o d i n g  a p a r t i c u l a r  p r o t e i n  i s  t o  
e x p r e s s  t h i s  cDNA i n  e u k a r y o t i c  c e l l s  ( G r a y  e t  a l .  , 
1 9 8 2 ;  D e v o s  e t  a l . ,  1 9 8 2 ;  T a n i g u c h i  e t  a l . ,  1 9 8 3 )  o r  
i n  Eh_ c o 1 i  c e l l s  ( G r a y  e t  a l . ,  1 9 8 2 ;  D e v o s  e t  a l . ,  
1 9 8 3 )  t o  p r o d u c e  b i o l o g i c a l l y  a c t i v e  p r o t e i n .  S e v e r a l  
s h u t t l e  v e c t o r s  h a v e  b e e n  d e v e l o p e d  f o r  t h e  e x p r e s s i o n  
o f  t h e  c l o n e d  cDNAs  i n  m a m m a l i a n  c e l l s  ( R i n g o l d  e t  
a l . ,  1 9 8 1 ;  O k a y a m a  a n d  B e r g ,  1 9 8 3 ;  S o u t h e r n  a n d  B e r g ,  
19 8 2 ;  G h e y s e n  a n d  F i e r s ,  1 9 8 2 ) .
T h e s e  s h u t t l e  v e c t o r s  a r e  c o m p o s e d  o f  ( i )  a 
p B R 3 2 2  o r i g i n  o f  r e p l i c a t i o n  t o g e t h e r  w i t h  a n  
a n t i b i o t i c  r e s i s t a n c e  g e n e  w h i c h  a l l o w s  t h e  v e c t o r  t o  
r e p l i c a t e  i n  Jh_ c o l i  a n d  p r o v i d e s  a s e l e c t a b l e  m a r k e r ,  
( i i )  a n  S V 4 0  o r i g i n  w h i c h  a l l o w s  t h e  v e c t o r  t o  
r e p l i c a t e  i n  e u k a r y o t i c  c e l l s ,  ( i i i )  a v i r a l  p r o m o t e r  
l i k e  t h e  SV40 e a r l y  p r o m o t e r  ( Ok a y a ma  a n d  B e r g ,  1 9 8 3 ) ,  
m o u s e  m a m m a r y  t u m o r  v i r u s  p r o m o t e r  ( R i n g o l d  e t  a l . ,
1 9 8 1 )  o r  t h e  SV40 l a t e  p r o m o t e r  ( G h e y s e n  a n d  F i e r s ,
1 9 8 2 )  w h i c h  c o n t r o l s  t h e  e x p r e s s i o n  o f  t h e  c l o n e d  
c D N A ,  ( i v )  a n  i n t e r v e n i n g  s e q u e n c e  a n d  a 
p o l y a d e n l y a t i o n  s i g n a l  f r o m  t h e  SV40 g e n e s  w h i c h  a l l o w  
t h e  p r o p e r  p r o c e s s i n g  o f  t h e  mRNA t r a n s c r i b e d  f r o m  t h e
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c l o n e  d cDNA.  T h e  d i r e c t  e x p r e s s i o n  o f  a f u l l  l e n g t h  
cDNA i n  e u k a r y o t i c  c e l l s  u s i n g  s h u t t l e  e x p r e s s i o n  
v e c t o r s  i s  mo r e  c o n v e n i e n t  t h a n  t h a t  i n  c o l i  s i n c e  
t h e  G- C t a i l s  o r  A - T  t a i l s  d o  n o t  p r e v e n t  t h e  
e x p r e s s i o n  o f  t h e  cDNA i n  t h e  m a m m a l i a n  c e l l s  ( Ok a y a ma  
a n d  B e r g ,  1 9 8 3 ) .  I n  a d d i t i o n ,  t h e  cDNA d o e s  n o t  h a v e  
t o  be  s p e c i f i c a l l y  e n g i n e e r e d  t o  a l l o w  e x p r e s s i o n  t o  
o c c u r  a n d  p r o c e s s i n g  o f  s i g n a l  p e p t i d e s  a n d  
g l y c o s y l a t i o n  a r e  e x p e c t e d  t o  o c c u r  n o r m a l l y .
The  c D N A - e x p r e s s i o n  v e c t o r  c a n  be  c o n s t r u c t e d  a n d  
p r o d u c e d  i n  q u a n t i t y  i n  b a c t e r i a l  c e l l s  a n d  c a n  be  
t r a n s f e c t e d  i n t o  e u k a r y o t i c  c e l l s  u s i n g  e i t h e r  t h e  
c a l c i u m  p h o s p h a t e  p r e c i p i t a t i o n  t e c h n i q u e  ( G r a h a m a n d  
Van de Eb,  1 9 7 3 ) ,  D E A E - d e x t r a n  ( M c C u t c h e n  a n d  P a g a n o ,  
1 9 6 8 ) ,  o r  b y  m i c r o i n j e c t i o n  ( G r a e s s r a a n n  a n d  
G r a e s s m a n n ,  1 9 7 6 ;  C a p e c c h i ,  1 9 8 0 ) .  I t  h a s  a l s o  b e e n  
r e p o r t e d  t h a t  p l a s m i d  DNA c a n  a l s o  be  t r a n s f e r e d  i n t o  
m a m m a l i a n  c e l l s  w i t h  h i g h  e f f i c i e n c y  by f u s i o n  w i t h  
b a c t e r i a l  p r o t o p l a s t s  c o n t a i n i n g  t h e  s h u t t l e  v e c t o r  
( R a s s o u l z a d e g a n  e t  a l . ,  1 9 8 2 ) .
An a l t e r n a t i v e  s y s t e m  f o r  t h e  e x p r e s s i o n  o f  
e u k a r y o t i c  cDNAs i s  t h a t  u s i n g  m i c r o i n j e c t i o n  i n t o  t h e  
n u c l e u s  o f  X e n o p u s o o c y t e s .  T h i s  s y s t e m  h a s  b e e n  
s t u d i e d  i n  d e t a i l  by G u r d o n  a n d  h i s  c o l l e a g u e s  ( G u r d o n  
a n d  M e l t o n ,  1 9 8 1 ) .  A l t h o u g h  s o me  e u k a r y o t i c  p r o m o t e r s  
l i k e  t h o s e  f o r  c h i c k  o v a l b u m i n  ( W i c k e n s  e t  a l . ,  19 8 0 )  
d o  n o t  f u n c t i o n  i n  X e n o p u s o o c y t e s ,  m a n y  o t h e r
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eukaryotic promoters like those for SV40 (Wicken and 
Gurdon, 1983), thymi d in e  kinase (McKnight and 
Kingsbury, 1982), and sea urchin histone (Probst et 
al., 1979) function quite well. The cDNA inserted 
into the shuttle vector can therefore be expressed in 
Xenopus oocytes after microinjection into the nucleus 
of the oocyte to yield biologically active proteins 
(Krieg et al., 1984). The oocyte system is not really 
suitable for the production of sufficient quantities 
of proteins for biological studies but provides a 
valuable system for studies on gene expression.
Although high levels of expression of foreign 
genes in mammalian cells has been achieved (Diamaio et 
al., 1984; Kopchick et al., 1985), the expression of 
r ec ombinant DNA in m i c r o o r g a n i s m s  is still an 
inexpensive way of obtaining large amounts of useful 
proteins (Jay et al., 1984; Ikehara et al., 1984). In 
the case of expression in E_;_ c o 1 i , a number of 
problems are encountered due to the fact that the 
mechanism of gene expression in eukaryotic cells is 
different from that in prokaryotic cells. These 
problems, however, have not been fully studied and the 
rules governing the expression of cloned genes are 
still largely empirical.
Since there are no introns in prokaryotic genes 
and no splicing enzymes present, genomic DNA cannot be 
generally used as a source of genes for expression in
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bacterial cells. cDNAs coding for mature proteins (de 
Boer et al., 1983) or synthetic genes (Jay et al. , 
1984) are therefore used.
In order to achieve high-level of expression of 
the genes, strong prokaryotic promoters are used to 
drive transcription of the cloned eukaryotic genes. 
The more commonly used promoters are t r p (Edman et 
al., 1981), t a c (Russell and Bennett, 1982), lac 
(Slocombe et al., 1982) and P_L (Simons et al., 1984) 
promoters. Each of these promoters is repressed under 
normal conditions and can either be induced by 
chemi c al s  in the case of the t r p , l a c and t a c 
promoters (Edman et al., 1981; Slocombe et al., 1982; 
Russell and Bennett, 1982) or by heat shock at 42°C 
for the P L promoter (Simons et al., 1 984). The 
repression of these strong promoters is believed to be 
important for maintaining the stability of the plasmid 
in E. c o 1 i cells (Russell and Bennett, 1 982). A very 
strong promoter, the T5 early promoter, was recently 
synthesized and used for the expression of human IFN-y 
(Jay et al., 1984). This promoter is not repressed 
under normal conditions, however, in this case the 
promoter was inserted in front of a tetracycline 
resistance gene whose promoter had been removed, 
allowing selection in a tetracycline containing 
medium. Termination of transcription can be ensured 
by placing a transcription termination sequence after
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t h e  c l o n e d  g e n e  ( N a k a m u r a  a n d  I n o u y e ,  1 9 8 2 ) ,  a l t h o u g h  
w h e t h e r  t h i s  i s  n e c e s s a r y  f o r  t h e  m a i n t e n a n c e  o f  h i g h  
l e v e l s  o f  t r a n s c r i p t i o n  i s  n o t  y e t  c l e a r .
T r a n s l a t i o n  o f  t h e  p r o k a r y o t i c  mRNA r e q u i r e s  t h e  
p r e s e n c e  o f  a r i b o s o m e  b i n d i n g  s i t e .  T h e  e x p r e s s i o n  
o f  a m a t u r e  e u k a r y o t i c  p r o t e i n  c a n  be  a c h i e v e d  by  
p l a c i n g  t h e  g e n e  t o g e t h e r  w i t h  a n  i n i t i a t i o n  c o d o n  
d o w n s t r e a m  o f  a r i b o s o m e  b i n d i n g  s i t e .  H o w e v e r ,  t h e  
s p a c i n g  b e t w e e n  t h e  r i b o s o m e  b i n d i n g  s i t e  a n d  t h e  
i n i t i a t i o n  c o d o n  c a n  h a v e  a g r e a t  i n f l u e n c e  on  t h e  
e f f i c i e n c y  o f  t h e  e x p r e s s i o n  o f  t h e  g e n e  ( S h e p a r d  e t  
a 1 .  , 1 9 8 2 ;  I t o h  e t  a 1 .  , 1 9 8 4 ) .  I n  a d d i t i o n ,  t h e  
p r i m a r y  a n d  s e c o n d a r y  s t r u c t u r e  o f  t h e  mRNA may a l s o  
p l a y  an  i m p o r t a n t  r o l e  i n  e x p r e s s i o n  ( T e s s i e r  e t  a l . ,  
1 9 8 4 ) .  I t  h a s  b e e n  s u g g e s t e d  t h a t  t h e  p r e s e n c e  o f  
s t e m - l o o p  s t r u c t u r e s  c a n  i n  s o m e  c a s e s  b l o c k  
t r a n s l a t i o n  i n i t i a t i o n  s i g n a l s  a n d  d r a s t i c a l l y  
d e c r e a s e  t h e  e f f i c i e n c y  o f  e x p r e s s i o n  ( T e s s i e r  e t  a l . ,  
1 9 8 4 ) .  T h e  s t a b i l i t y  o f  t h e  e x p r e s s e d  mRNA c a n  b e  
i n c r e a s e d  t o  a c e r t a i n  e x t e n t  u s i n g  b a c t e r i a l  s t r a i n s  
l a c k i n g  p o l y n u c l e o t i d e  p h o s p h o r y l a s e  ( H a u t a l a  e t  a l . ,  
1979 ;  T a l m a d g e  a n d  G i l b e r t ,  1 9 8 2 ) .  A p a r t  f r o m  v a r y i n g  
t h e  l e n g t h  o f  s p a c i n g  b e t w e e n  t h e  r i b o s o m e  b i n d i n g  
s i t e  a n d  i n i t i a t i o n  c o d o n  o r  v a r y i n g  t h e  c o d i n g  
s e q u e n c e s  t o  g i v e  mo r e  f a v o u r a b l e  s e c o n d a r y  s t r u c t u r e s  
o f  t h e  e x p r e s s e d  mRNA,  a n o t h e r  wa y  t o  o v e r c o m e  t h e  
t r a n s l a t i o n  b a r r i e r  i s  t o  f u s e  t h e  f o r e i g n  g e n e  t o  a 
p r o k a r y o t i c  g e n e  s o  t h a t  t h e  b a c t e r i a l  r i b o s o m e
- 1 1 3 -
b i n d i n g  s i t e  a n d  i n i t i a t i o n  c o d o n  a n d  t h e  f i r s t  f e w  
b a c t e r i a l  c o d o n s  a r e  u s e d  f o r  t r a n s l a t i o n  ( G o e d d e l  e t  
a l . , 1 9 7 9 ) .  T h e  t r a n s l a t i o n  e f f i c i e n c y  o f  t h e  
e x p r e s s e d  mRNA i s  a l s o  g o v e r n e d  by t h e  c o d o n  u s a g e  
( R o b i n s o n  e t  a l . ,  1 9 8 4 ) .  T h e  c o d o n s  u s e d  i n  mRNA 
c o d i n g  f o r  h i g h l y  e x p r e s s e d  p r o k a r y o t i c  g e n e s  a p p e a r  
n o t  t o  be  r a n d o m  a n d  t h e r e  a p p e a r s  t o  be  a m a r k e d  
p r e f e r e n c e  f o r  p a r t i c u l a r  c o d o n s  f o r  s o me  a m i n o  a c i d s  
( G r a n t h a m  e t  a l . ,  1 9 8 1 ;  G r o s  j e a n  a n d  F i e r s ,  1 9 8 2 ) .  
T h i s  p r e f e r e n c e  a p p e a r s  t o  c o r r e l a t e  w i t h  t h e  
a b u n d a n c e  o f  d i f f e r e n t  t RNA s p e c i e s  ( I k e m u r a ,  1 9 8 1 ) .  
The  c o d o n  p r e f e r e n c e  c a n  be o p t i m i z e d  by s y n t h e s i z i n g  
c o d i n g  s e q u e n c e s  e m p l o y i n g  t h e  c o d o n s  mo s t  f r e q u e n t l y  
u s e d  i n  h i g h l y  e x p r e s s e d  E^  c o 1 i  g e n e s  ( I k e h a r a  e t  
a l . ,  1 9 8 4 ) .
The  s t a b i l i t y  o f  t h e  e x p r e s s e d  e u k a r y o t i c  p r o t e i n  
i s  l e s s  e a s y  t o  c o n t r o l ,  l a r g e l y  b e c a u s e  t h e  
s t r u c t u r a l  f e a t u r e s  g o v e r n i n g  p r o t e i n  s t a b i l i t y  i n  E. 
c o l i  a r e  n o t  w e l l  u n d e r s t o o d .  T h e r e  i s  s ome  e v i d e n c e  
t h a t  s h o r t  f o r e i g n  p o l y p e p t i d e s  a r e  u n s t a b l e  i n  E . 
c o l i  ( I t a k u r a  e t  a l . ,  1 9 7 7 ;  G o e d d e l  e t  a l . ,  1 9 7 9 ) .  
T h e  u s e  o f  b a c t e r i a l  s t r a i n s  l a c k i n g  o n e  o r  m o r e  o f  
t h e  n o r m a l  c o m p l e m e n t  o f  p r o t e a s e s  i n  E_  ^ c_ o> ^ 1 i_ 
( G o t t e s r a a n  e t  a l . ,  1 9 81 ;  G o l d b e r g  e t  a l . ,  1 9 8 1 )  i s  one  
w a y  o f  r e d u c i n g  t h e  d e g r a d a t i o n  o f  e u k a r y o t i c  
p r o t e i n s .  I n  a d d i t i o n ,  t h i s  p r o b l e m  c a n  o f t e n  b e  
a l l e v i a t e d  by  f u s i n g  t h e  p e p t i d e  t o  a l a r g e r  c o l i
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p r o t e i n  f r o m  w h i c h  t h e  p e p t i d e  i s  t h e n  c l e a v e d  ( N a g a i  
a n d  T h o g e r s e n ,  1 9 8 4 ;  G e r m i n o  a n d  B a s t i a ,  1 9 8 4 ) .
I n  t h i s  c h a p t e r ,  t h e  cDNA i n s e r t  i n  p I L M3  w a s  
e x p r e s s e d  i n  m o n k e y  COS - 1  c e l l s ,  Xe n o pu s o o c y t e s  a n d  
E . c o 1 i . T h e  s h u t t l e  v e c t o r  p S V 2 ~ n e o  ( S o u t h e r n  a n d  
B e r g ,  1 9 8 2 )  w a s  u s e d  f o r  t h e  e x p r e s s i o n  o f  t h e  cDNA i n  
b o t h  m o n k e y  COS - 1  c e l l s  a n d  Xe n o p u s o o c y t e s .  T h e  
r e c o m b i n a n t  I L - 3  p r o d u c e d  by  t h e  t r a n s f o r m e d  m o n k e y  
COS - 1  c e l l s  w a s  u s e d  t o  s t u d y  o f  t h e  w i d e  r a n g e  o f  
b i o l o g i c a l  a c t i v i t i e s  o f  I L - 3 .  I n  a n  a t t e m p t  t o  
p r o d u c e  a l a r g e  a m o u n t  o f  r e c o m b i n a n t  I L - 3  i n  EL_ c o l i , 
a n  e x p r e s s i o n  p l a s m i d ,  p D R 5 4 0  ( R u s s e l l  a n d  B e n n e t t ,  
1 9 8 2 ) ,  w h i c h  c a r r i e d  a s t r o n g  t a c  p r o m o t e r  w a s  u s e d .
A f u s i o n  p r o t e i n  s t r a t e g y  wa s  a l s o  t r i e d  u s i n g  M13mp9.
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I I .  M a t e r i a l s .
R e a g e n t s
1.  B r o m o c r e s o l  g r e e n ,  wa s  o b t a i n e d  f r o m  BDH C h e m i c a l  
L t d  .
2 .  T4 DNA p o l y m e r a s e ,  w a s  o b t a i n e d  f r o m  New E n g l a n d  
B i o l a b s  ( No .  2 0 3 ) .
3 .  D N A - p o l y m e r a s e  I  ( l a r g e  f r a g m e n t ,  K l e n o w  e n z y m e ) ,  
w a s  o b t a i n e d  f r o m  B o e h r i n g e r  M a n n h e i m  ( N o .  
1 0 9 4 5 2 3 ) .







p S V 2 ~ n e o , w a s  o b t a i n e d  f r o m  Dr .  P.  B e r g  ( s e e  
F i g u r e  4 . 1 ) .
p D R 5 4 0 ,  w a s  o b t a i n e d  f r o m  P h a r m a c i a  P - L  
B i o c h e m i c a l  I n c .  ( s e e  F i g u r e  4 . 2 ) .
E. c o 1 i  RB791 ( = W3110 l a c I ^ L 8 ) , wa s  o b t a i n e d  f r o m  
Dr  . M. P t a s h n e .
E. c o l i  SG1606 F*t r a D 3 6 , p r o AB, l a c l ^ , l a c ZAM15/ A 
( l a c  p r o ) I o n  ::  T n l 0 1 D46A g a l , wa s  o b t a i n e d  f r o m
D r .  S.  G o t t e s m a n .
E. c o 1 i  SG1095 ( I o n : : T n l 0 1 D 4 6 ) , w a s  o b t a i n e d  f r o m  
D r .  S.  G o t t e s m a n .





N C O  1(37)
Hind III
Pvu II * Hinc II
Nco I
Pvu II
Figure 4.1 The restriction map of the shuttle vector 
p S V 2 ~ n e o . The restriction map of p S V p - neo was 
constructed from published information (Southern and 
Berg, 1982) and restriction endonuclease digestion 
followed by agarose gel analysis of the plasmid. The 
nie region of pBR322 has been deleted in the vector so 
the PvuII site between the junction of the SV40 origin 
and the pBR322 origin is not present. The H i n d i  
restriction site between the Tn5neo gene and SV40 
fragment was removed during construction. The hatched 
area denotes sequence derived from pBR322; the dotted 
region is the neo gene from Tn5 and the open box is 
from SV40. The size of the restriction fragments in 




translational stop codons 
\  in all 3 reading frames
168 bp 'leader' T constant polarity
pDR-540
( 4kb)
Galactokinase (700 bp core region)
trp
-3 5
-16 bp -- lac 
- 1 0 mRNA Bam HI
CCC CTGTTGACAATTAATCATCGGCTCGTATAATGTGTGGAATTGTGAGCGGATAACAATTTCACACAGGAAACAGtSATCOCTACGCCGATAAGCT GGG
C
F i g u r e  4 . 2  T h e  r e s t r i c t i o n  ma p  o f  t h e  e x p r e s s i o n
v e c t o r  pDR540.  ( a )  The  r e s t r i c t i o n  map o f  pDR540 wa s
c o n s t r u c t e d  f r o m  p u b l i s h e d  i n f o r m a t i o n  ( R u s s e l l  a n d  
B e n n e t t ,  1 9 8 2 ;  M c K e n n e y  e t  a 1 . , 1 9 8 1 ) .  T h e
g a l a c t o k i n a s e  g e n e  i s  u n d e r  t h e  c o n t r o l  o f  t h e  t  a c 
p r o m o t e r .  ( b )  DNA s e q u e n c e  o f  t h e  t  a c p r o m o t e r
r e g i o n .  ( TTGACA) ,  t h e  - 3 5  c o n s e n s u s  s e q u e n c e  o f  t r p  
p r o m o t e r .  (TATAAT) ,  t h e  - 1 0  c o n s e n s u s  s e q u e n c e  o f  l a c  
p r o m o t e r .  ( AGGA) ,  S h i n e - Da 1 g a  r  n o s e q u e n c e .  ( c )
P a r t i a l  s e q u e n c e  o f  l a c  UV5 p r o m o t e r  s h o w i n g  t h e  
S h i n e - Da 1 g a r n o  s e q u e n c e  a n d  t h e  f i r s t  a m i n o  a c i d  
c o d o n .
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III. Solutions.
1. High salt NET buffer: 1.0M NaCl, O.lmM EDTA, 20mM 
Tris-HCl pH8.
2. NET buffer: 0.15M NaCl, O.lmM EDTA, 20mM Tris-HCl 
pH8.
3. STE buffer: lOmM NaCl, lOmM Tris-HCl, pH7.5,
0.5mM EDTA.
4. Z medium: LB medium (1 0 g Bacto-1ryptone , 5g
Bacto-yeast extract, 10g NaCl, 1 liter 92^» 
pH7.5), plus 2.5mM CaCl2.
5. Z agar: 10g Bacto-agar in 500ml Z medium.
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I V .  M e t h o d s .
4 . 1  I s o l a t i o n  o f  DNA f r a g m e n t s  f r o m  a g a r o s e  g e l  u s i n g  
DEAE m e m b r a n e .
The  DEAE m e m b r a n e  ( S c h l e i c h e r  a n d  S c h u e l l  NA- 45)  
wa s  c u t  i n t o  s t r i p s  o f  s u i t a b l e  s i z e  f o r  t h e  w i d t h  o f  
t h e  DNA b a n d  t o  be  r e c o v e r e d .  T h e  DEAE m e m b r a n e  w a s  
w a s h e d  f o r  10 m i n  i n  10mm EDTA,  p H 7 . 6 ,  5 m i n  i n  0 . 5M 
NaOH,  f o l l o w e d  by  s e v e r a l  r a p i d  w a s h e s  i n  d i s t i l l e d  
w a t e r .  M e m b r a n e s  p r e p a r e d  i n  t h i s  way c o u l d  be  s t o r e d  
i n  w a t e r  a t  4°C f o r  s e v e r a l  w e e k s .
A f t e r  e l e c t r o p h o r e t i c  s e p a r a t i o n  o f  t h e  DNA 
f r a g m e n t s  i n  a h o r i z o n t a l  s l a b  a g a r o s e  g e l ,  a s t r i p  o f  
p r e t r e a t e d  DEAE m e m b r a n e  wa s  p l a c e d  i n  a s l o t  c u t  j u s t  
a h e a d  o f  t h e  b a n d  o f  i n t e r e s t .  T h e  s l o t  w a s  f i l l e d  
w i t h  e l e c t r o p h o r e s i s  b u f f e r ,  a n d  e l e c t r o p h o r e s i s  
c o n t i n u e d  ( a p p r o x i m a t e l y  5 m i n )  u n t i l  b i n d i n g  w a s  
c o m p l e t e  a s  j u d g e d  by e t h i d i u m  b r o m i d e  f l u o r e s c e n c e .  
The  DEAE m e m b r a n e  s t r i p  wa s  f r e e d  o f  r e s i d u a l  a g a r o s e  
by t h o r o u g h  s h a k i n g  i n  a s c i n t i l l a t i o n  v i a l  c o n t a i n i n g  
NET b u f f e r .  The  DEAE m e m b r a n e  s t r i p  wa s  s u b m e r g e d  i n  
2 5 0 pi 1 h i g h  s a l t  NET b u f f e r  ( f o r  d o u b l e  s t r a n d e d  DNA) 
i n  a s i l i c o n i z e d  q u i c k - f i t  t u b e .  The  t u b e  was  s h a k e n  
a t  a b o u t  65° C f o r  35 mi n .  The  b u f f e r  was  t r a n s f e r r e d  
i n t o  a s t e r i l i z e d  a n d  s i l i c o n i z e d  E p p e n d o r f  t u b e  a n d  
t h e  m e m b r a n e  wa s  w a s h e d  w i t h  a n o t h e r  5 0 y l  o f  h i g h  s a l t  
NET b u f f e r .  The  b u f f e r  c o n t a i n i n g  t h e  e l u t e d  DNA wa s
e x t r a c t e d  t w i c e  w i t h  3 v o l u m e s  o f  w a t e r - s a t u r a t e d  n -
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b u t a n o l ,  2 . 5  v o l u m e s  o f  a b s o l u t e  e t h a n o l  w e r e  a d d e d  
a n d  m i x e d  w e l l .  T h e  m i x t u r e  w a s  k e p t  i n  a d r y - i c e  
e t h a n o l  b a t h  f o r  3 h r  a n d  c e n t r i f u g e d  i n  an  E p p e n d o r f  
c e n t r i f u g e  f o r  3 0  m i n  a t  4 ° C .  T h e  p e l l e t  w a s  w a s h e d  
w i t h  c o l d  a b s o l u t e  e t h a n o l  a n d  d r i e d  u n d e r  v a c u u m .  
The  DNA wa s  r e - p r e c i p i t a t e d  f r o m  0. 3M s o d i u m  a c e t a t e ,  
pH5. 5 ,  t o  r e m o v e  a n y  r e s i d u a l  Na Cl .
4 . 2  F i l l i n g  r e c e s s e d  3 ’ e n d s  o f  d o u b 1 e - s t r a n d e d  DNA 
u s i n g  Kl e n o w f r a g m e n t  o f  c o l i  DNA p o l y m e r a s e  I .
T h e  r e a c t i o n  w a s  c a r r i e d  o u t  i n  a 2 5 y l  r e a c t i o n  
v o l u m e  c o n t a i n i n g  t h e  DNA f r a g m e n t  (<_ l pi g,  50mM T r i s -  
HC1,  p H7 . 2 ,  l OmM M g C l 2 , O. l mM DTT, 0 . 2mM o f  e a c h  
d N T P s ,  1 u n i t  o f  K l e n o w  f r a g m e n t  o f  E . c o l i  DNA 
p o l y m e r a s e  I ,  a t  r o o m  t e m p e r a t u r e  f o r  30  m i n .  T h e  
r e a c t i o n  w a s  s t o p p e d  by  a d d i n g  1 ]i 1 o f  0 . 5M EDTA,  pH8.  
T h e  r e a c t i o n  m i x t u r e  w a s  e x t r a c t e d  w i t h  a n  e q u a l  
v o l u m e  o f  p h e n o l :  c h 1 o r o f o r m : i s o a m  y l a l c o h o 1 m i x t u r e  
( 5 0 : 4 8 : 2 ) .  1 / 1 0  v o l u m e  o f  3M s o d i u m  a c e t a t e ,  p H5 . 5 ,  
a n d  2. 5 v o l u m e s  o f  a b s o l u t e  e t h a n o l  w e r e  a d d e d  t o  t h e  
a q u e o u s  p h a s e  a n d  m i x e d  w e l l .  The  m i x t u r e  wa s  k e p t  i n  
a d r y - i c e  e t h a n o l  b a t h  f o r  1 h r  a n d  c e n t r i f u g e d  i n  
E p p e n d o r f  c e n t r i f u g e  f o r  15 m i n  a t  4 ° C .  T h e  DNA 
p e l l e t  wa s  w a s h e d  w i t h  c o l d  a b s o l u t e  e t h a n o l  a n d  d r i e d  
u n d e r  v a c u u m .  I t  w a s  f i n a l l y  r e s u s p e n d e d  i n  l OmM 
T r i s - H C l ,  p H7 . 5 ,  O. l mM EDTA.
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4 . 3  C o n v e r s i o n  o f  p r o t r u d i n g  3'  t e r m i n i  t o  b l u n t  e n d s  
u s i n g  T4 DNA p o l y m e r a s e .
T h e  r e a c t i o n  w a s  c a r r i e d  o u t  i n  a 2 0 y l  r e a c t i o n  
v o l u m e  c o n t a i n i n g  up t o  5 \i g o f  DNA f r a g m e n t  w i t h  
p r o t r u d i n g  3 '  e n d s ,  66mM T r i s - H C l ,  p H8,  6 . 6mM M g C1 2 > 
ImM DTT,  0 . 5mM o f  e a c h  d NT P s  a n d  10  u n i t s  o f  T4 DNA 
p o l y m e r a s e ,  a t  1 5 ° C  f o r  2 h r .  T h e  r e a c t i o n  w a s  
s t o p p e d  by a d d i n g  l j i l  o f  0. 5M EDTA,  pH8,  a n d  e x t r a c t e d  
w i t h  p h e n o 1 : c h 1 o r o f o r m : i s o a m y 1 a 1 c o h o 1 m i x t u r e  
( 5 0 : 4 8 : 2 ) .  1 / 1 0  v o l u m e  o f  3M s o d i u m  a c e t a t e ,  p H5 . 5 ,
a n d  2 . 5  v o l u m e s  o f  a b s o l u t e  e t h a n o l  w e r e  a d d e d  t o  t h e  
a q u e o u s  p h a s e  a n d  m i x e d  w e l l .  The  m i x t u r e  wa s  k e p t  i n  
a d r y - i c e  e t h a n o l  b a t h  f o r  1 h r  a n d  c e n t r i f u g e d  i n  a n  
E p p e n d o r f  c e n t r i f u g e  f o r  15 m i n  a t  4 ° C .  T h e  DNA 
p e l l e t  wa s  w a s h e d  w i t h  c o l d  a b s o l u t e  e t h a n o l  a n d  d r i e d  
u n d e r  v a c u u m .  I t  w a s  t h e n  r e s u s p e n d e d  i n  l OmM T r i s -  
HC l ,  p H7 . 5  , 0 . 1 m M EDTA.
4 . 4  L a r g e  s c a l e  p r e p a r a t i o n  o f  p l a s m i d  DNA u s i n g  t h e  
r a p i d  b o i l i n g  m e t h o d  ( H o l m e s  a n d  Q u i g l e y ,  1 9 8 1 ) .
11 o f  56  c u l t u r e  m e d i u m  w a s  i n o c u l a t e d  w i t h  t h e  
p l a s m i d  c a r r y i n g  s t r a i n  a n d  s h a k e n  a t  3 7 ° C  u n t i l  t h e  
c u l t u r e  r e a c h e d  l a t e  l o g a r i t h m i c  p h a s e  ( a b o u t  4 h r ) .  
0 . 1 5 g  o f  c h l o r a m p h e n i c o l  w a s  a d d e d  a n d  t h e  c u l t u r e  
s h a k e n  a t  3 7 ° C  f o r  a n o t h e r  16  h r .  C e l l s  w e r e  
c o l l e c t e d  by c e n t r i f u g a t i o n  i n  a S o r v a l l  GS3 r o t o r  a t  
5 0 0 0 r p m  f o r  10 m i n  a t  0 ° C  a n d  r e s u s p e n d e d  i n  7 0 m l
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STET buffer. 10ml of lysozyme (10mg/ml in 250mM Tris- 
HC1, pH8) was added and mixed well. It was then 
aliquoted into SS34 centrifuge tubes (3ml per tube) 
and the tubes heated at 100°C for 2 min then 
centrifuged at 20,000rpm, 0°C for 30 min. The clear 
supernatants were pooled and extracted twice with an 
equal volume of pheno1:ch1orofor m : i s o a ra y 1 a 1 coho 1 
mixture (50:48:2). An equal volume of isopropanol was 
added to the aqueous phase and mixed well. The 
mixture was kept in a dry-ice ethanol bath for 15 min 
and centrifuged in an SS34 rotor at 15,000rpm, 0°C for 
10 min. The pellet was washed with ether and dried 
under vacuum. It was resuspended in 16ml of lOmM 
Tris-HCl, pH7.5, O.lmM EDTA. 16g of CsCl was added 
and mixed gently until all of the salt was dissolved. 
0.8ml of ethidium bromide (10mg/ml) was added and 
mixed well. The solution was divided into two 50 Ti 
centrifuge tubes and centrifuged in a 50 Ti rotor at 
43,000 rpm, 16°C for 46 hr. The lower band of plasmid 
DNA was withdrawn using a syringe with an 18 gauge 
needle. The DNA solution was extracted 5 times with 2 
volumes of CsC1-saturated isopropanol. The plasmid 
DNA was then dialyzed against three changes of STE 
buffer.
4.5 Microinjection of plasmid DNA into the nucleus of 
Xenopus laevis oocytes.
The m i c ro i n j e c t i on  of plasmid DNA into the
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n u c l e u s  o f  t h e  o o c y t e  wa s  e s s e n t i a l l y  t h e  s a me  a s  f o r  
t h e  i n j e c t i o n  o f  mRNA i n t o  o o c y t e s  i n  M e t h o d  2 . 6  
e x c e p t  t h a t  t h e  o o c y t e  w a s  o r i e n t a t e d  w i t h  a p a i r  o f  
w a t c h - m a k e r  f o r c e p s  s o t h a t  t h e  n e e d l e  wa s  p l a c e d  a t  
t h e  c e n t e r  o f  t h e  b l a c k  p i g m e n t e d  h e m i s p h e r e  a n d  wa s  
p e r p e n d i c u l a r  t o  t h e  e q u a t o r  o f  t h e  o o c y t e .  T h e  
n e e d l e  wa s  t h e n  p u n c h e d  i n t o  t h e  o o c y t e  u n t i l  t h e  t i p  
o f  t h e  n e e d l e  w a s  o n e - t h i r d  o f  t h e  wa y  f r o m  t h e  t o p  t o  
t h e  o p p o s i t e  p o l e  o f  t h e  o o c y t e .  A b o u t  3 0 n l  o f  t h e  
p l a s m i d  DNA wa s  i n j e c t e d  p e r  o o c y t e .
4 . 6  S y n t h e s i s  o f  s i n g 1 e - s t r a n d e d  r a d i o a c t i v e  p r o b e s  
u s i n g  M13 t e m p l a t e s .
mI LM5  i s  a r e c o m b i n a n t  p h a g e  o f  M1 3 mp 9  ( F i g u r e  
4 . 3 )  c o n t a i n i n g  t h e  P s t l - N c o l  f r a g m e n t  f r o m  p I L M3  
i n s e r t e d  i n  t h e  S m a I  s i t e  s o  t h a t  t h e  I L - 3  c o d i n g  
s e q u e n c e  i s  i n  t h e  o p p o s i t e  d i r e c t i o n  t o  $ -  
g a 1 a t o s i d a s e . A s y n t h e t i c  o l i g o n u c l e o t i d e  p r i m e r ,  
P I  , (~* AACCCCTTGGAGGACCA^ ) w a s  u s e d  t o  c o p y  t h e  
mILM5 i n s e r t .
2 y g  o f  p r i m e r  PI  w a s  a n n e a l e d  t o  3 4 y g  o f  t h e  
mI LM5 t e m p l a t e  i n  5 0 y l  a n n e a l i n g  b u f f e r  c o n t a i n i n g  
l OmM T r i s - H C l ,  p H 8 . 5 ,  l OmM M g C1 2 . T h e  m i x t u r e  w a s  
s e a l e d  i n  a c a p i l l a r y  t u b e  a n d  b o i l e d  a t  1 0 0 ° C  f o r  3 
mi n  t h e n  c o o l e d  t o  r o o m t e m p e r a t u r e .  The  a n n e a l e d  DNA 
wa s  a d d e d  t o  a n o t h e r  5 0 y l  r e a c t i o n  m i x t u r e  c o n t a i n i n g  




.a a g g g g t t c c ...ccc(ggg3 M13mp9
F i g u r e  4 . 3  DNA s e q u e n c e  o f  t h e  mILM5 t e m p l a t e .
T h e  b o x e d  r e g i o n  r e p r e s e n t s  t h e  P s t l - N c o l  f r a g m e n t  
f r o m  p l a s m i d  p I L M 3 .  T h i s  f r a g m e n t  w a s  m a d e  b l u n t -  
e n d e d  a n d  i n s e r t e d  i n t o  t h e  S m a I s i t e  o f  M13mp9.  On l y  
t h e  j u n c t i o n  s e q u e n c e s  a r e  s h o w n .  Th e  o r i e n t a t i o n  o f  
t h e  I L - 3  c o d i n g  s e q u e n c e  i s  o p p o s i t e  t o  t h a t  o f  t h e  $ -  
g a  1 a t o s i d a s e . A s y n t h e t i c  o l i g o n u c l e o t i d e  p r i m e r ,  
P I  , u s e d  f o r  m a k i n g  p r o b e s  c o m p l e m e n t a r y  t o  t h e  
i n s e r t  i s  a l s o  s h o wn  a b o v e .
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dCTP, dGTP, 1.3 y M of d AT P , 20yCi of [a-32P]dATP (- 
3000 Ci/mmole) and 50 units of Klenow fragment of E. 
c o 1 i DNA polymerase I. The reaction mixture was 
incubated at 37° for 7 min then stopped by adding lOyl 
of 0.5M of EDTA, pH8. 2yl of 1M NaOH, 4yl of 0.25% 
bromocresol green and 20]il glycerol were added. The 
synthesized cDNA was separated from the template by 
electrophoresis on a 1% alkaline agarose gel. 3yg of 
HinfI digested pBR322 was run in parallel as a size 
marker. The 1% alkaline agarose gel was prepared by 
melting 1.3g agarose in 125ml distilled water. 3.9ml 
1M NaOH and 0.52ml of 0.5M EDTA were added to the 
melted agarose, mixed well and the solution poured 
into the agarose gel apparatus. The gel was 
electrophoresed in the alkaline buffer containing 30mM 
NaOH, 2mM EDTA. The gel was run at 150mA constant 
current for 2 hr. The gel was neutralized in 200ml of 
lOOmM Tris-HCl, pH7.5, lOOmM NaCl for 30 min. The 
marker lane was cut out and stained with 10y g /m 1 of 
ethidium bromide in water for 30 min. The single- 
stranded radioactive DNA corresponding to the region 
of 300 base pair to 600 base pairs was excised from 
the gel and melted in the minimum volume of lOOmM 
Tris-HCl, pH7.5, lOOmM NaCl by boiling at 100°C for 5 
min in an Eppendorf tube. The melted gel containing 
the radioactive single-stranded DNA probe could then 
be added directly to the hybridization fluid in the 
colony hybridization as in Method 3.9.
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4 . 7  P l a s m i d  s e q u e n c i n g  by  t h e  c h a i n  t e r m i n a t i o n  
m e t h o d  ( W a l l a c e ,  e t  a l . ,  1 9 8 1 c ) .
( a )  P r e p a r a t i o n  o f  p l a s m i d  DNA f o r  DNA 
s e q u e n c i n g .
The  p l a s m i d  DNA wa s  p r e p a r e d  on a s m a l l  s c a l e  by 
t h e  r a p i d  b o i l i n g  m e t h o d  ( M e t h o d  3 . 2 a ) .  THe f i n a l  DNA 
p e l l e t  wa s  r e s u s p e n d e d  i n  5 0 y l  lOmM T r i s - H C l ,  pH8,  ImM 
EDTA a n d  5 0 y g / m1 o f  p r e t r e a t e d  RNAa s e A ( M e t h o d  3 . 2 b )  
a n d  i n c u b a t e d  a t  3 7 ° C  f o r  10  m i n .  I t  w a s  t h e n  
e x t r a c t e d  f i v e  t i m e s  w i t h  p h e n o 1 : c h 1 o r o f o r m : 
i s o a m y 1 a 1 c o h o 1 m i x t u r e  ( 5 0 : 4 8 : 2 ) .  1 / 1 0  v o l u m e  o f  3M
s o d i u m  a c e t a t e ,  p H 5 . 5 ,  a n d  2 . 5  v o l u m e s  o f  a b s o l u t e  
e t h a n o l  w e r e  a d d e d  a n d  m i x e d  w e l l .  T h e  m i x t u r e  w a s  
k e p t  i n  a d r y - i c e  e t h a n o l  b a t h  f o r  1 h r  a n d  
c e n t r i f u g e d  i n  E p p e n d o r f  c e n t r i f u g e  f o r  15 mi n  a t  4° C.  
Th e  DNA p e l l e t  wa s  w a s h e d  w i t h  c o l d  a b s o l u t e  e t h a n o l  
a n d  d r i e d  u n d e r  v a c u u m.
T h e  p l a s m i d  DNA w a s  l i n e a r i z e d  w i t h  a s u i t a b l e  
r e s t r i c t i o n  e n d o n u c l e a s e .  The  l i n e a r i z e d  p l a s m i d  DNA 
wa s  a d j u s t e d  t o  l y g / y l .
( b )  D e n a t u r a t i o n  o f  t h e  d o u b 1 e - s t r a n d e d  
t e m p l a t e .
l y l  o f  t e m p l a t e  ( l y g ) ,  l y l  o f  p r i m e r  ( l O n g )  a n d  
7 y l  o f  w a t e r  w e r e  m i x e d  w e l l  a n d  s e a l e d  i n  a c a p i l l a r y  
t u b e .  T h e  t u b e  w a s  h e a t e d  a t  1 0 0 ° C  f o r  3 m i n s  t h e n
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q u i c k l y  c h i l l e d  i n  a b e a k e r  o f  c o l d  e t h a n o l  w h i c h  wa s  
h e l d  i n  a d r y - i c e  e t h a n o l  b a t h .
( c )  I n i t i a t i n g  t h e  r e a c t i o n .
T h e  N* m i x  w e r e  p r e p a r e d  a s  i n  m e t h o d  3 . 6 c .  2 y 1
o f  N* mi x  ( dA*,  dG*,  dC*)  wa s  a d d e d  t o  t h e  b o t t o m  o f  a 
s t e r i l i z e d  a n d  s i l i c o n i z e d  c a p l e s s  E p p e n d o r f  t u b e  
p l a c e d  i n  a r a c k  w h i c h  w a s  i n c l i n e d  a t  a n  a n g l e  o f  
4 5 ° .
The  c a p i l l a r y  wa s  t h a w e d  u n d e r  r u n n i n g  d i s t i l l e d  
w a t e r  a n d  d r i e d  w i t h  t i s s u e .  T h e  c a p i l l a r y  w a s  c u t  
o p e n  a n d  p u t  i n t o  a c o l d  E p p e n d o r f  t u b e  i n  a n  i c e  
b a t h .  l y l  1 OX a n n e a l i n g  b u f f e r  a n d  0 . 5 y l  K l e n o w  
f r a g m e n t  o f  E^ c o 1 i  DNA p o l y m e r a s e  I  w e r e  a d d e d  t o  t h e  
c a p i l l a r y  t u b e .  T h e  a n n e a l e d  DNA a n d  K l e n o w  w e r e  
mi x e d  w e l l  a n d  e x p e l l e d  i n t o  t h e  c o l d  E p p e n d o r f  t u b e .  
2 y l  o f  t h e  a n n e a l e d  DNA a n d  K l e n o w  m i x t u r e  w a s  a d d e d  
t o  t h e  t o p  o f  e a c h  E p p e n d o r f  t u b e  w i t h  N* m i x .  T h e  
t u b e s  w e r e  b r i e f l y  c e n t r i f u g e d  t o  m i x  t h e  d r o p s  a n d  
p l a c e d  i n  a m e t a l  r a c k  a t  3 7° C f o r  10 mi n .
T h e  dNTP c h a s e  r e a c t i o n ,  t e r m i n a t i o n  o f  r e a c t i o n  
a n d  e l e c t r o p h o r e s i s  o f  t h e  s a m p l e s  w e r e  t h e  s a m e  a s  i n  
M e t h o d  3 . 6 d .
4 . 8  S c r e e n i n g  f o r  t h e  o r i e n t a t i o n  o f  M13 t e m p l a t e s  by 
a n n e a l i n g  ( B a r n e s  a n d  B e v a n ,  1 9 8 3 ) .
T h e  t e m p l a t e  o f  t h e  r e c o m b i n a n t  M13 p h a g e  t o  b e
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t e s t  e d w a s  a n n e a l e d  t o  a k n o w n  t e m p l a t e .  l y l  o f  t h e  
k n o w n  t e m p l a t e  ( mI L  M 5 ) ,  1 y 1 o f  t h e  t e m p l a t e  t o  b e  
t e s t e d ,  1 y 1 o f  10XSSC a n d  2 y l  o f  w a t e r  w e r e  m i x e d  w e l l  
a n d  s e a l e d  i n  a c a p i l l a r y  t u b e .  T h e  t u b e  w a s  b o i l e d  
a t  1 0 0 ° C  f o r  3 mi n  t h e n  k e p t  a t  6 7 ° C  f o r  1 h r .  T h e  
c a p i l l a r y  t u b e  wa s  c u t  o p e n  a n d  t h e  a n n e a l e d  t e m p l a t e  
e x p e l l e d  i n t o  5 y l  o f  BPB d y e  m i x .  T h e  s a m p l e  w a s  
a n a l y z e d  by a g a r o s e  g e l  e l e c t r o p h o r e s i s .
4 . 9  I n d u c t i o n  o f  pILM5 i n  E_^ _ c o l i .
4 0 ml  LB me d i u m wa s  i n o c u l a t e d  w i t h  p l a s m i d  pI LM5 
a n d  s h a k e n  a t  3 7 ° C  t o  a K l e t t  v a l u e  o f  80  ( ~ 2 x l 0 8 
c e l l s / m l ) .  2 0 m l  o f  t h e  c u l t u r e  w a s  t r a n s f e r r e d  t o  
a n o t h e r  c u l t u r e  f l a s k  a s  a c o n t r o l .  2 0 y i l  o f  1M I P TG 
w a s  a d d e d  t o  o n e  f l a s k  o f  2 0 m l  c u l t u r e .  B o t h  f l a s k s  
w e r e  s h a k e n  a t  3 7 ° C  f o r  t h e  r e q u i r e d  t i m e  (1 h r ,  2 h r  
o r  4 h r ) .
l m l  o f  c u l t u r e  f r o m  e a c h  f l a s k  w a s  t r a n s f e r r e d  
i n t o  a n  E p p e n d o r f  t u b e .  The  t u b e s  w e r e  c e n t r i f u g e d  i n  
a n  E p p e n d o r f  c e n t r i f u g e  f o r  5 m i n .  S u p e r n a t a n t  w a s  
r e m o v e d  b y  a s p i r a t i o n .  T h e  c e l l  p e l l e t  w a s  
r e s u s p e n d e d  i n  9 0 y l  o f  l y s i s  b u f f e r .  1 0 y l  o f  h o t  20% 
SDS w a s  a d d e d  a n d  m i x e d  w e l l .  T h e  s a m p l e  w a s  b o i l e d  
a t  1 0 0 ° C  f o r  5 m i n  b e f o r e  l o a d i n g  o n t o  a 15% 
p o l y a c r y l a m i d e - S D S  g e l  ( L a e m m l i ,  1 9 7 0 ) .
T h e  r e s t  o f  t h e  c u l t u r e  w a s  p r e p a r e d  f o r  t h e
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biological assay of IL-3. 20ml of induced or 
uninduced culture was centrifuged in an SS34 rotor at 
5000rpra, 0°C for 5 min. The supernatant was collected 
in a small bottle and retained for the biological 
assay of IL-3. The cell pellet was resuspended in 1ml 
of 10m M Tris-HCl, pH7.2, 30 m M NaCl, lmg/ml BSA and 
lmg/ml lysozyme. The sample was transferred to a 10ml 
Sorvall centrifuge tube and kept on ice for 30 min. 
The sample was sonicated until clear in an ice-water 
bath and centrifuged at 20,000rpm, 0°C for 30 min. 
The supernatant of the cell extract was collected in 
an Eppendorf tube for the biological assay of IL-3.
4.10 Induction of mILM6 in coli.
A phage stock of mILM6 was prepared with a titer 
of ”5 x 1 0 ^ 0  /ml. The host, SG1606, was grown in 40ml 
LB medium to a Klett value of 80 (~2xl0^ cells/ml). 
mILM6 phage stock was added to the culture to a 
multiplicity of infection equal to 100. The phage was 
allowed to adsorb the host at 37°C for half an hour. 
The infected culture was then divided into 2 flasks. 
2 0 u 1 of 1M IPTG was added to one flask. Both flasks 
were shaken at 37°C for the required time (1 hr, 2 hr 
or 4 hr).
Samples for analysis on 15% po1yacry1amide-SDS 
gel and for biological assay of IL-3 were prepared as
in Method 4.9.
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4.11 Construction of IY103 by transduction.
SG1095 was grown in Z medium overnight. 0.1ml of 
PI phage (■'10^0/ml) was mixed with 0.2ml of overnight 
culture of SG1095 and plated in 3ml of Z 
top agar. After incubation at 37°C overnight, the 
top agar harvested from 5 plates was resuspended in 
10ml Z medium with 0.2ml chloroform. It was vortexed 
for 5 min and c e n t r i f u g e d  in an SS34 rotor at 
15,000rpm, 4°C for 30 min. The supernatant was stored 
over a drop of chloroform.
RB791 was grown in Z medium overnight. 20ml of 
the overnight RB791 culture was centrifuged in an SS34 
rotor at 5000r pm , 4°C for 5 min. The cell pellet was 
resuspended in 2ml Z medium. For the transduction 
experiment, 0.2ml of concentrated RB791 cells, 1ml PI 
phage prepared from SG1095 and 4ml Z medium were mixed 
well and kept at 37°C for 20 min. The c o n tr o l  
experiment was done without the PI phage. After 
incubation the cells were centrifuged in an SS34 rotor 
at 5,000rpm, 4°C for 5 min and the cell pellet was 
resuspended in 1ml of 1M sodium citrate. 9ml LB 
medium was added and the cells were grown at 37°C for 
2 generations (~4 hr). The cells were centrifuged in 
an SS34 rotor at 5,000rpm, 4°C for 5 min and the cell 
pellet was resuspended in 1ml of (1X)56 medium. 0.1ml 
of the cells was plated on each agar plate containing
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t e t r a c y c l i n e  ( 2 5 u g / m 1 )  a n d  i n c u b a t e d  a t  3 7 ° C  
o v e r n i g h t .  T e t r a c y c l i n e  r e s i s t a n t  a n d  m u c o i d  c o l o n i e s  
w e r e  i s o l a t e d .
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V. R e s u l t s .
1 .  C o n s t r u c t i o n  o f  p I LM4.
pSV2 - n e o  i s  a s h u t t l e  v e c t o r  w h i c h  c a n  r e p l i c a t e  
i n  b o t h  e u k a r y o t i c  c e l l s  a n d  i n  E.  c o 1 i  ( S o u t h e r n  a n d  
B e r g  1 9 8 2 ) .  Any cDNA c l o n e d  i n t o  t h e  H i  n d 1 1 1  s i t e  o f  
p S V p - n e o  c a n  be  e x p r e s s e d  i n  t h e  COS c e l l  s y s t e m  u n d e r  
t h e  c o n t r o l  o f  t h e  SV40 e a r l y  p r o m o t e r .
T h e  I L - 3  cDNA i n s e r t  i n  p I L M 3  w a s  t h e r e f o r e  
c l o n e d  i n t o  t h e  H i n d I I I  s i t e  o f  t h e  p S V 2 - n e o  a s  s h o w n  
i n  F i g u r e  4 . 4 .  The  I L - 3  c o d i n g  s e q u e n c e  wa s  r e s e c t e d  
f r o m  p l a s m i d  p I L M - 3  by d i g e s t i o n  w i t h  t h e  r e s t r i c t i o n  
e n d o n u c l e a s e s  P s t I  a n d  N c o l  ( M e t h o d  3 . 3 ) ,  t h e  f r a g m e n t  
p u r i f i e d  by a g a r o s e  g e l  e l e c t r o p h o r e s i s  a n d  r e c o v e r e d  
u s i n g  DEAE m e m b r a n e  ( M e t h o d  4 . 1 ) .  T h e  f r a g m e n t  w a s  
ma d e  b l u n t - e n d e d  u s i n g  t h e  K l e n o w  f r a g m e n t  o f  EL_ c o l i  
DNA p o l y m e r a s e  I  ( M e t h o d  4 . 2 )  a n d  l i g a t e d  w i t h  pSV2 ~ 
n e o w h i c h  h a d  b e e n  l i n e a r i z e d  by d i g e s t i o n  w i t h  
H i n  d 1 1 1  r e s t r i c t i o n  e n d o n u c l e a s e ,  m a d e  b l u n t - e n d e d  
( M e t h o d  4 . 2 )  a n d  d e p h o s p h o r y l a t e d  w i t h  c a l f  i n t e s t i n a l  
a l k a l i n e  p h o s p h a t a s e  ( M e t h o d  3 . 4 ) .  T h e  l i g a t e d  DNA 
w a s  t r a n s f o r m e d  i n t o  EL_ c o l i  HB101 a n d  a m p i c i l l i n  
r e s i s t a n t  c o l o n i e s  w e r e  s e l e c t e d .  S m a l l  s c a l e  p l a s m i d  
p r e p a r a t i o n s  o f  a m p i c i l l i n  r e s i s t a n t  c l o n e s  w e r e  
p r e p a r e d  ( M e t h o d  3 . 2 a ) ,  t h e  DNA d i g e s t e d  w i t h  Ba m HI  
r e s t r i c t i o n  e n d o n u c l e a s e  a n d  e x a m i n e d  by a g a r o s e  g e l  
e l e c t r o p h o r e s i s .  C l o n e s  g i v i n g  t h e  e x p e c t e d  2 




ES 1 - Nco 1 frogmen) 
ligoled Z blunt ended 
pSVj neo plLM-4
Eil l /  Nco
G -C  toilG -C  toil
G—C toil
I 1 restriction site lost
F i g u r e  4 . 4  C o n s t r u c t i o n  o f  SV4 0  e x p r e s s i o n  v e c t o r  
c a r r y i n g  t h e  I L - 3  g e n e .  I L - 3  cDNA i n s e r t  w a s  r e s e c t e d  
f r o m  pI LM3 by d i g e s t i o n  w i t h  P s t I  a n d  N c o l  r e s t r i c t i o n  
e n d o n u c l e a s e s .  The  P s t I - N c o l  f r a g m e n t  wa s  ma d e  b l u n t -  
e n d e d  a n d  l i g a t e d  w i t h  p S V 2 - n e o w h i c h  h a d  b e e n  
d i g e s t e d  w i t h  H i n  d 1 1 1  r e s t r i c t i o n  e n d o n u c l e a s e  a n d  
a l s o  m a d e  b l u n t - e n d e d  ( S e e  R e s u l t s ) .  A f t e r  
t r a n s f o r m a t i o n  i n t o  H B 1 0 1 ,  r e c o m b i n a n t  p l a s m i d s  
c a r r y i n g  t h e  I L - 3  cDNA i n  t h e  c o r r e c t  o r i e n t a t i o n  w e r e  
i d e n t i f i e d  by r e s t r i c t i o n  a n a l y s i s .
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restriction endonuclease and examined by agarose gel 
electrophoresis. One of these clones, designated 
pILM4, had the IL-3 cDNA sequence arranged in the same 
orientation as the direction of transcription from the 
SV40 early promoter and showed the predicted 1615 base 
pair fragment.
Plasmid DNA was prepared from pILM4 on a large 
scale by the rapid boiling method and then purified on 
a CsC1-ethidium bromide gradient (Method 4.4). The 
purified pILM4 plasmid DNA was used in the experiments 
on the expression of IL-3 in X e n o p u s 1ae vis oocytes 
nuclei and in monkey Cos-1 cells.
2. Microinjection of the pILM4 DNA into the nucleus 
of Xenopus laevis oocytes.
It was of interest to determine if pILM4 could be 
expressed in the oocyte nucleus. 30nl of lyg/pl pILM4 
DNA was injected into the nucleus or injected into the 
cytoplasm of Xenopus laevis oocytes (Method 4.5). 20 
oocytes from each injection were incubated in 10]_i 1 of 
oocyte incubation medium at 20° for 48 hr. The oocyte 
incubation medium was then centrifuged for 15 min at 
4°C. The supernatant was assayed for IL-3 activity as 
described in Method 2.7. The results (Table 4.1) 
showed that the IL-3 cDNA in pILM4 could be 
transcribed and translated to give biologically active 
IL-3 when it was injected into the nucleus of Xeno pus
Table 4.1 Nuclear injection of pILM4 into X_;_ 1 a e v i s 
oocytes .






Purified plasmid, pILM4, DNA was injected into the 
nucleus or the cytoplasm of the Xenopus laevis oocytes 
(Method 4.5). After 48 hrs the incubation medium was 
harvested and assayed for IL-3 activity using an IL-3 
dependent cell line (Method 2.7) * Maximum activity 
in the IL-3 assay was 42,250 c.p.m. using WEHI-3B 
conditioned medium.
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1 a e v i  s o o c y t e s ,  b u t  n o t  w h e n  i n j e c t e d  i n t o  t h e  
c y t o p l a s m .  T h e  e x p r e s s i o n  o f  t h e  I L - 3  g e n e  i n  t h e  
o o c y t e  n u c l e u s  w i l l  be  o f  i n t e r e s t  i n  c o n n e c t i o n  w i t h  
f u t u r e  e x p e r i m e n t s  on  t h e  r e g u l a t i o n  o f  I L - 3  g e n e  
e x p r e s s i o n  ( s e e  D i s c u s s i o n ) .
3.  E x p r e s s i o n  o f  t h e  I L - 3  g e n e  i n  m o n k e y  c e l l s  a n d  
b i o l o g i c a l  p r o p e r t i e s  o f  r e c o m b i n a n t  I L - 3 .
T h e s e  e x p e r i m e n t s  w e r e  d o n e  i n  c o l l a b o r a t i o n  w i t h  
Dr .  A n d r e w  H a p e l ,  D e p a r t m e n t  o f  M e d i c i n e  a n d  C l i n i c a l  
S c i e n c e ,  JCSMR a n d  D r s .  G. J o h n s o n  a n d  D. M e t c a l f ,  
W a l t e r  a n d  E l i z a  H a l l  I n s t i t u t e  f o r  M e d i c a l  R e s e a r c h ,  
M e l b o u r n e .
T h e  e x p r e s s i o n  o f  t h e  I L - 3  cDNA c l o n e  i n  m o n k e y  
COS c e l l s  w a s  t h e  m o s t  c o n v e n i e n t  way  o f  p r o d u c i n g  
m o d e r a t e  a m o u n t s  o f  a ’ r e c o m b i n a n t ’ I L - 3  w h i c h  w a s  
c l o s e l y  r e l a t e d  t o  a u t h e n t i c  m a t u r e  I L - 3 .  T h e  
’ r e c o m b i n a n t ’ I L - 3  s e c r e t e d  f r o m  COS c e l l s  w o u l d  b e  
e x p e c t e d  t o  be  c o r r e c t l y  p r o c e s s e d  w i t h  r e s p e c t  t o  t h e  
s i g n a l  p e p t i d e  a n d  t o  b e  a p p r o p r i a t e l y  g l y c o s y l a t e d .  
T h i s  m a t e r i a l  c o u l d  t h e r e f o r e  be  u s e d  t o  e s t a b l i s h  t h e  
r a n g e  o f  b i o l o g i c a l  a c t i v i t i e s  p o s s e s s e d  by I L - 3 .
The  e x p r e s s i o n  p l a s m i d  p I LM4 wa s  t r a n s f e c t e d  i n t o  
mo n k e y  COS-1 c e l l s  t o  a l l o w  r e p l i c a t i o n  a n d  e x p r e s s i o n  
o f  t h e  I L - 3  g e n e .  C u l t u r e  s u p e r n a t a n t s  w e r e  c o l l e c t e d  
p e r i o d i c a l l y  a f t e r  t r a n s f e c t i o n  a n d  a s s a y e d  f o r  I L - 3
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activity using the IL-3 dependent cell line 32Dcl-23. 
Maximal activity was achieved 72 hr after transfection 
(Figure 4.5). No activity was detected when COS-1 
cells were transfected with the parent vector pSV 2 ~ 
neo. The culture supernatants, collected 72 hr after 
transfection with pILM4, were used in a variety of 
biological assays as described below. Analogous 
material collected 72 hr after transfection with pSV2 ~ 
neo was used as a control.
In some cases assays were also carried out using 
partially-purified expressed IL-3 which was partially 
purified by c h r o m a t o g r a p h y  on D E AE-S e p h a c e 1 and 
phenyl-Sepharose. The expressed IL-3 showed the same 
chromatographic properties as the IL-3 from the WEHI- 
3B cell line and the procedure resulted in a 
purification of at least 10,000 fold compared with the 
starting material.
Expressed IL-3 supported the growth of the IL-3 
dependent cell lines 32Dcl-23 and FDC-P1. The 32Dcl- 
23 line consistently gave a 4 to 8 fold higher titre 
with the expressed IL-3 than the FDC-P1 cell line. 
This has also been observed with IL-3 from WEHI-3B 
conditioned medium (Hapel et al., 1984).
Expressed IL-3 also ’induced’ 20a-SDH in splenic 
lymphocytes from nu-nu mice in a standard assay as 
p r e v i o u s l y  d e s c r i b e d  (Ihle et al., 1981).
o0 8  g H 1 I I 1.
2 4 6 8 10 12 14
TIME (days) AFTER TRANSFECTION
Figure 4.5 Production of IL-3 by COS-1 cells 
transfected with pILM4. COS-1 cells were seeded at 5 x 
10°/60mm petri dish in DMEM 10% FCS and transfected 
with pILM4 using the calcium phosphate precipitation 
and glycerol shock technique. Cells were washed, fed 
with DMEM 10% FCS (5mls/dish) and incubated at 37°C in 
a humidified atmosphere containing 5% COo. Media were 
replaced every 24 hours and tested for IL-3 activity 
(proliferation of 32D cl-23 cells). The data plotted 
were obtained at a dilution of 1/8. The dotted lines 
designated (a) and (b) represent incorporation of 100% 
and background plus three standard deviations 
respectively.
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S u p e r n a t a n t s  f r o m  COS - 1  c e l l s  t r a n s f e c t e d  w i t h  t h e  
p a r e n t  v e c t o r  p S V 2 ~ n e 0  s h o w e d  no d e t e c t a b l e  a c t i v i t y  
i n  a s s a y s  w i t h  t h e  I L - 3  d e p e n d e n t  c e l l s  o r  i n  t h e  
i n d u c t i o n  o f  2 0 a  -  S D H. T h e  t i t r e s  ( E D ^ q / iiiI )  f o r  2 0 a -  
SDH i n d u c t i o n  w e r e  t h e  s a m e  a s  f o r  g r o w t h  f a c t o r  
a c t i v i t y  on FDC-P1 c e l l s  w h e r e a s  t h e  t i t r e  f o r  g r o w t h  
f a c t o r  a c t i v i t y  on 3 2 D c l - 2 3  wa s  s o me  4 f o l d  h i g h e r .
T h e  e x p r e s s e d  I L - 3  a l s o  s u p p o r t e d  t h e  g r o w t h  o f  
’ P T c e l l s  ( S c h r a d e r  1 9 8 1 ) .
Me d i u m f r o m  COS c e l l s  t r a n s f e c t e d  w i t h  p I LM4 wa s  
a b l e  t o  s t i m u l a t e  t h e  f o r m a t i o n  f r o m  f e t a l  l i v e r  c e l l s  
o f  t y p i c a l  d a y  2 e r y t h r o i d  c o l o n i e s .  T h i s  c o n d i t i o n e d  
m e d i u m  w a s  a b l e  t o  s u s t a i n  a n d / o r  e l e v a t e  l e v e l s  o f  
e r y t h r o i d  ( B F U - E )  a n d  n o n - e r y t h r o i d  ( G M - C F C )  
p r o g e n i t o r  c e l l s  i n  s u s p e n s i o n  c u l t u r e s  o f  f e t a l  l i v e r  
c e l l s ,  a p r o p e r t y  o f  m a t e r i a l s  c o n t a i n i n g  I L - 3 .
T i t r a t i o n  o f  t h e  t e n f o l d  c o n c e n t r a t e  o f  p I L  M 4 -  
t r a n s f e c t e d  COS c e l l  c o n d i t i o n e d  me d i u m on c u l t u r e s  o f  
a d u l t  m a r r o w  c e l l s  e s t a b l i s h e d  t h a t  t h e  CSF l e v e l s  
w e r e  4 0 0  u n i t s  p e r  0 . 1 m l ,  b a s e d  o n  g r a n u l o c y t e -  
m a c r o p h a g e  c o l o n y  f o r m a t i o n .  I n  t h e  a n a l y s i s  o f  t h e  
c o l o n i e s  d e v e l o p i n g  i n  a d u l t  m a r r o w  c u l t u r e s  
c o n t a i n i n g  0 . 1 ml  o f  c o n c e n t r a t e d  c o n d i t i o n e d  me d i u m,  
i t  w a s  o b s e r v e d  t h a t  g r a n u l o c y t e ,  g r a n u l o c y t e /  
m a c r o p h a g e  a n d  m a c r o p h a g e  c o l o n i e s  d e v e l o p e d  a n d  i n  
a d d i t i o n ,  l o w  n u m b e r s  o f  t y p i c a l  m e g a k a r y o c y t e  a n d  
e o s i n o p h i l  c o l o n i e s .  A l s o  d e v e l o p i n g  w e r e  t h e
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d i s p e r s e d  c o l o n i e s  o f  c a n d i d a t e  N K - l i k e  c e l l s  ( C l a e s o n  
e t  a l . , 1 9 8 2 )  t h a t  a r e  c h a r a c t e r i s t i c a l l y  s t i m u l a t e d  
by  WE H I - 3 B  c o n d i t i o n e d  m e d i u m  a n d  by SCM ( p o k e w e e d  
m i t o g e n - s t i m u l a t e d  s p l e e n  c o n d i t i o n e d  me d i u m)  ( D j e u  e t  
a l . ,  1 9 8 3 ;  M e t c a l f  e t  a l . ,  1 9 6 9 ;  M e t c a l f  e t  a l . ,  
1 9 7 4 ) .  I n  c u l t u r e s  c o n t a i n i n g  4 0 0  u n i t s  o f  I L - 3  
p u r i f i e d  f r o m  W E H I - 3 B  c o n d i t i o n e d  m e d i u m ,  a n  
e s s e n t i a l l y  s i m i l a r  d i s t r i b u t i o n  o f  c o l o n y  t y p e s  wa s  
o b s e r v e d .
A d d i t i o n  o f  m e d i u m  c o n d i t i o n e d  by p e r i t o n e a l  
c e l l s  h a s  b e e n  r e p o r t e d  t o  e n h a n c e  m e g a k a r y o c y t e  
c o l o n y  f o r m a t i o n  s t i m u l a t e d  by I L - 3  ( W i l l i a m s  e t  a l . ,  
1 9 8 2 ) .  Whe n  0 . 1 m l  o f  p e r i t o n e a l  c e l l  c o n d i t i o n e d  
m e d i u m  w a s  a d d e d  t o  c u l t u r e s  o f  m a r r o w  c e l l s ,  no  
m e g a k a r y o c y t e  c o l o n i e s  d e v e l o p e d  b u t  i n  c u l t u r e s  
c o n t a i n i n g  a m i x t u r e  o f  p e r i t o n e a l  c e l l  c o n d i t i o n e d  
m e d i u m  a n d  p I L M 4 - C 0 S  c e l l  c o n d i t i o n e d  m e d i u m ,  
m e g a k a r y o c y t e  n u m b e r s  r o s e  t o  8% o f  t o t a l  c o l o n i e s  a n d  
w e r e  i n c r e a s e d  i n  a v e r a g e  s i z e .
I n  a g a r  c u l t u r e s  o f  12 d a y  CBA f e t a l  l i v e r  c e l l s ,  
p I L M 4  t r a n s f e c t e d  COS c e l l  c o n d i t i o n e d  m e d i u m  
s t i m u l a t e d  t h e  f o r m a t i o n  o f  g r a n u l o c y t e  a n d / o r  
m a c r o p h a g e ,  e o s i n o p h i l ,  m e g a k a r y o c y t e  a n d  p u r e  a n d  
m i x e d  e r y t h r o i d  c o l o n i e s .  T h e  v a r i o u s  c o l o n y  t y p e s  
w e r e  s i m i l a r  t o  t h o s e  s t i m u l a t e d  by I L - 3  p u r i f i e d  f r o m  
WEHI - 3B c o n d i t i o n e d  me d i u m.  A d e t a i l e d  c o m p a r i s o n  o f  
t h e  e r y t h r o i d  c e l l  c o n t e n t  o f  m i x e d  c o l o n i e s  a n d  o f
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the hemoglobinization of the erythroid cells in pure 
and mixed-erythroid colonies indicated that purified 
IL-3 from WEHI-3B conditioned medium was a relatively 
w e a k  s t i m u l u s  for e r y t h r o i d  cell p r o l i f e r a t i o n  and 
h e m o g 1 o b i n i z a t i o n  c o m p a r e d  w i t h  the s i z e  and 
hemoglobinization of the erythroid colonies stimulated 
by SCM. This characteristic has been noted previously 
in a c o m p a r i s o n  of I L - 3  p u r i f i e d  f r o m  W E H I - 3 B  
c o n d i t i o n e d  m e d i u m  versus that purif i e d  from SCM 
(Cutler, R.L., Metcalf, D., Johnson, G.R. and Nicola, 
N.A., u n p u b l i s h e d  data) and it was of inter e s t  that 
the erythroid colonies stimulated by pILM4-transfected 
COS cell c o n d i t i o n e d  m e d i u m  also were of s m a l l  size 
and exhibited incomplete hemoglobinization.
Thus the recombinant IL-3 possessed the range of 
biological activities appropriate for a multi-lineage 
haemopoietic growth factor and these activities were 
in b r o a d  a g r e e m e n t  w i t h  t h o s e  c l a i m e d  f o r  
biochemically purified IL-3 (see Discussion).
4. Construction of pILM5.
Although the p IL M 4 transfected monkey COS-1 cells 
yielded s u f f i c i e n t  ’r e c o m b i n a n t *  mu r i n e  IL-3 for 
initial determination of the biological properties of 
I L - 3  it w a s  of i n t e r e s t  w i t h  r e s p e c t  to f u t u r e  
r e s e a r c h  to try and obtain e x p r e s s i o n  of IL-3 in E .
coli .
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T h e  I L - 3  cDNA w a s  f i r s t  e x p r e s s e d  i n  c o 1 i
u n d e r  t h e  c o n t r o l  o f  t h e  t a c  p r o m o t e r  u s i n g  t h e  pDR540
e x p r e s s i o n  v e c t o r .  T h e  s t r a t e g y  o f  c o n s t r u c t i n g  t h e
I L - 3  e x p r e s s i o n  p l a s m i d  i s  s h o w n  i n  F i g u r e  4 . 6 .  T h e
5 7 0  b a s e  p a i r  H p a 11 f r a g m e n t  c o n t a i n i n g  t h e  I L - 3
c o d i n g  s e q u e n c e  s t a r t i n g  w i t h  t h e  a m i n o  a c i d  n u m b e r  32
( A r g i n i n e ) ,  w a s  i s o l a t e d  a f t e r  d i g e s t i o n  o f  p I LM3 w i t h  
r e s t r i c t i o n
H p a 11 a n d  H p h I  ^  e n d o n u c l e a s e s  u s i n g  a g a r o s e
g e l  e l e c t r o p h o r e s i s  a n d  DEAE m e m b r a n e  ( M e t h o d  4 . 1 ) .  
Two c o m p l e m e n t a r y  o l i g o n u c l e o t i d e  p r i m e r s ,  P 2 2  ( 5 ’ 
GATC ATG TCA ATC AGT GGC3 1 ) a n d  P 2 3  ( 5 T CG GCC ACT GAT
O  1
TGA CAT0 1 ) w e r e  s y n t h e s i z e d .  T h e y  w e r e  a n n e a l e d  t o  
f o r m  a s h o r t  l i n k e r  w i t h  Ba m HI  a n d  H p a 11  " s t i c k y  
e n d s " .  The  H p a l I  f r a g m e n t  w a s  t h e n  l i g a t e d  w i t h  t h i s  
s h o r t  l i n k e r  a n d  t h e  BamHI d i g e s t e d  pDR540 i n  a m o l a r  
r a t i o  o f  1 : 1 0 0 : 1  r e s p e c t i v e l y  a n d  t r a n s f o r m e d  i n t o  
J M 1 0 1 .  T h e  u s e  o f  l a r g e  a m o u n t  o f  l i n k e r  w a s  t o  t r y  
a n d  e n s u r e  t h e  i s o l a t i o n  o f  c o n s t r u c t s  h a v i n g  b o t h  t h e  
l i n k e r  a n d  t h e  I L - 3  i n s e r t .
620  a m p i c i l l i n  r e s i s t a n t  c l o n e s  w e r e  s c r e e n e d  by 
c o l o n y  h y b r i d i z a t i o n  ( M e t h o d  3 . 9 )  u s i n g  a s i n g l e -  
s t r a n d e d  DNA p r o b e  c o p i e d  f r o m  mILM5 t e m p l a t e  ( M e t h o d  
4 . 6 ) .  mILM5 i s  a r e c o m b i n a n t  o f  M13mp9 c o n t a i n i n g  t h e  
P s t l - N c o l  f r a g m e n t  o f  I L - 3  cDNA ( F i g u r e  4 . 3 ) .  25 
c l o n e s  w e r e  f o u n d  t o  c o n t a i n  t h e  I L - 3  cDNA s e q u e n c e .  
P l a s m i d  DNA p r e p a r a t i o n s  o f  t h e s e  c l o n e s  w e r e  p r e p a r e d  




Ligated with linker 
GATC ATG TCA ATC AGT GGC




Figure 4.6 C on s tr u ct io n of pILM5. The H p aII 
fragment containing the complete IL-3 coding sequence 
was isolated from pILM3 and joined to the Ba m HI 
linearized pDR540 with a synthetic linker. After 
transformation into JM101, recombinant plasmids 
carrying the IL-3 insert were identified by colony 
hybridization. The positive clones carrying the IL-3 
insert in the correct orientation were identified by 
restriction analysis.
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s h o w n  i n  F i g u r e  4 . 7 .  I n  t h i s  c o n s t r u c t  t h e  I L - 3  
c o d i n g  s e q u e n c e  s t a r t s  w i t h  m e t h i o n i n e  a n d  t h e n  
r e s i d u e  28 ( S e r i n e ,  F i g u r e  4 . 7 ) .  T h e  s p a c i n g  b e t w e e n  
t h e  r i b o s o m e  b i n d i n g  s i t e  a n d  t h e  s t a r t i n g  c o d o n  ATG 
w a s  2 b a s e  p a i r s  m o r e  t h a n  t h e  o r i g i n a l  s p a c i n g  i n  t h e  
l a c  UV5 p r o m o t e r  ( F i g u r e  4 . 2 ) .
6 .  C o n s t r u c t i o n  o f  mILM6.
I L - 3  w a s  a l s o  e x p r e s s e d  i n  b a c t e r i a  a s  a f u s e d  
p o l y p e p t i d e  by c l o n i n g  t h e  I L - 3  s e q u e n c e  i n  P s 1 1 s i t e  
o f  M1 3 mp 9  i n  p h a s e  w i t h  t h e  3 - g a 1 a c t o s i d a s e  r e a d i n g  
f r a m e .  The  s t r a t e g y  i s  s h o w n  i n  F i g u r e  4 . 8 .  The  I L - 3  
c o d i n g  s e q u e n c e  s t a r t i n g  w i t h  a m i n o  a c i d  n u m b e r  27  
( A l a n i n e ,  F i g u r e  4 . 8 )  was  r e s e c t e d  f r o m  p l a s m i d  p I LM3 
b y  d i g e s t i o n  w i t h  H_ i n _ d I I I  a n d  N c o I  r e s t r i c t i o n  
e n d o n u c l e a s e s  a n d  t h e  f r a g m e n t  p u r i f i e d  by a g a r o s e  g e l  
e l e c t r o p h o r e s i s  a n d  DEAE m e m b r a n e  ( M e t h o d  4 . 1 ) .  T h e  
f r a g m e n t  w a s  t h e n  m a d e  b l u n t - e n d e d  u s i n g  t h e  K l e n o w  
f r a g m e n t  o f  EL_ c o l i  DNA p o l y m e r a s e  I ,  g i v i n g  o n e  e x t r a  
b a s e  p a i r  b e f o r e  t h e  c o d o n  f o r  A l a n i n e .  T h e  v e c t o r  
M 1 3 m p 9  w a s  d i g e s t e d  w i t h  £  s_ _t I  r e s t r i c t i o n  
e n d o n u c l e a s e .  The  3'  p r o t r u d i n g  e nd  w a s  r e m o v e d  u s i n g  
T4  DNA p o l y m e r a s e  ( M e t h o d  4 . 3 ) ,  a n d  t h e  M 1 3 m p 9  
f r a g m e n t  w a s  t h e n  t r e a t e d  w i t h  c a l f  i n t e s t i n a l  
a l k a l i n e  p h o s p h a t a s e  ( M e t h o d  3 . 4 ) .  1 0 n g  o f  t h e  
H i n d l l l - N c o l  I L - 3  f r a g m e n t  wa s  l i g a t e d  w i t h  1 5 0 n g  o f  
t h e  M1 3 mp 9  f r a g m e n t  a n d  t r a n s f o r m e d  i n t o  J M 1 0 1 .  
T e m p l a t e s  w e r e  p r e p a r e d  f r o m  24 o f  t h e  w h i t e  p l a q u e s
t ac promoter M S  I S G R D T H R L
...... AGGAAACAGGATC ATG TCA ATC AGT GGC CGG GAT ACC CAC CGT TTA
SD
Figure 4.7 DNA sequence of the junction between the 
tac promoter in pDR540 and the IL-3 sequence. The DNA 
sequence of the junctions were determined by plasmid 
sequencing using the chain termination method (Method 
4.7). The encoded amino acid sequence is shown in the one letter code.
M13mp9 plLM3
L A A G
TTG GCT GCA^GGT 
AAC CCyV CGT CCA
Pst I
A S I
A*AGCT TCA ATC............ C*CATGG
TTCGAaAGT TAG*........... GGTACC
l_________________T___ | |________________T |
Hind ill •
cut with Pst I
made blunt ended by 
T4 DNA polymerase




double digested with 
Hind III and Nco I
filled in with Klenow fragment 
of E.coli DNA polymerase I
t
AGCT TCA ATC......CCATG
TCGA AGT TAG GGTAC
__________ I
ligated and transformed into JM101
L A A S wl
TTG GCA GCT TCA A T C ......CCATG GGT-
■AAC CGT CGA AGT T A G .... -GGTAC CCA-
mlLM6
F i g u r e  4 . 8  C o n s t r u c t i o n  o f  mI L M6 .  T h e  H i n d l l l - Nco  I  
f r a g m e n t  c o n t a i n i n g  t h e  I L - 3  c o d i n g  s e q u e n c e  w a s  
i s o l a t e d  f r o m  p I L M3  a n d  m a d e  b l u n t - e n d e d  u s i n g  t h e  
K l e n o w  f r a g m e n t  o f  JL_ c o 1 i  DNA p o l y m e r a s e  I .  T h e  
f r a g m e n t  w a s  l i g a t e d  t o  t h e  P s 1 1 l i n e a r i z e d  M1 3 mp 9  
w h i c h  h a d  b e e n  m a d e  b l u n t - e n d e d  u s i n g  T4  DNA 
p o l y m e r a s e  a nd  d e p h o s p h o r y l a t e d  u s i n g  c a l f  i n t e s t i n a l  
a l k a l i n e  p h o s p h a t a s e .  A f t e r  t r a n s f o r m a t i o n  t o  J M1 0 1  
t h e  r e c o m b i n a n t  p h a g e s  c a r r y i n g  t h e  I L - 3  c o d i n g  
s e q u e n c e  i n  t h e  c o r r e c t  o r i e n t a t i o n  w e r e  i d e n t i f i e d  by 
a n n e a l i n g  w i t h  t h e  mI LM5 t e m p l a t e  ( Me t h o d  4 . 8 ) .
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obtained (Method 3.6a). The templates of these clones 
were annealed to the template of mILM5 and examined on 
agarose gel electrophoresis (Method 4.8). Since the 
IL-3 coding sequence in mILM5 is in the opposite 
direction to the direction of the transcription of the 
lac promoter in M13mp9, any clones annealing with 
mILM5 should have the IL-3 coding sequence arranged in 
the direction of the transcription of the lac promoter 
in M13mp9. 3 clones could be annealed with the mILM5 
templated (Figure 4.9).
The DNA sequence of the junctions between the IL - 
3 coding sequence and M13mp9 of these 3 clones were 
determined by the chain termination method using the 
internal primer, P24 and the universal primer 
described by Duckworth et al. (1981). Only one of the 
clones (designate pILM6) showed a sequence in which 
the IL-3 coding sequence was in phase with the $- 
galatosidase of the M13mp9 (Figure 4.10). In this 
construct the IL-3 would be expressed as a fusion 
polypeptide with 9 extra amino acids in front of the 
IL-3 amino acid sequence, starting with residue 27 
(Alanine, Figure 4.10).
7. Expression of IL-3 from pILM5 in different hosts.
It is well established that eukaryotic proteins 
expressed in c o 1 i are often unstable due to 
proteolytic cleavage by endogenous proteases. In an
Figure 4.9 Test for orientation of IL-3 coding 
inserts by annealing with raILM5. In lanes, 1, 3, 5, 
7, 9 and 11 recombinant single stranded templates were 
annealed with the single stranded template of mILM5 
while in lanes 2, 4, 6, 8, 10 and 12 the corresponding 
recombinant single stranded templates were self- 
annealed. In lanes 3, 7 and 11 the template of the 
tested clones has hybridized to the mILM5 template 
forming slower migrating partially doub1e- stranded 





5' M T M I T P S L A
......AGCT ATG ACC ATG ATT ACG CCA AGC TTG GCA
A S I S G R D T H R L  
GCT TCA ATC AGT GGC CGG GAT ACC CAC CGT TTA
T R T L N C S S I V K 3 '  
ACC AGA ACG TTG AAT TGC AGC TCT ATT GTC AAG-**
( d )





F i g u r e  4 . 1 0  DNA s e q u e n c e  o f  t h e  j u n c t i o n s  b e t w e e n  t h e  
I L - 3  i n s e r t  a n d  t h e  M13rap9 v e c t o r  i n  t h e  r e c o m b i n a n t  
p h a g e  mI L M6 .  ( a )  a n d  ( b ) ,  A u t o r a d i o g r a p h s  o f  t h e  
s e q u e n c i n g  g e l  s h o w i n g  t h e  DNA s e q u e n c e  o f  t h e  
j u n c t i o n s  a t  t h e  s t a r t i n g  c o d o n  a n d  t h e  t e r m i n a t i o n  
c o d o n  o f  t h e  I L - 3  i n s e r t  r e s p e c t i v e l y .  T h e  DNA 
s e q u e n c e  w a s  d e t e r m i n e d  by t h e  c h a i n  t e r m i n a t i o n  
m e t h o d  ( Me t h o d  3 . 6 ) .  Th e  d i r e c t i o n  o f  e l e c t r o p h o r e s i s  
w a s  f r o m  t o p  t o  b o t t o m .  ( c ) ,  T h e  DNA s e q u e n c e  
c o m p l e m e n t a r y  t o  t h a t  r e a d  f r o m  ( a ) .  T h e  p r e d i c t e d  
a m i n o  a c i d  s e q u e n c e  i s  s h o w n  i n  t h e  o n e - l e t t e r  c o d e .  
Th e  I L - 3  c o d i n g  s e q u e n c e  i s  f u s e d  w i t h  t h e  N - t e r m i n a l  
s e q u e n c e  o f  3 - g a l a c t o s i d a s e  a n d  s t a r t s  a t  a m i n o  a c i d  
n u m b e r  1 0  ( A l a n i n e ) .  ( d ) ,  T h e  DNA s e q u e n c e  
c o m p l e m e n t a r y  t o  t h a t  r e a d  f r o m  ( b ) .  G l u t a m a t e  ( E)  
a n d  C y s t e i n e  (C)  a r e  t h e  l a s t  t w o  a m i n o  a c i d s  o f  I L - 3 .  
TAA ( * )  i s  t h e  t e r m i n a t i o n  c o d o n .
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attempt to overcome this problem protease-deficient 
strains are often used. The most commonly employed 
strains are deficient in the Ion protease (Gottesman 
et al., 1981) and in the present work a Ion strain 
(SG1606) which carries a mini TnlO insertion in the 
Ion gene, was used. This strain was kindly provided 
by Dr. S. Gottesman, NIH. The Ion ::Tnl01D46 allele 
was also transferred to strain RB791 by transduction 
using P1KC phage (Method 4.11) to give straing IY103. 
The two Ion strains, SG1606 and IY103, were used 
together with JM101 as hosts for the expression of 
pILM5. Both JM101 and SG1606 have a 1 acIQ mutation 
carried on an F prime factor (Messing, 1983). IY103 
carries a chromosomal 1 acI^ mutation. In all three 
strains the tac promoter of pILM5 should be repressed 
by the overproduced lac repressor under normal 
conditions.
Induction was achieved by the addition of ImM 
IPTG to cells in early log phase (2xl0^cells/ml). The 
efficiency of induction was checked using the parental 
vector pDR540 in which expression of galactokinase is 
under the control of the _t_a c_ promoter. In all three 
strains a prominent new protein band of MW approx 
38,000 was evident in the cell extracts after 
induction (Figure 4.14) indicating efficient induction 
under the conditions used.
Controls were also done to check if IL-3 activity
Figure 4.14 SDS/PAGE analysis of cell extracts from 
different host strains carrying pDR540. Lanes are: 
(1) and (2), JM101; (3) and (4), SG1606; (5) and (6),
IY103. The extracts in lanes 1, 3 and 5 were from
cells induced with IPTG whereas those in lanes 2, 4 
and 6 were from uninduced cells. For induction, 1 m M 
IPTG was added to cells in early log phase (2x10° 
cells/ml) and growth was continued at 37°C. After 2 
hr induction the cell extracts were prepared and 
analyzed on a 15% polyacrylamide-SDS gel (Method 4.9). 
The size markers are indicated by ► (X1000). The
new band arising from the induction with IPTG is 
m a r k e d  w i t h  an a r r o w .  T h e  d i r e c t i o n  of 
electrophoresis is from top to bottom.
1 2 3  4  5 6
Ü If +• ff *2 JJ
17.2
14 .3
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c o u l d  be  r e a d i l y  d e t e c t e d  i n  i n d u c e d  c e l l  e x t r a c t s  a n d  
c u l t u r e  s u p e r n a t a n t s .  WEHI - 3B c o n d i t i o n e d  me d i u m wa s  
m i x e d  w i t h  a n  e q u a l  v o l u m e  o f  c e l l  e x t r a c t  f r o m  J M101  
a n d  I L - 3  a c t i v i t y  d e t e r m i n e d .  I t  i s  c l e a r  f r o m  t h e  
r e s u l t s  t h a t  h i g h  l e v e l s  o f  b a c t e r i a l  c e l l  e x t r a c t  
i n h i b i t  t h e  I L - 3  a s s a y  ( F i g u r e  4 . 1 1 ) ,  b u t  t h a t  t h e  
i n h i b i t i o n  d i s a p p e a r s  p r o g r e s s i v e l y  w i t h  d i l u t i o n .  
T h u s ,  a l t h o u g h  i t  i s  n o t  p o s s i b l e  t o  m e a s u r e  l o w  
l e v e l s  o f  I L - 3  i n  b a c t e r i a l  c e l l  e x t r a c t s ,  l e v e l s  o f  
a c t i v i t y  c o m p a r a b l e  t o  t h o s e  f o u n d  i n  W E H I - 3 B  
c o n d i t i o n e d  m e d i u m  c a n  b e  r e a d i l y  d e t e c t e d  ( F i g u r e  
4 . 1 2 ) .  I n  s i m i l a r  e x p e r i m e n t s  i t  w a s  f o u n d  t h a t  
b a c t e r i a l  c u l t u r e  s u p e r n a t a n t s  d i d  n o t  i n h i b i t  t h e  I L -  
3 a s s a y  ( F i g u r e  4 . 1 3 ) .
S i n c e  t h e  i n d u c t i o n  o f  t h e  t a c  p r o m o t e r  a p p e a r e d  
t o  b e  e f f i c i e n t  a n d  t h e  a s s a y  o f  I L - 3  i n  b a c t e r i a l  
e x t r a c t s  w a s  s a t i s f a c t o r y ,  a t t e m p t s  w e r e  m a d e  t o  
e x p r e s s  I L - 3  f r o m  p I L M5  i n  t h e  h o s t  s t r a i n s  J M 1 0 1 ,  
S G 1 6 0 6  a n d  I Y 1 0 3 .  p I L M5  w a s  i n d u c e d  by t h e  a d d i t i o n  
o f  1 mM I P T G  t o  c e l l s  i n  e a r l y  l o g  p h a s e  ( 2 x 1 0 ^  
c e l l s / m l ) .  T h e  c e l l s  a n d  c u l t u r e  s u p e r n a t a n t  w e r e  
h a r v e s t e d  a t  d i f f e r e n t  t i m e s  a f t e r  i n d u c t i o n .  C e l l  
e x t r a c t s  a n d  c u l t u r e  s u p e r n a t a n t s  w e r e  p r e p a r e d  
( M e t h o d  4 . 9 )  a n d  a s s a y e d  f o r  I L - 3  a c t i v i t y  ( M e t h o d  
2 . 7 )  .
The  r e s u l t s  ( T a b l e  4 . 2 )  s h o w e d  t h a t  b i o l o g i c a l l y




F i g u r e  4 . 11  The  i n h i b i t o r y  e f f e c t  o f  t h e  c e l l  e x t r a c t  
o n  t h e  I L - 3  a s s a y .  E_^  c o 1 i  ( J M 1 0 1 )  c e l l  e x t r a c t  w a s  
p r e p a r e d  a s  d e s c r i b e d  i n  M e t h o d  4 . 9 ,  m i x e d  w i t h  a n  
e q u a l  v o l u m e  o f  WEHI - 3B c o n d i t i o n e d  me d i u m a n d  a s s a y e d  
f o r  I L - 3  a c t i v i t y  a s  d e s c r i b e d  i n  M e t h o d  2 . 7 .  
S y m b o l s :  •  , WE H I - 3 B  c o n d i t i o n e d  m e d i u m  + a s s a y
d i l u e n t  ( 1 : 1 ) ;  □ , WEHI - 3B c o n d i t i o n e d  me d i u m + c e l l
e x t r a c t  ( 1 : 1 ) .  T h e  b r o k e n  l i n e  ( a )  r e p r e s e n t s  















F i g u r e  4 . 1 2  I L - 3  a c t i v i t y  a s s a y  o f  t h e  c e l l  e x t r a c t  
f r o m  SG1606  c a r r y i n g  p I LM5 a f t e r  2 h r s  i n d u c t i o n .  The  
p l a s m i d  w a s  i n d u c e d  by  t h e  a d d i t i o n  o f  ImM I P T G t o  
c e l l s  i n  e a r l y  l o g  p h a s e  ( 2 x 1 0 ^  c e l l s / m l ) .  T h e  c e l l  
e x t r a c t  wa s  p r e p a r e d  a n d  a s s a y e d  f o r  I L - 3  a c t i v i t y  a s  
d e s c r i b e d  i n  M e t h o d s  4 . 9  a n d  2 . 7  r e s p e c t i v e l y .  
S y m b o l s :  •  , WEHI - 3B c o n d i t i o n e d  me d i u m;  □ ,  c e l l
e x t r a c t  f r o m  S G 1 6 0 6  c a r r y i n g  p I L M 5 .  T h e  b r o k e n  l i n e  
( a )  r e p r e s e n t s  t h e  b a c k g r o u n d  p l u s  t h r e e  t i m e s  





F i g u r e  4 . 1 3  I L - 3  a c t i v i t y  o f  c u l t u r e  s u p e r n a t a n t s  
f r o m  I Y1 0 3  c a r r y i n g  p I LM5 a f t e r  4 h r s  i n d u c t i o n .  The  
p l a s m i d  w a s  i n d u c e d  by  t h e  a d d i t i o n  o f  ImM I P T G  t o  
c e l l s  i n  e a r l y  l o g  p h a s e  ( 2 x 1 0 ®  c e l l s / m l ) .  T h e  
c u l t u r e  s u p e r n a t a n t  a f t e r  4 h r  i n d u c t i o n  wa s  p r e p a r e d  
a n d  a s s a y e d  f o r  I L - 3  a c t i v i t y  a s  d e s c r i b e d  i n  M e t h o d s  
4 . 9  a n d  2 . 7  r e s p e c t i v e l y .  S y m b o l s :  •  , WE H I - 3 B  
c o n d i t i o n e d  m e d i u m ;  □ , c u l t u r e  s u p e r n a t a n t  I Y 1 0 3  
c a r r y i n g  p I L M 5 .  T h e  b r o k e n  l i n e  ( a )  r e p r e s e n t s  t h e  
b a c k g r o u n d  p l u s  t h r e e  s t a n d a r d  d e v i a t i o n s .
T a b l e  4 . 2  
s t r a i n s
E x p r e s s i o n  o f  I L - 3  i n  d i f f e r e n t  E.  c o l i
V e c t o r h o s t no i n d u c t i o n  
2 h r
T i me 
1 h r
a f t e r  
2 h r
i n d u c t i o n  
4 h r
p DR5 4 0 J M1 0 1 C. E. ND - ND ND
p DR- p H1 J M101 C . E . ND - ND ND
pILM5 JM101 C . E . 128 - 445 ND
p ILM5 SGI  606 C . E . ND - 2 1 , 6 2 0 2 , 3 5 0
s u p . 12 - 25 39
pILM5 I Y 103 C . E . ND 2 8 , 526 2 4 , 8 3 0 1 , 6 6 0
s u p . 73 68 111 97
mILM6 SG 1606 C . E . ND - 1 7 , 5 6 0 3 2 , 7 7 0
s u p  . ND — — 194
T h e  c e l l s  w e r e  g r o w n  i n  LB m e d i u m  t o  2 x 1 0 ^  c e l l s / m l .  
The  t a c  p r o m o t e r  i n  pI LM5 o r  l a c UV5  p r o m o t e r  i n  mILM6 
w a s  t h e n  i n d u c e d  by t h e  a d d i t i o n  o f  ImM I P TG a s  
d e s c r i b e d  i n  M e t h o d s  4 . 9  a n d  4 . 1 0 .  C e l l s  o r  c u l t u r e  
s u p e r n a t a n t  w e r e  h a r v e s t e d  a t  d i f f e r e n t  t i m e s  a f t e r  
i n d u c t i o n  a n d  w e r e  p r e p a r e d  a s  d e s c r i b e d  i n  Me t h o d  4 . 9  
a n d  a s s a y e d  f o r  I L - 3  a c t i v i t y  a s  d e s c r i b e d  i n  M e t h o d  
2 . 7 .  T h e  I L - 3  a c t i v i t y  i s  p r e s e n t e d  i n  e n d  p o i n t  
u n i t s .  T h i s  i s  t h e  r e c i p r o c a l  o f  t h e  d i l u t i o n  w h e r e  
t h e  t i t r a t i o n  c u r v e  o f  I L - 3  a c t i v i t y  m e e t s  t h e  
b a s e l i n e  l e v e l  o f  b a c k g r o u n d  p l u s  3 s t a n d a r d  
d e v i a t i o n s .  F o r  c o m p a r i s o n  t h e  a v e r a g e  I L - 3  a c t i v i t y  
i n  WEHI - 3B c o n d i t i o n e d  me d i u m was  2 , 4 6 0  u n i t s / m l .
ND,  n o  d e t e c t a b l e  a c t i v i t y .  C . E . ,  c e l l  e x t r a c t ,  
s u p . ,  c u l t u r e  s u p e r n a t a n t .
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JM101. This indicated that g1ycosy1 ation is not 
essential for biological activity and that expression 
in bacteria is feasible. Some expressed IL-3 was 
detected in uninduced cell extracts of JM101 but no 
expressed IL-3 could be detected after induction with 
IPTG in the cell extracts of JM101 carrying either the 
parent vector pDR540 or pDR-pHl which carries the IL-3 
gene in the wrong orientation for expression.
Much higher levels of expressed IL-3 were 
obtained with the Ion strains SG1606 and IY103 after 2 
hrs induction, presumbaly due to the greater stability 
of IL-3 in strains defective for the Ion protease. 
However the levels of IL-3 activity after 4 hrs 
induction were only about one tenth of those after 2 
hrs induction, suggesting that IL-3 was still being 
degraded in the Ion strains. The levels of IL-3 
activity 2 hr post induction were about 10-fold higher 
than typical WEHI-3B conditioned medium. If the 
bacterial recombinant IL-3 has a normal specific 
activity these levels would indicate that even at 2 
hrs after induction only a small amount of IL-3 
protein was produced. In agreement with this 
prediction, no new bands were evident after induction 
when the cell extracts were examined by SDS/PAGE using 
15% polyacrylamide gels (Figure 4.15). However, the 
large number of protein bands in the region of 
interest make it likely that the IL-3 protein would
Figure 4.15 SDS/PAGE analysis of cell extracts from 
different host strains carrying pILM5 or mILM6. Lanes 
are: (1) and (2), p I L M 5 / J M 1 0 1 ;  (3) and (4), 
pILM5/SG1606; (5) and (6), pILM5/IY103; (7) and (8), 
m I L M 6/SG 1 606. The extracts in lanes 1, 3, 5 and 7 
were from cells induced with ImM IPTG whereas those in 
lanes 2, 4, 6 and 8 were from uninduced cells. 
Strains carrying pILM5 were induced by the addition of 
ImM IPTG to cells in early log phase (2x10° cells/ml) 
and growth was continued at 37°C. Phage mILM6 was 
transfected SG1606 cells in early log phase and was 
induced by the addition of ImM IPTG (Method 4.10). 
After 2 hr induction cell extracts were prepared and 
analyzed on a 15% polyacrylamide-SDS gel (Method 4.9). 
The size markers are indicated by ► (X1000). The 
direction of electrophoresis is from top to bottom.
4 0 .0 - 
3 4 .6  ►
17 .2 -
14 .3 -
1 2  3 4
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o n l y  be  d e t e c t e d  i f  i t  w e r e  p r o d u c e d  i n  h i g h  l e v e l s .  
A s a m p l e  o f  c e l l s  f r o m  t h e  i n d u c e d  c u l t u r e s  w a s  
e x a m i n e d  t o  t e s t  f o r  l o s s  o f  t h e  p l a s m i d  a f t e r  
i n d u c t i o n .  T h e  r e s u l t s  ( T a b l e  4 . 3 )  i n d i c a t e  t h a t  a 
h i g h  p r o p o r t i o n  o f  t h e  c e l l s  s t i l l  p o s s e s s e d  t h e  
p l a s m i d  pI LM5 i n  t h e s e  e x p e r i m e n t s .
T h e  l o w e r  t h a n  e x p e c t e d  e x p r e s s i o n  o f  I L - 3  f r o m  
t h e  t  a c p r o m o t e r  c o u l d  h a v e  b e e n  d u e  t o  o n e  o r  a 
n u m b e r  o f  t h e  f o l l o w i n g  f a c t o r s : -  ( 1)  d e g r a d a t i o n  o f  
t h e  e x p r e s s e d  I L - 3 ,  ( 2 )  p o o r  t r a n s c r i p t i o n  d u e  t o  t h e  
p r e s e n c e  o f  t r a n s c r i p t i o n  t e r m i n a t i o n  s i g n a l s  i n  t h e  
I L - 3  c o d i n g  s e q u e n c e ,  ( 3 )  p o o r  t r a n s l a t i o n  d u e  t o  
c o d o n  u s a g e ,  s u b o p t i m a l  r i b o s o m e  b i n d i n g  s i t e  s p a c i n g  
o r  t h e  s e q u e n c e  u s e d  a r o u n d  t h e  i n i t i a t i o n  c o d o n .  Due 
t o  t h e  l i m i t e d  t i m e  a v a i l a b l e  i n  t h e  p r e s e n t  w o r k  
t h e s e  p o s s i b i l i t i e s  w e r e  n o t  i n v e s t i g a t e d  i n  d e t a i l  
a n d  i t  w a s  d e c i d e d  t o  t r y  t h e  e x p r e s s i o n  o f  a f u s i o n  
p r o t e i n .
8 .  E x p r e s s i o n  o f  I L - 3  f r o m  mILM6 i n  SG1 6 0 6 .
G o o d  l e v e l s  o f  t r a n s l a t i o n  a n d  i n c r e a s e d  
s t a b i l i t y  o f  e x p r e s s e d  p r o t e i n  c a n  s o m e t i m e s  b e  
a c h i e v e d  by j o i n i n g  t h e  c o d i n g  s e q u e n c e  f o r  t h e  
p r o t e i n  o f  i n t e r e s t  t o  t h e  r i b o s o m e  b i n d i n g  s i t e  a n d  
N - t e r m i n a l  c o d i n g  s e q u e n c e  o f  a b a c t e r i a l  g e n e .  I n  
t h e  M13 v e c t o r  mI L M6 ,  t h e  I L - 3  c o d i n g  s e q u e n c e  f r o m  
r e s i d u e  n u m b e r  27 ( A l a n i n e )  w a s  j o i n e d  t o  t h e  3 -
Table 4.3 Stability of pILM5 following IPTG induction 
of various host strains
% of cells carrying pILM5
Time after 
induction JM101 SGI 606 IY103
0 hr 100% 100% 100%
2 hr 100% 92% 100%
4 hr 96% 88% 96%
pILM5 in different host strains was grown in LB medium 
at 37°C to 2x10^ cell/ml. IPTG was added to ImM final 
concentration and the cells grown at 37°C. Samples 
were taken out at 0 hr, 2 hr and 4 hr after induction, 
serial dilutions prepared and plated on LB agar plates 
with and without ampicillin.
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g a l  a c t  o s i  d a s e g e n e  s u c h  t h a t  t h e  f i r s t  9 r e s i d u e s  o f  
t h e  e x p r e s s e d  p r o t e i n  w e r e  f r o m  3 - g a l a c t o s i d a s e .
o
S G 1 6 0 6  w a s  g r o w n  t o  e a r l y  l o g  p h a s e  ( 2 x 1 0  
c e l l s / m l )  a n d  i n f e c t e d  w i t h  m I L M 6  p h a g e  a t  a 
m u l t i p l i c i t y  o f  i n f e c t i o n  o f  1 0 0 .  T h e  p h a g e  w a s  
a l l o w e d  t o  a b s o r b  on  t h e  c e l l s  f o r  30  m i n  a t  3 7 ° C  a n d  
t h e n  i n d u c e d  w i t h  ImM I PTG ( Me t h o d  4 . 1 0 ) .  The  r e s u l t s  
( T a b l e  4 . 2 )  s h o w e d  t h a t  t h e  e x p r e s s e d  I L - 3  l e v e l  i n  
t h e  c e l l  e x t r a c t  a f t e r  4 h r  p o s t  i n d u c t i o n  i s  r o u g h l y  
t w i c e  t h a t  p r e s e n t  a f t e r  2 h r  i n d u c t i o n .  T h i s  
i n d i c a t e s  t h a t  t h e  h y b r i d  3 - g a l a c t o s i d a s e - I L - 3  
p o l y p e p t i d e  i s  m o r e  s t a b l e  i n  c o 1 i  t h a n  t h e  n o n ­
f u s i o n  I L - 3  p o l y p e p t i d e .
9 .  F u t u r e  p o s s i b i l i t i e s  f o r  e x p r e s s i o n  o f  I L - 3 .
The  e n h a n c e d  s t a b i l i t y  o f  t h e  I L - 3  f u s i o n  p r o t e i n  
s u g g e s t s  t h a t  a f u s i o n  p r o t e i n  s t r a t e g y  c o u l d  b e  t h e  
m o s t  s u c c e s s f u l  f o r  I L - 3  e x p r e s s i o n  i n  c o 1 i .
R e c e n t  e x p e r i m e n t s  by  Dr .  S.  C l a r k  o f  B i o t e c h n o l o g y  
A u s t r a l i a  h a v e  s h o wn  t h a t  g o o d  l e v e l s  o f  a c t i v i t y  c a n  
be  o b t a i n e d  u s i n g  a s i m i l a r  f u s i o n  s t r a t e g y  t o  t h a t  o f  
mI LM6  b u t  u s i n g  v e c t o r  pUC9.  I n  t h i s  c a s e  t h e  l e v e l  
o f  e x p r e s s i o n  h a s  i n c r e a s e d  t o  t h e  p o i n t  w h e r e  a n e w 
b a n d  o f  MW a b o u t  17K c a n  be  s e e n  i n  c e l l  e x t r a c t s  
a n a l y z e d  by SDS/ PAGE.
A n o t h e r  i n t e r e s t i n g  f u s i o n  a p p r o a c h  w h i c h  w o u l d  
y i e l d  I L - 3  w i t h o u t  a f o r e i g n  N - t e r m i n a l  s e q u e n c e  w o u l d
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be to use the strategy of Nagai and Thogersen (1984). 
In this strategy the protein of interest was fused to 
the A c11 protein with a factor X recognition signal 
peptide (ILe-Glu-Gly-Arg). The expressed hybrid 
protein can, therefore, be cleaved by factor Xa just 




To confirm the identity of the cloned cDNA as 
that encoding murine IL-3, the cDNA insert in pILM3 
was ligated into PSV2 -n e o such that it was under the 
control of the SV40 early promoter. This construct 
was then expressed in monkey COS-1 cells and in 
X e n o p u s oocytes. Biologically active IL-3 was 
produced in both cases. The expression of the IL-3 
gene in the oocyte nucleus provides a potentially 
useful assay for future studies on the regulation of 
the IL-3 gene. Expression of the IL-3 gene in the 
monkey COS-1 cell system allowed sufficient 
recombinant IL-3 to be produced to determine its 
biological properties. IL-3 produced in the pIL M 4 
transfected COS cells was indistinguishable from that 
of the IL-3 produced by WEHI-3B cells in terms of its 
chromatographic properties on DEAE Sephacel and 
phenylsepharose. The recombinant IL-3 not only 
supported the growth of the IL-3 dependent cell lines 
32Dcl-23 and FDC-P1 but also induced 20aSDH in splenic 
lymphocytes from nu-nu mice. The expressed IL-3 also 
showed a multilineage hemopoietic growth factor 
activity. It supported the growth of T P ’ cells and 
s timulated p roliferation and differentiation of 
granulocyte, granu1ocyte/macrophag e , macrophage, 
eosinophil, megakaryocyte and erythroid cells.
The IL-3 cDNA was also expressed in E. co 1 i as a
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r a a t u r e  p r o t e i n  s t a r t i n g  w i t h  t h e  a m i n o  a c i d  n u m b e r  28 
( S e r i n e )  o r  a s  a f u s e d  p o l y p e p t i d e  w i t h  a n  e x t r a  9 
a m i n o  a c i d s  a n d  s t a r t i n g  w i t h  t h e  a m i n o  a c i d  n u m b e r  27 
( A l a n i n e ) .  I n  b o t h  c a s e s ,  t h e  e x p r e s s e d  I L - 3  w a s  
b i o l o g i c a l l y  a c t i v e .  T h i s  i n d i c a t e d  t h a t  
g l y c o s y l a t i o n  i s  n o t  e s s e n t i a l  f o r  b i o l o g i c a l  a c t i v i t y  
a n d  t h a t  e x p r e s s i o n  i n  b a c t e r i a  i s  f e a s i b l e .  The  I L - 3  
e x p r e s s e d  f r o m  p I L M5  a p p e a r s  t o  be  l e s s  s t a b l e  t h a n  
t h e  I L - 3  f u s i o n  p o l y p e p t i d e  p r o d u c e d  u s i n g  mI LM6 
( T a b l e  4 . 2 ) .  T h e  b a c t e r i a l  e x p r e s s i o n  e x p e r i m e n t s  
c a r r i e d  o u t  s o  f a r  i n d i c a t e  s e v e r a l  p o t e n t i a l l y  u s e f u l  
f u t u r e  s t r a t e g i e s  f o r  e n h a n c e d  I L - 3  e x p r e s s i o n .
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Chapter 5 - General Discussion
5.1 Application of recombinant DNA techniques to the 
study of IL-3.
Lymphokines and hemopoietic growth factors are 
produced in minute amounts by cells and are active at 
very low concentrations (approx. 10_ ^-^M). The 
purification of these factors by conventional 
biochemical methods is therefore quite difficult and 
it is not easy to completely rule out the possibility 
of contamination with other factors. The isolation of 
cDNA clones encoding these proteins is a valuable 
complementary approach and enables definition of 
factors from their protein sequences. Production of 
recombinant lymphokines and hemopoietic growth factors 
in eukaryotic and prokaryotic systems on a large scale 
allows wide ranging biological studies to be carried 
out including clinical trials in the case of human 
lymphokines.
The work described in this thesis is an attempt 
to apply recombinant DNA techniques to the study of 
IL-3. An assay for murine IL-3 mRNA was developed 
using microinjection in Xenopus laevis oocytes. This 
enabled purification of IL-3 mRNA, construction of a 
cDNA library and the isolation of a cDNA clone for IL- 
3. The cDNA clone was expressed in monkey COS cells 
using an SV40 expression vector providing recombinant
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IL-3 for biological studies. Preliminary studies were 
also carried out concerning the expression of IL-3 in 
E , coli.
A short time after the work described in this 
thesis was published (Fung et al., 1984) a report 
appeared describing the isolation of a cDNA clone for 
a murine mast cell growth factor (Yokota et al., 1984) 
from a cDNA library prepared from a T cell line of 
C57BL/6 origin. The DNA sequences of the IL-3 cDNA 
clone described in the present work and that of the 
MCGF cDNA clone are virtually identical except for 1 
nucleotide difference at position 463. It is 
therefore clear that the MCGF cDNA actually encodes 
IL-3, which is known to have MCGF activity and this 
was subsequently verified in biological studies of 
recombinant factor produced using the MCGF cDNA clone 
( R e n n i c k  et al., 1985; H a p e l  et al., 1985a; 
Greenberger et al., in Press).
A detailed study of the biological activity of 
recombinant IL-3 purified from pILM4 transfected COS-1 
cells (see Chapter 4) was made in collaboration with 
Dr. A. Hapel and Dr. D. Metcalf and his colleagues 
(Hapel et al., 1985a). The studies with recombinant 
IL-3 provide strong support for the proposal that the 
biological activities previously reported under the 
names of IL-3, BPA, PSF, MCGF, HCGF, HCSF and multi- 
CSF can be attributed to a single factor and that IL-3
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i s  a r a u l t i l i n e a g e  CSF ( S c h r a d e r  a n d  H a p e l ,  1 9 8 5 ) .
The  w o r k  d e s c r i b e d  i n  C h a p t e r  4 on t h e  e x p r e s s i o n  
o f  I L - 3  i n  c o 1 i  e s t a b l i s h e d  t h a t  b i o l o g i c a l l y  
a c t i v e  I L - 3  c o u l d  b e  p r o d u c e d  i n  E_^_ c o  1 i  i n d i c a t i n g  
t h a t  g 1 y c o s y 1 a t i o n  i s  n o t  e s s e n t i a l  f o r  a c t i v i t y .  
T h i s  w o r k  h a s  b e e n  e x t e n d e d  i n  c o l l a b o r a t i o n  w i t h  
B i o t e c h n o l o g y  A u s t r a l i a  a n d  p u r i f i e d  b a c t e r i a l  
r e c o m b i n a n t  I L - 3  c a n  now be  p r e p a r e d  i n  mg q u a n t i t i e s .  
T h i s  s h o u l d  g r e a t l y  a s s i s t  f u t u r e  b i o l o g i c a l  s t u d i e s  
i n c l u d i n g  t h o s e  o f  t h e  I L - 3  r e c e p t o r  ( P a l a s y n s k i  a n d  
I h l e ,  1 9 8 4 ) .
The  a v a i l a b i l i t y  o f  cDNA c l o n e s  f o r  I L - 3  h a s  a l s o  
e n a b l e d  t h e  i s o l a t i o n  o f  t h e  m u r i n e  I L - 3  g e n e ,  b o t h  i n  
t h i s  l a b o r a t o r y  a n d  e l s e w h e r e  ( C a m p b e l l  e t  a l . ,  198 5 ;  
M i y a t a k e  e t  a l . ,  1 9 8 5 ) .  L i k e  t h e  g e n e s  f o r  I L - 2 ,  y -  
I FN a n d  GM- CSF ( F u j i t a  e t  a l . ,  1 9 8 3 ;  G r a y  e t  a l . ,  
1 9 8 2 ;  G o u g h  e t  a l . ,  1 9 8 4 ) ,  t h e  I L - 3  g e n e  e x i s t s  a s  a 
s i n g l e  c o p y  i n  t h e  h a p l o i d  g e n e .  T h e  I L - 3  g e n e  
c o n t a i n s  f o u r  i n t r o n s  i n t e r r u p t i n g  t h e  c o d i n g  
s e q u e n c e .  A s h o r t  t a n d e m  r e p e a t  i s  f o u n d  i n  i n t r o n  2 
w h i c h  s h a r e s  e x t e n s i v e  h o m o l o g y  w i t h  a n  e n h a n c e r  f o u n d  
i n  h u m a n  g e n o m e .  E i g h t  o u t  o f  n i n e  r e p e a t s  f o r m  a 7 3 -  
bp d u p l i c a t e d  s e q u e n c e  a n d  e a c h  7 3 - b p  r e p e a t  c o n t a i n s  
s e q u e n c e s  h o m o l o g o u s  t o  t h e  c o r e  s e q u e n c e  s u g g e s t e d  
f o r  e n h a n c e r  e l e m e n t s .  I n  a d d i t i o n ,  a G + C - r i c h  r e g i o n  
i s  f o u n d  i n  t h e  5* f l a n k i n g  r e g i o n  ( C a m p b e l l  e t  a l . ,  
1 9 8 5 ;  M i y a t a k e  e t  a l . ,  1 9 8 5 ) .  D e t e r m i n a t i o n  o f  t h e
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s t r u c t u r e  o f  t h e  m u r i n e  I L - 3  g e n e  s e r v e s  a s  a b a s i s  
f o r  f u r t h e r  s t u d i e s  c o n c e r n i n g  t h e  r e g u l a t i o n  o f  I L - 3  
e x p r e s s i o n  a n d  g e n e  r e a r r a n g e m e n t s  g i v i n g  a l t e r e d  I L - 3  
e x p r e s s i o n .
I n t e r e s t i n g  p o s s i b i l i t i e s  f o r  f u t u r e  w o r k  i n v o l v e  
g e n e  t r a n s f e r  e x p e r i m e n t s  u s i n g  r e t r o v i r a l  v e c t o r s .  
A l s o  i s o l a t i o n  a n d  e x p r e s s i o n  o f  a cDNA c l o n e  f o r  
h u m a n  I L - 3  s h o u l d  e n a b l e  s t u d i e s  on  p o t e n t i a l l y  
i m p o r t a n t  c l i n i c a l  a p p l i c a t i o n s  o f  h u ma n  I L - 3  i n  b o n e  
ma r r o w  t r a n s p l a n t a t i o n .
5 . 2  R e c e n t  a d v a n c e s  i n  t h e  m o l e c u l a r  b i o l o g y  o f  o t h e r  
l y m p h o k i n e s .
T h e  i s o l a t i o n  o f  cDNA c l o n e s  a n d  t h e  r e s p e c t i v e  
g e n e s  f o r  h u m a n  y - I F N  a n d  h u m a n  I L - 2  ( G r a y  e t  a l . ,  
1 9 8 2 ;  D e v o s  e t  a l . ,  1 9 8  2 ;  N i s h i  e t  a l . ,  1 9 8 5 ;  
T a n i g u c h i  e t  a l . ,  1 9 8 3 ;  C l a r k  e t  a l . ,  1 9 8 4 ;  D e v o s  e t  
a l . ,  1 9 8 3 ;  F u j i t a  e t  a l . ,  1 9 8 3 ;  D e g r a v e  e t  a l . ,  1 9 8 3 ;  
G r a y  a n d  G o e d d e l ,  1 9 8 3 ;  T a y a  e t  a l . ,  1 9 8 2 ;  M a e d a  e t  
a l . ,  1 9 8 3 )  w a s  d e s c r i b e d  i n  t h e  I n t r o d u c t i o n .  M o r e  
r e c e n t l y ,  cDNA c l o n e s  h a v e  b e e n  i s o l a t e d  f o r  m u r i n e  y -  
I FN ( G r a y  e t  a l . ,  1 9 8 3 ) ,  m u r i n e  I L - 2  ( Y o k o t a  e t  a l . ,  
1 9 8 5 ;  K a s h i m a  e t  a l . ,  1 9 8 5 ) ,  m u r i n e  GM- CSF ( G o u g h  e t  
a l . ,  1 9 8 4 ) ,  h u m a n  e r y t h r o p o i e t i n  ( L e e - H u a n g ,  1 9 8 4 ;  
J a c o b s  e t  a l . ,  1 9 8 5 )  a n d  h u m a n  l y m p h o t o x i n  ( G r a y  e t  
a l . ,  1 9 8 4 ) .  A l s o  cDNA c l o n e s  h a v e  b e e n  i s o l a t e d  f o r  
t h e  m o n o k i n e s ,  m u r i n e  I L - 1  ( L o m e d i c o  e t  a l . ,  1 9 8 4 )  a n d
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human IL-1 (Auron et al., 1984). Currently the field 
of lymphokine biology is being intensively studied 
using recombinant DNA methods and a considerable 
amount of this research is being done by biotechnology 
companies.
In the cases which have been examined so far 
there is only a single gene coding for each factor in 
the haploid genome. The structures of the genes for 
the lyraphokines IL-2, IL-3 and y-IFN show only limited 
homologies (Campbell et al., 1985; Degrave et al., 
1983; Fujita et al., 1983) and considerably more work 
is needed to try and understand the regulation of 
lymphokine gene expression in lymphocytes.
To date no significant homologies in primary 
amino acid sequences have been reported between the 
various haemopoietic growth factors and lymphokines 
which have been cloned. In the present work the 
program "Dragon" (Staden, 1982b) was used to compare 
the protein sequences of murine GM-CSF, murine and 
human IL-2, murine and human y-IFN, and human 
erythropoietin with that of murine IL-3. Little 
homology was detected. In the case of erythropoietin 
and IL-3 one short region of homology was detected as
shown below.
-1 5 3 -
125 138
murine IL-3 D D F R K K L R F Y M V H L
•* •* * -x- -x- -x- *
human erythropoietin D T F R K L F R V Y S N F L
1 6 3  176
Thus even though some factors like GM-CSF and IL-3 
have biological activities in common, the haemopoietic 
growth factors and lymphokines all appear to be unique 
and don't belong to a family of related protein 
sequences.
5.3 Recent studies on the biology of IL-3.
The biological activities of IL-3 have recently 
been reviewed by Iscove and Roitsch (1985). IL-3 is 
now considered as a raultilineage hemopoietic growth 
factor. It is believed to act on the p 1 uripotentia 1 
hemopoietic progenitors and early committed precursors 
in all the hemopoietic lineages. It can induce the 
differ e n ti a t i on  and m at uration of neutrophilic 
granulocytes, macrophages, eosinophils and mast cells 
(Prystowsky et a1., 1984; Greenberger et a1., 1983;
Iscove and Roitsch, 1 985; Hapel et al. , 1 985a).
However, the maturation of erythroid and megakaryocyte 
cells require additional factors apart from IL-3 
(Iscove, 1978; Williams et al., 1981 and 1982).
The early proposal of the direct effect of IL-3 
on early T-cell differentiation (Ihle et al., 1981;
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I h l e  e t  a l . ,  1 9 8 3 b )  s e e m s  l i k e l y  t o  be  i n c o r r e c t .  One 
s o u r c e  o f  e r r o r  w a s  t h e  i n i t i a l  a s s u m p t i o n  t h a t  t h e  
e n z y m e ,  2 0 a S D H , t h e  i n d u c t i o n  o f  w h i c h  w a s  t h e  
d e f i n i t i v e  a s s a y  f o r  I L - 3 ,  w a s  a s p e c i f i c  m a r k e r  o f  
t h e  T - c e l l  l i n e a g e .  I t  h a s  b e e n  s h o w n  t h a t  20aSDH i s  
e x p r e s s e d ,  n o t  o n l y  i n  T l y m p h o c y t e s ,  b u t  a l s o  i n  
m y e l o i d  c e l l s ,  i n c l u d i n g  m a c r o p h a g e s  ( H a p e l  e t  a l . ,  
1 9 8 5 b ) .  F u r t h e r m o r e ,  t h e  2 0 a S DH c a n  b e  i n d u c e d  ( i )  
i n  n u / n u  s p l e e n  a n d  i n  n o r m a l  f e t a l  l i v e r  c e l l s  by GM-  
CSF,  ( i i )  i n  l o n g e r  t e r m  c u l t u r e s  o f  f e t a l  l i v e r  a n d  
a d u l t  m a r r o w  by M- CS F  ( H a p e l  e t  a 1 . ,  1 9 8 5 b ) ,  a n d
( i i i )  i n  f e t a l  l i v e r  a n d  n u / n u  m a r r o w  c e l l s  by h o r s e  
s e r u m  a n d  h y d r o c o r t i s o n e  ( G a r l a n d  a n d  D e x t e r ,  1 9 8 2 ) .  
I t  wa s  r e c e n t l y  r e p o r t e d  t h a t  I L - 3  e n h a n c e d  t h e  m u r i n e  
p r i m a r y  c y t o l y t i c  T l y m p h o c y t e  r e s p o n s e  t o  a l l o g e n i c  
t u m o r  c e l l s  a n d  m i g h t  b e  i n v o l v e d  i n  t h e  
d i f f e r e n t i a t i o n  o f  c y t o l y t i c  T l y m p h o c y t e s  ( C u r t s i n g e r  
a n d  F a n ,  1 9 8 4 ) .  H o w e v e r ,  t h e r e  w a s  n o  e v i d e n c e  t h a t  
I L - 3  w a s  d i r e c t l y  a c t i n g  o n  t h e  c y t o l y t i c  T 
l y m p h o c y t e s  s i n c e  a m i x t u r e  o f  s p l e e n  c e l l s  wa s  u s e d  
i n  t h e  a s s a y  a n d  t h e  r e a c t i o n  o f  I L - 3  ma y  h a v e  b e e n  a n  
i n d u c e d  e f f e c t .  I t  h a s  b e e n  r e p o r t e d  t h a t  I L - 3  
s u p p o r t s  t h e  g r o w t h  o f  m o u s e  p r e - B  c e l l  c l o n e s  
( P a l a c i o s  e t  a l . ,  1 9 8 4 ) .  H o w e v e r ,  t h e  m o n o c l o n a l  
a n t i b o d y  u s e d  t o  i d e n t i f y  p r e - B  c e l l s  wa s  k n o wn  t o  be 
n o n - s p e c i f i c .  T h e r e f o r e  t h e  p o s s i b i l i t y  o f  I L - 3  
a c t i n g  d i r e c t l y  on  T o r  B l y m p h o c y t e s  n e e d s  f u r t h e r  
i n v e s t i g a t i o n .
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Recently, Luger et al. (1985) and Frei et al. 
(1984) reported that keratinocytes and astroglia 
respectively produce a molecule with IL-3-like 
activities. If this can be confirmed by measurement 
of mRNA by Northern blots using the IL-3 cDNA probe it 
raises the interesting possibility that IL-3 is 
produced in other cell types apart from T lymphocytes 
and the WEHI-3B cells. However, the types of tissues 
that produce IL-3 in vivo is still not clear. In this 
connection future application of tissue hybridization 
methods using the IL-3 cDNA probe should greatly 
assist our understanding of the role of IL-3 i_n vivo.
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